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A B S T R A C T
Background
Personalised care planning is a collaborative process used in chronic condition management in which patients and clinicians identify
and discuss problems caused by or related to the patient’s condition, and develop a plan for tackling these. In essence it is a conversation,
or series of conversations, in which they jointly agree goals and actions for managing the patient’s condition.
Objectives
To assess the effects of personalised care planning for adults with long-term health conditions compared to usual care (i.e. forms of care
in which active involvement of patients in treatment and management decisions is not explicitly attempted or achieved).
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO, ProQuest, clinical-
trials.gov and WHO International Clinical Trials Registry Platform to July 2013.
Selection criteria
We included randomised controlled trials and cluster-randomised trials involving adults with long-term conditions where the interven-
tion included collaborative (between individual patients and clinicians) goal setting and action planning. We excluded studies where
there was little or no opportunity for the patient to havemeaningful influence on goal selection, choice of treatment or support package,
or both.
Data collection and analysis
Two of three review authors independently screened citations for inclusion, extracted data, and assessed risk of bias. The primary
outcomes were effects on physical health, psychological health, subjective health status, and capabilities for self management. Secondary
outcomes included effects on health-related behaviours, resource use and costs, and type of intervention. A patient advisory group of
people with experience of living with long-term conditions advised on various aspects of the review, including the protocol, selection
of outcome measures and emerging findings.
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Main results
We included 19 studies involving a total of 10,856 participants. Twelve of these studies focused on diabetes, three on mental health,
one on heart failure, one on end-stage renal disease, one on asthma, and one on various chronic conditions. All 19 studies included
components that were intended to support behaviour change among patients, involving either face-to-face or telephone support. All
but three of the personalised care planning interventions took place in primary care or community settings; the remaining three were
located in hospital clinics. There was some concern about risk of bias for each of the included studies in respect of one or more criteria,
usually due to inadequate or unclear descriptions of research methods.
Physical health
Nine studies measured glycated haemoglobin (HbA1c), giving a combined mean difference (MD) between intervention and control
of -0.24% (95% confidence interval (CI) -0.35 to -0.14), a small positive effect in favour of personalised care planning compared to
usual care (moderate quality evidence).
Six studies measured systolic blood pressure, a combined mean difference of -2.64 mm/Hg (95% CI -4.47 to -0.82) favouring
personalised care (moderate quality evidence). The pooled results from four studies showed no significant effect on diastolic blood
pressure, MD -0.71 mm/Hg (95% CI -2.26 to 0.84).
We found no evidence of an effect on cholesterol (LDL-C), standardised mean difference (SMD) 0.01 (95% CI -0.09 to 0.11) (five
studies) or body mass index, MD -0.11 (95% CI -0.35 to 0.13) (four studies).
A single study of people with asthma reported that personalised care planning led to improvements in lung function and asthma control.
Psychological health
Six studies measured depression. We were able to pool results from five of these, giving an SMD of -0.36 (95% CI -0.52 to -0.20), a
small effect in favour of personalised care (moderate quality evidence). The remaining study found greater improvement in the control
group than the intervention group.
Four other studies used a variety of psychological measures that were conceptually different so could not be pooled. Of these, three
found greater improvement for the personalised care group than the usual care group and one was too small to detect differences in
outcomes.
Subjective health status
Ten studies used various patient-reported measures of health status (or health-related quality of life), including both generic health
status measures and condition-specific ones. We were able to pool data from three studies that used the SF-36 or SF-12, but found no
effect on the physical component summary score SMD 0.16 (95% CI -0.05 to 0.38) or the mental component summary score SMD
0.07 (95% CI -0.15 to 0.28) (moderate quality evidence). Of the three other studies that measured generic health status, two found
improvements related to personalised care and one did not.
Four studies measured condition-specific health status. The combined results showed no difference between the intervention and
control groups, SMD -0.01 (95% CI -0.11 to 0.10) (moderate quality evidence).
Self-management capabilities
Nine studies looked at the effect of personalised care on self-management capabilities using a variety of outcome measures, but they
focused primarily on self efficacy. We were able to pool results from five studies that measured self efficacy, giving a small positive result
in favour of personalised care planning: SMD 0.25 (95% CI 0.07 to 0.43) (moderate quality evidence).
A further five studies measured other attributes that contribute to self-management capabilities. The results from these were mixed:
two studies found evidence of an effect on patient activation, one found an effect on empowerment, and one found improvements in
perceived interpersonal support.
Other outcomes
Pooled data from five studies on exercise levels showed no effect due to personalised care planning, but there was a positive effect on
people’s self-reported ability to carry out self-care activities: SMD 0.35 (95% CI 0.17 to 0.52).
We found no evidence of adverse effects due to personalised care planning.
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The effects of personalised care planning were greater when more stages of the care planning cycle were completed, when contacts
between patients and health professionals were more frequent, and when the patient’s usual clinician was involved in the process.
Authors’ conclusions
Personalised care planning leads to improvements in certain indicators of physical and psychological health status, and people’s capability
to self-manage their condition when compared to usual care. The effects are not large, but they appear greater when the intervention
is more comprehensive, more intensive, and better integrated into routine care.
P L A I N L A N G U A G E S U M M A R Y
Effects of personalised care planning for people with long-term conditions
Background
People with long-term health conditions play an important part in managing their own health. But some of the tasks involved can
be complicated, and require confidence and skill. Such tasks include taking medicines properly, monitoring symptoms, adopting or
maintaining healthy lifestyles, managing their emotions, solving practical problems, knowing when and how to seek medical advice or
community support, and coping with the impact of the condition(s) on their daily lives. Personalised care planning aims to provide
support from health professionals that is tailored to the needs of individual patients. Such support recognises patients’ concerns, and
helps them become more able to manage their own health. Personalised care planning is a conversation, or series of conversations,
between a patient and a clinician when they jointly agree on goals and actions for managing the patient’s health problems.
Review question
We carried out this systematic review to find out whether a personalised approach, in which patients are encouraged to participate in
setting goals and action plans and determining their support needs, leads to better outcomes than when these decisions are taken by
health professionals alone.
Results
We found 19 randomised trials published before July 2013 that addressed this issue, involving 10,856 participants with conditions such
as diabetes, mental health problems, heart failure, kidney disease, and asthma. The studies looked at a range of different interventions
designed to involve patients and support self management. We combined and summarised results from studies that measured similar
outcomes and found that involvement in personalised care planning probably led to small improvements in some indicators of physical
health (better blood glucose levels, lower blood pressure measurements among people with diabetes, and control of asthma). It also
probably reduced symptoms of depression, and improved people’s confidence and skills to manage their health. We observed no effect
on cholesterol, body mass index or quality of life. We found no evidence of any harms arising from personalised care planning. We
found that the process worked best when it included preparation, record-sharing, care co-ordination and review, involvedmore intensive
support from health professionals, and was integrated into routine care. However, the quality of evidence was only moderate, meaning
that further research might change these findings.
Conclusion
We concluded that personalised care planning is a promising approach that offers the potential to provide effective help to patients,
leading to better health outcomes. More research is needed to work out which aspects are most effective for specific patient groups.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Personalised care planning compared with usual care
Patient or population: Adult patients with long-term health conditions
Settings: All settings
Intervention: Personalised care planning
Comparison: Usual care or enhanced usual care
Outcomes Illustrative comparative
effect sizes* (95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Usual care (control) vs
personalised care plan-
ning (intervention)
Physical health:
blood glucose
(HbA1c)
Follow-up: 6 to 12
months
The mean difference in
blood glucose was 0.
24% lower (better) in
the intervention groups
than in the control groups
(95% CI 0.35 to 0.14
lower)
1916
(9 studies)
⊕⊕⊕©
moderate
(variation in intervention
types led to significant
heterogeneity and risk of
bias was unclear)
Physical health:
systolic blood pressure
Follow-up: 6 to 12
months
The mean difference in
systolic blood pressure
was 2.64 mm/Hg lower
(better) in the interven-
tion groups than in the
control groups (95% CI 4.
47 to 0.82 lower)
1200
(6 studies)
⊕⊕⊕©
moderate
(variation in intervention
types led to significant
heterogeneity and risk of
bias was unclear)
Physical health:
cholesterol
(LDL-C)
Follow-up: 6 to 12
months
The standardised mean
difference in LDL choles-
terol did not differ be-
tween the intervention
and control groups: 0.
01 standard deviations
(95% CI -0.09 to 0.11)
1545
(5 studies)
⊕⊕⊕©
moderate
(results were inconsis-
tent)
Psychological health:
depression
(PHQ-
9, SCL-20, Beck Depres-
sion Inventory, CES-D)
Follow-up: 1.5 to 12
months
The standardised mean
difference in depression
scores was 0.36 stan-
dard deviations lower
(better) in the interven-
tion groups than in the
control groups (95% CI 0.
52 to 0.20 lower), a small
effect in favour of person-
alised care planning
599
(5 studies)
⊕⊕⊕©
moderate
(multiple outcome mea-
sures)
In addition, 3 out of 4
studies that used con-
ceptually different mea-
sures of psychological
outcomes (and so could
not be pooled) reported
better outcomes for the
intervention groups than
the control groups. The
remaining study was too
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small to detect an effect
Subjective health status:
condition-specific
(PAID-2, Illness Intrusive-
ness, AQLQ)
Follow-up: 12 months
The standardised mean
difference in condition-
specific health status
scores did not differ be-
tween the intervention
and control groups: -0.
01 standard deviations
(95% CI -0.11 to 0.10)
1330
(4 studies)
⊕⊕⊕©
moderate
(variation in intervention
types led to significant
heterogeneity)
Three studies that mea-
sured generic health sta-
tus (SF-36 or SF-12)
found no difference be-
tween intervention and
control groups: physical
component score SMD 0.
16 (95% CI -0.05 to 0.
38); mental component
score SMD 0.07 (95% CI
-0.15 to 0.28)
Self-management capa-
bilities: self efficacy
(Stanford, SUPPH,
PCDS)
Follow-up: 1.5 to 12
months
The standardised mean
difference in self-efficacy
scores was 0.25 stan-
dard deviations higher
(better) in the interven-
tion groups than in the
control groups (95% CI 0.
07 to 0.43 higher), a small
effect in favour of person-
alised care planning
471
(5 studies)
⊕⊕⊕©
moderate
(variation in intervention
types led to significant
heterogeneity and risk of
bias was unclear)
Mixed effects were found
in 5 studies that mea-
sured other attributes that
contribute to self-man-
agement capabilities. We
also found a positive ef-
fect on performance of
self-care activities asso-
ciated with personalised
care planning, SMD 0.35
(95% CI 0.17 to 0.52)
Harms associated with
personalised care plan-
ning
Only 1 study reported any
adverse events (hospital-
isation and deaths), but
there were no differences
between intervention and
usual-care groups and no
reason to assume that
these were due to the in-
tervention
* CI: Confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
5Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
B A C K G R O U N D
Description of the condition
The treatment and management of long-term health conditions
(including those associated with physical, psychological, sensory,
or cognitive problems) is the greatest challenge facing health sys-
tems around theworld today (UN SecretaryGeneral 2011). Strate-
gies used by health professionals to engage, support and empower
people with long-term conditions have an important role in im-
proving health outcomes (George Institute 2011; Wanless 2002).
Patients who are better informed,more involved in decisions about
their care and more ’activated’ (i.e. recognise that they have an
important role in self-managing their condition(s) and have the
skills and confidence to do so) (Hibbard 2004) experience im-
proved health and better quality of life (Michie 2003; Schmittdiel
2008). Strengthening patients’ autonomy and capacity to self-
manage their health is pivotal to policymakers’ attempts to achieve
value formoney, particularly in times of economic recession. Some
policymakers hope that this may also help to tackle unacceptable
health inequalities between socioeconomic groups (Department
of Health 2009).
The Chronic Care Model, which has been highly influential in-
ternationally, stresses the need to transform health care for people
with long-termhealth conditions from a system that is largely reac-
tive, responding mainly when a person is sick, to one that is much
more proactive, focused on supporting people’s ability to self-man-
age their health (Epping-Jordan 2004;Nolte 2008;Wagner 1998).
The model advocates an active role for patients, who are encour-
aged to become both more knowledgeable about factors affecting
their condition(s) (including strategies for preventing exacerba-
tions or ameliorating symptoms), and more actively involved in
decisions about their care. The clinician’s responsibility is to gauge
the extent of the patient’s knowledge, skills and confidence to self-
manage his or her health, to strengthen this where necessary, and
to ensure that relevant interventions and support services are avail-
able (Department of Health 2011; Von Korff 1997; Year of Care
2011). At the heart of the model is an informed, active patient,
supported by a well-prepared, proactive primary care team, work-
ing together to develop and implement a personalised care plan.
The rising prevalence of multi-morbidity makes the search for
effective ways of developing personalised approaches even more
important. Demographic change and longer life expectancy mean
that increasing numbers of people have more than one chronic
condition, requiring specially tailored approaches to the manage-
ment of complex combinations of conditions and treatment strate-
gies (Barnett 2012). The specialty-led, single disease framework
that characterises the organisation of most medical care is out-
dated. Ideally, care for people with multiple long-term conditions
should be holistic: person-focused rather than disease-focused, and
responsive to individuals’ experiences of illness and treatment ef-
fects and their personal priorities (Mangin 2012).
In managing long-term health conditions, the aims are: to min-
imise the negative impacts and maximise the potential for im-
proved functioning and well-being; to strengthen people’s capa-
bilities for self-managing their condition; to reduce health risks
by improving health-related behaviours; and to minimise depen-
dence on resource-intensive, costly health services. Personalised
care planning is seen as a promising way to achieve these goals.
Description of the intervention
Personalised care planning aims to ensure that individuals’ val-
ues and concerns shape the way long-term conditions are man-
aged. Instead of focusing on a standard set of disease manage-
ment processes determined by health professionals, this approach
encourages patients to select treatment goals and to work with
clinicians to determine their specific needs for treatment and sup-
port (Reuben 2012). The process involves a shift from reactive
care (waiting for people to consult with symptoms) to a proactive
approach in which patients are invited to attend specially sched-
uled care planning consultations. For the purpose of this review,
we define personalised care planning as: an anticipatory (forward-
looking), negotiated discussion or series of discussions between a
patient and a health professional (perhaps with other professional
or family members present) to clarify goals, options and prefer-
ences and develop an agreed plan of action based on this mutual
understanding.
In personalised care planning, patients and clinicians identify and
discuss problems caused by or related to the patient’s condition(s),
giving due consideration to both clinical tests and treatments and
the practical, social, and emotional effects of their condition(s)
and treatment(s) on their daily lives. They then engage in a shared
decision-making process involving goal setting and action plan-
ning, focused on determining priorities, agreeing realistic objec-
tives, solving specific problems, and identifying relevant sources of
support. In some cases a family member, carer/caregiver or friend
may also be included in the discussion. Management options and
support needs under discussion might include any or all of the
following:
• clinical tests and treatments,
• self-management information,
• education or support,
• strategies for modifying health-related behaviours,
managing stress, or solving practical problems.
A collaborative process inwhich patient and clinician discuss treat-
ment or management goals (goal setting: see B below) and agree
a plan for tackling these (action planning: see C below) are the
essential features, but the full process may involve any of the fol-
lowing seven steps (see Figure 1):
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Figure 1. Conceptual model for the review
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• A. Preparation: the patient may be invited to a preliminary
appointment to check their progress and undergo relevant
clinical tests. Information (printed, electronic, written, or verbal)
may be provided before or during the care planning
appointment, to encourage the person to reflect on his or her
condition and situation. This might include test results, and
information about treatment options, or about health-related
behaviours such as diet, exercise or smoking.
• B. Goal setting: aimed at agreeing treatment or
management goals, the goal-setting process involves eliciting and
clarifying patients’ understanding of their condition, their values,
outcome preferences and priorities. Patients may be encouraged
to talk about their experience of living with the condition, their
beliefs and concerns, and their comprehension of, and reactions
to, the information provided.The discussion of what matters to
them may cover treatment or management options, desired
outcomes, lifestyle or behaviour changes, practical, social and
emotional challenges, and problem-solving strategies. In
personalised care planning, patients have scope to influence the
agenda for discussion, and the choice of goals and priorities is
not restricted to a prespecified list of professionally determined
options.
• C. Action planning: a plan is jointly developed for working
towards agreed goals. This may include identifying practical ways
in which the patient can achieve their behavioural goals (for
example, how and when to take more exercise), referring the
patient to external sources of support, either within formal
health services (for example, health coaching or rehabilitation
services) or in the community (for example, exercise or cookery
classes), or peer support. The plan may also include clinician-
ordered tests or treatments, referral to other clinical specialists or
professionals, educational materials or courses, access to aids or
appliances, care assistance or domestic help.
• D. Documenting: the agreed actions are usually
documented in a specially-designed record (printed, electronic,
or written) for use by the clinician(s) involved in the patient’s
care or for use by the patient as an aide-mémoire, or for both.
These may be either a single shared record, or two separate
records containing appropriate detail for clinician or patient.
• E. Co-ordinating: the clinician ensures that all tests,
treatments, interventions, education, or support packages agreed
in the action plan are available to the patient and provided in a
well-co-ordinated fashion. This may include input from multi-
disciplinary team members, from hospital- or community-based
specialists, from educationalists and other staff, or from
community organisations or support groups.
• F. Supporting: patient and clinician agree a schedule for
regular, systematic follow-up that may involve a number of
contacts (face-to-face, telephone, or electronic) to provide
appropriate support to help the patient solve problems and
achieve his or her goals. This might take the form of health
coaching, motivational support, problem solving, or simply
checking and reinforcing progress in implementing the agreed
plan.
• G. Reviewing: a meeting (face-to-face or remote) during
which patient and clinician jointly review progress and plan next
steps.
How the intervention might work
Personalised care planning aims to ensure that people receive ap-
propriate support for self-managing their condition alongside any
necessary clinical treatments from health professionals. The prin-
ciples of self management have been developed in a number of
theoretical models, mostly from the fields of psychology and be-
havioural science. They focus on understanding the factors that
shape behaviour and those that might help people make the nec-
essary adaptations to improve their health and ability to cope with
illness and disability. Of these, Bandura’s Social Cognitive Theory
(Bandura 1977), Prochaska and DiClemente’s ’Stages of Change’
trans-theoretical model (Prochaska 1992), and Leventhal’s Self-
Regulation Theory (Leventhal 1998) are most often referred to.
Taken together, these point to the importance of a sense of control
or empowerment that can give people the confidence and moti-
vation to take on and persist with new and difficult tasks. Inter-
ventions focus on confidence building and equipping individuals
with the knowledge and skills to set personal goals and develop
effective problem-solving strategies.
A commitment by both clinician and patient to shared decision
making is considered essential for personalised care planning. The
process is unlikely to succeed if either party is reluctant to par-
ticipate. In shared decision making, health professionals and pa-
tients work together to understand problems, preferred goals and
outcomes, sharing information and identifying options with the
aim of reaching mutual agreement on the best course of action
for the individual patient (Charles 1999; Elwyn 2012b; Entwistle
2012; Glasgow 2005b; Mulley 2012). This approach recognises
explicitly that it is usually appropriate to enable people to make
decisions about their care, ensuring they are well informed and
well supported in the process of deliberation and decision making.
Shared decision making takes as its starting point the notion that
two types of expertise should be involved in selecting treatment
or management options. Clinicians’ expertise is based primarily
on knowledge of the diagnosis, likely prognosis, treatment and
support options, and the range of possible outcomes based on re-
search evidence and population data; patients usually know more
about the impact of the condition on their daily life, their personal
values, preferences and attitude to risk, and the constraints they
may face in implementing any recommended behaviour changes.
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Both types of knowledge are needed tomanage illness successfully,
so both parties should be prepared to share information and take
decisions jointly.
This concept (shared decision making) has often been applied to
’acute’ or ’elective’ situations where there are choices between dis-
crete interventions that are professionally controlled (for exam-
ple, choice between a prescribed medicine or surgery, or choice
about whether or not to have a ’preference-sensitive’ screening test
that only licensed professionals can administer), but it is also cen-
tral to personalised care planning for long-term conditions when
health professionals work with patients to determine goals and
priorities (Bodenheimer 2003; Tsai 2005). Effective management
of chronic conditions usually involves both tests and treatments
prescribed by clinicians and actions that individuals must do for
themselves, such as administering medication appropriately, or
making lifestyle changes. In some cases, a patient may be bet-
ter informed about their condition than the clinician, in which
case the clinician should respect this expertise and take account of
it in the planning process. Some patients may not need support
for self management or behaviour change, but, for those that do,
collaboratively-set goals and self-selected behavioural targets are
seen as more motivational than clinician-assigned goals (Michie
2003). The process involves both shared decisions about how best
to manage the condition, and shared responsibilities for imple-
menting mutually agreed actions (Montori 2006). The experience
of working together in a collaborative manner may lead to im-
provements in people’s sense of confidence and well-being. Inter-
ventions to promote collaborative goal setting and action planning
might, for example, make someone with a long-term condition
feel respected, cared about, encouraged and capable of making a
meaningful contribution to their state of health (Entwistle 2013).
Why it is important to do this review
Despite widespread support for the principle of personalised care
planning, the nature and extent of evidence in support of this ap-
proach is unclear. The model has been promoted by the World
Health Organization (WHO) and encouraged in a number of
countries including Australia, the UK and USA (Singh 2008),
but international surveys show that many people with long-term
conditions do not receive sufficient support from health profes-
sionals to enable them to plan their care and self-manage their
condition(s) effectively (Schoen 2011). For example, it has been
government policy in England since 2010 to ensure that all people
with long-term conditions are involved in a care-planning pro-
cess (Department of Health 2009). This commitment has recently
been strengthened by inclusion of an explicit promise in the Na-
tional Health ServiceMandate that “everyone with long term con-
ditions, including people with mental health problems, will be
offered a personalised care plan that reflects their preferences and
agreed decisions”(Department of Health 2012). In certain cases
people with complex conditions or combinations of conditions
may be offered a personal health budget to cover the costs of needs
identified during the care planning process (Forder 2012). How-
ever, a co-ordinated, personalised approach is not yet the norm in
everyday practice. While most people with long-term conditions
in England report having some sort of care-planning discussions
with clinicians in primary care, only a small proportion experience
proactive, systematic support along the lines described above (Burt
2012; Newbould 2012).
Implementing care planning in primary care involves significant
organisational and cultural change (Year of Care 2011). Health
professionals may be reluctant to embark on this if they do not
believe it is warranted by the evidence (Blakeman 2006). They
may also be unwilling to adopt this approach if they feel it will be
too time-consuming for themor too burdensome for their patients
(Coulter 2011). There is a need formore information about which
components of care planning are necessary and which may not be,
and which types of tools or interventions are helpful (Burt 2013).
For example, when it is important to complete the cycle of support
and review, and when it might be sufficient to engage patients
in goal setting and action planning only. Interventions specially
designed for patients, clinicians or both may help to overcome
barriers to implementation (see Types of interventions below).
Peoplewithmultiple co-morbidities or cognitive impairmentsmay
find participation in care planning and self management especially
difficult (May 2009).There are also concerns that this approach
could exacerbate health inequalities if people with low levels of
health literacy or communication difficulties are seen as less able
to participate or lacking the capacity to self-manage their health
(Coulter 2011).
Several systematic reviews have pointed to the importance of a
patient-centred, personalised approach to care management. Pa-
tient-oriented interventions to support self management (for ex-
ample, information provision or educational programmes) have
led to improvements in health outcomes for people with dia-
betes (Deakin 2005; Renders 2000), asthma (Powell 2002) and a
number of other chronic conditions (Foster 2007; Murray 2005).
Various strategies for increasing people’s motivation to adopt
healthy behaviours (for example, motivational interviewing or use
of written contracts) have led to improved health outcomes for
some patients (Bosch-Capblanch 2007; Lai 2010; Rubak 2005;
Smedslund 2011). Interventions designed to improve commu-
nications and encourage greater patient involvement in decision
making have been shown to improve people’s knowledge of screen-
ing or treatment options, but effects on health outcomes have been
mixed (Dwamena 2012; Edwards 2013; Kinnersley 2007; Legare
2014; Levack 2012 (full review in press); Stacey 2014; Wetzels
2007). There is some overlap of focus between this latter group
of reviews and the current one, in that they all cover strategies for
engaging patients in decisions about their care, but none of the
earlier reviews looked specifically at the effects of personalised care
planning for people with long-term conditions.
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O B J E C T I V E S
To assess the effects of personalised care planning for adults with
long-term health conditions compared to usual care (i.e. forms of
care in which the active involvement of patients in treatment and
management decisions is not explicitly attempted or achieved).
We addressed the following primary research questions:
• is personalised care planning effective for improving
physical health (e.g. lipid measurements)?
• is personalised care planning effective for improving
psychological health (e.g. anxiety and depression)?
• is personalised care planning effective for improving
subjective health status (or health-related quality of life)?
• is personalised care planning effective for improving
people’s capabilities for self-managing their condition?
We also looked for evidence to address the following secondary
research questions:
• is personalised care planning effective for improving
people’s health-related behaviours?
• how does personalised care planning impact on rates of use
and costs of formal health services?
• what is the relative effectiveness of different types of
intervention used to promote personalised care planning?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials and cluster-randomised controlled
trials only.
Types of participants
We were interested in the ways that healthcare professionals and
health services engage people in personalised care planning relating
to chronic or long-term conditions. Chronic conditions are de-
fined as “diseases of long duration and generally slow progression”
(WorldHealthOrganization 2012): for example, heart disease and
stroke, cancers, respiratory conditions such as asthma and chronic
obstructive pulmonary disease (COPD), diabetes, kidney or liver
disease, chronic pain and arthritis, neurological conditions such as
epilepsy and multiple sclerosis, HIV/AIDS, and psychiatric con-
ditions such as bipolar, schizophrenia or chronic depression.
We searched for studies where the participants were adults (aged
18 or over) with any long-term physical, psychological, sensory, or
cognitive condition or combination of conditions affecting their
health, treated in any setting (primary care, secondary care, com-
munity care or residential care). This could include people with
long-term disabilities not necessarily caused by disease, such as
blindness, deafness, mobility, communication problems or intel-
lectual disabilities, if they are receiving treatment from health pro-
fessionals.
We excluded studies involving simulated patients, or patients re-
quiring treatment for acute or self-limiting problems only.
Types of interventions
The review examined trials that evaluated interventions (including
changes to practice styles) that explicitly engaged patients in a
shared decision-making process involving both goal setting and
action planning as described in Description of the intervention
above (B, C).
We excluded studies in which the intervention did not explicitly
engage participants actively in determining their goals or priori-
ties and developing a treatment/care/support plan, and those in
which they were not encouraged to exert meaningful influence on
goals and plans, or where their choices were unduly constrained.
We also excluded studies that focused solely on group education
programmes without one-to-one clinical engagement, and those
designed primarily to engage people in making plans for end-of-
life care (advance directives).
Various interventions or practices have been developed to encour-
age or support personalised care planning. These may be targeted
at patients, clinicians or both, and may be used singly or in com-
bination. Examples include the following:
Patient-focused interventions:
• information materials or decision aids for patients
(Protheroe 2010)
• computer-based interventions to help patients identify and
achieve behavioural goals (Glasgow 2004)
• suggested lists of questions the patient can ask to prompt
the clinician to involve them more actively in decisions about
their care (Shepherd 2011)
• health coaching and motivational support to help patients
clarify objectives, solve problems and achieve behavioural goals
(Frosch 2011)
• patient-held records for summarising personal goals and
test results (Dijkstra 2005)
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Clinician-focused interventions:
• specific training programmes in shared decision making,
care planning and/or motivational interviewing (Kennedy 2005)
• guidelines and feedback emphasising the need to elicit
patients’ preferences during care-planning consultations
(Wensing 2003)
• algorithms embedded in clinical record systems to guide the
care-planning process (Ell 2010)
Interventions designed to influence the behaviour of both
clinicians and patients:
• brief tools for use within care-planning consultations to
guide the discussion about options and agreed actions (Elwyn
2012a)
• an electronic or printed template for documenting jointly-
agreed actions for use in monitoring and follow-up (Ross 2004).
Not all examples of these kinds of interventions met the review’s
inclusion criteria. We were primarily interested in the care-plan-
ning process itself. This could include any of the above-listed in-
terventions, or others not described above. The point is that per-
sonalised care planning should cover whatever is required to help
individual patients identify and achieve their own condition-re-
lated goals. In some cases both parties may conclude that the pa-
tient is managing well and that no additional medical intervention
or support is needed.
Our focus was on patient engagement to support and enhance
self management of long-term conditions in clinical settings. We
excluded studies in which personalised care planning was not a
major focus of the evaluation, or where it was not possible to isolate
the specific effects of the personalised care planning process.
We originally planned to compare the following types of interven-
tion:
• personalised care planning (as defined above) compared to
forms of care where individual involvement in treatment or
management decisions is not explicitly encouraged (usual care)
• ’limited’ approaches involving goal setting, action planning
and no more than two additional steps (preparation,
documenting, co-ordinating, supporting, reviewing: see Figure
1) versus ’extended’ approaches involving five or more steps in
the care-planning cycle
• patient-focused interventions versus those that aimed to
change both patient and clinician behaviours
In the event we found even greater diversity among the interven-
tions than predicted, so we added the following comparisons to
tease out the likely effects of attributes such as the intensity of the
intervention and whether it was integrated into the practice of the
patient’s usual care provider or an add-on service:
• intensity of intervention (high = at least one contact per
month for more than three months; low = shorter duration and
fewer contacts)
• integration into usual care (high = usual-care clinician
involved in care planning and informed about patients’ goals and
plans; low = usual clinician not involved, not informed or both).
Types of outcome measures
See Figure 1 for an outline of the conceptual model used in the
review, showing primary and secondary outcomes and subgroups.
We focused on two main primary outcomes and two secondary
outcomes, each of which included a number of potential measures.
Primary outcomes
1. Changes in health and well-being, including each of the
following three dimensions measured separately:
i) physical health: measured instrumentally (e.g. blood
pressure, blood lipids, body mass index, HbA1c, urinary
albumin, etc.) or by observation or self report (including
symptom scales, pain scores).
ii) psychological health: observation or self-report scales
(e.g. depression or anxiety scores).
iii) subjective health status: patient-reported scales
(including health-related quality of life, fatigue, self esteem,
coping, activities of daily living, etc.) or proxy reports (clinicians’
observations or family member/carer reports).
2. Changes in patients’ self-management capabilities or
indicators relevant to those capabilities: measured by self reports
or observations (knowledge of their condition and its treatment
or management options, self efficacy, activation, confidence or
perceived competence, and ability to access relevant support).
We included validated measures where possible. Non-validated
measures were recorded but excluded from the meta-analysis.
Secondary outcomes
1. Changes in health-related behaviours: diet, exercise,
smoking, use of relaxation techniques, self-management actions,
condition-relevant self monitoring, adherence to treatment
recommendations, attainment of personal goals.
2. Changes in use of formal health services: number and
length of hospital admissions, number of outpatient, emergency
department, or primary care visits, and, where recorded, effects
on the costs of care.
We also recorded any reports of harms or adverse events associated
with personalised care planning.
Timing of outcome assessment
We originally intended to group the outcomes into short-term
(three months or less), medium-term (six to 12 months) and long-
term (more than one year), but this proved difficult to do given the
relatively small number of studies, so we have reported only the
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final outcome measures in each study and pooled these wherever
possible.
Selecting outcome measures for use in the analysis
The outcomes listed above are broad categories. In the case of
studies that reported more than one outcome within each of these
groupings, we adopted the following process: two review authors
(AC, AE or SR) independently listed outcomes (without consider-
ing either the size of the effect or its statistical significance). Many
of the outcome measures used standardised self-completion ques-
tionnaires to obtain patients’ reports. We pooled outcome data
from studies that examined the same constructs, even if the mea-
sures were slightly different. Those that looked at different con-
structs or measured these in very different ways we reported nar-
ratively but did not include them in the meta-analysis.
Search methods for identification of studies
Electronic searches
In July 2013 we searched the following databases for all years:
• Cochrane Central Register of Controlled Trials
(CENTRAL), The Cochrane Library (July 2013, Issue 7)·
• Dissertations & Theses (ProQuest) (1743 - July 2013)
• MEDLINE & MEDLINE In-process (Ovid) (1946 to July
2013)
• EMBASE (Ovid) (1974 to July 2013)
• PsycINFO (Ovid) (1967 to July 2013)
• Trial registers (clinicaltrials.gov) (21st June 2013)
• WHO International Clinical Trials Registry Platform (June
2013)
The search strategy was tailored to each of these databases and
is reported in Appendix 1. It includes a list of terms developed
by the Cochrane Consumers and Communication Review Group
that covers most long-term conditions. There were no language
restrictions.
Searching other resources
We scanned reference lists of relevant retrieved articles and reviews
on this topic, to identify additional papers reporting results from
the same study and relevant studies not identified by the electronic
searches. We did not systematically search grey literature, conduct
handsearches or contact experts. We included relevant studies ir-
respective of publication status.
Data collection and analysis
Selection of studies
We merged search results using EndNote software, and removed
duplicates. Two of three review authors (AC, AE and SR) screened
titles and abstracts independently to exclude clearly irrelevant ref-
erences. Where, in the opinion of at least one review author, the
abstract indicated that the study might be eligible for inclusion,
or where it was not clear that the study should be excluded, we
obtained full-text versions. We linkedmultiple reports of the same
study.
We developed a standard form to record details of each study and
reasons for inclusion or exclusion, based on the checklist below.
Two review authors (AC, AE or SR) independently scrutinised all
identified trial reports to determine eligibility, and recorded the
reasons for including or excluding a study, which are documented
in a PRISMA flow chart (Figure 2) and in the table Characteristics
of included studies. After reviewing all relevant papers indepen-
dently, the two authors compared notes and discussed any discrep-
ancies. In cases where there was disagreement about eligibility, we
referred papers to one of the review authors not involved in the
initial selection process (VE, SS or RP).
We used the following checklist to determine eligibility:
1. Does the paper present primary data? EXCLUDE if review
article, commentary, protocol, etc., but flag for later reference
scan.
2. Was this a randomised controlled trial (RCT) or cluster-
randomised trial (C-RCT)? EXCLUDE if not RCT or C-RCT,
but flag for later reference scan to check for eligible studies not
previously identified.
3. Did the study include adults aged over 18? EXCLUDE if all
participants were children or young people aged under 18.
INCLUDE if age not stated or if participants included a
majority of adults.
4. Did participants have one or more chronic conditions?
EXCLUDE if participants were healthy people or simulated
patients or were consulting for acute (time-limited) conditions.
5. Was the intervention concerned solely with planning for
end-of-life care (advance directives)? If so, EXCLUDE.
6. Was the intervention a patient decision aid only, without
one-to-one personalised care planning? If so, EXCLUDE.
7. Was the intervention patient education only, without one-
to-one personalised care planning? If so, EXCLUDE.
8. Was the intervention a psychological treatment only,
without one-to-one personalised care planning? If so,
EXCLUDE.
9. Was personalised care planning with active involvement of
the patients in a collaborative or shared decision-making process
an explicit component of the intervention?
i) Were patients actively involved in planning their
treatment or care with a clinician(s), coach or community health
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worker? INCLUDE IF THIS AND OTHER INCLUSION
CRITERIA LISTED BELOW ARE MET
ii) Did the intervention include both collaborative goal
setting and collaborative action planning? INCLUDE.
iii) Did trial include patient-based outcomes? If not,
EXCLUDE; for example if outcomes related to clinicians only.
Trials of training programmes for clinicians that included
measures of their effects on patients should be considered for
inclusion in the review if the training covered personalised care
planning.
iv) Were patients encouraged to set their own goals or
priorities and/or were they offered a choice of treatment or
support package? INCLUDE if the intention of the intervention
was to enable patients to have meaningful influence on goal
selection and/or choice of treatment or support package.
EXCLUDE if choices were constrained to only a few
predetermined options, for example, only a choice between
treatment A or treatment B.
v) Was the care/action plan pre-prepared so patients had
no opportunity to influence it? EXCLUDE.
vi) Was the care/action plan simply a pre-prepared list of
instructions about what to do in particular circumstances?
EXCLUDE.
vii) Is there any other evidence to suggest that the care-
planning process did not allow the patient to be involved or to
influence it? EXCLUDE
We recorded and reported all studies excluded for any of the rea-
sons listed in criterion 9 (a - g) above (Characteristics of excluded
studies). Studies excluded for any of the reasons itemised in 1 -
8 above have not been included in this table, but the numbers in
each category are reported in Figure 2.
We collected and report below (Characteristics of ongoing studies)
the details (citation details and other relevant information) of on-
going studies.
Data extraction and management
Two of three review authors (AC, AE and SR) independently ex-
tracted study characteristics and outcomes from reports.
We used a modified version of the template developed by the
Cochrane Consumers and Communication Review Group to
extract data from eligible studies (Characteristics of included
studies).
Assessment of risk of bias in included studies
We assessed and reported the methodological risk of bias of in-
cluded studies in accordance with the Cochrane Handbook for Sys-
tematic reviews of Interventions (Higgins 2011) and the guidelines
of the Cochrane Consumers and Communication Review Group
(Ryan 2011), which recommend explicit reporting of the follow-
ing individual elements for RCTs: random sequence generation;
allocation concealment; blinding of participants and personnel;
blinding of outcome assessment; completeness of outcome data,
selective reporting; and any other obvious sources of bias, such
as comparability between groups at baseline or the possibility of
contamination between the groups.
For cluster-RCTs we also assessed and reported the risk of bias as-
sociated with an additional domain: selective recruitment of clus-
ter participants (Ryan 2011).
In all cases, two review authors extracted data and independently
assessed the risk of bias of included studies, with any disagree-
ments resolved by discussion and consensus. We contacted study
authors for additional information or for clarification of the study
methods, as required. We assessed the risk of bias in respect of ran-
dom sequence generation. We made provision to exclude studies
where this was assessed as high, but in fact we identified no such
problems. We included all studies meeting the inclusion criteria
in the review regardless of the assessment of risk of bias, but we
conducted a sensitivity analysis (by excluding the study) if risk of
bias due to method of randomisation or allocation concealment
was unclear. The results of the ’Risk of bias’ assessment were in-
corporated into the review through standard tables and narrative
commentary, leading to an overall assessment of the risk of bias of
the included studies and a judgement about the internal validity
of the review’s results.
Measures of treatment effect
We calculated effect sizes using mean difference (MD) with 95%
confidence intervals (CI) in cases where studies had used the same
measure (e.g. HbA1c). For most other outcomes, for example
those using a variety of standardised questionnaires or patient-
reported outcome measures (PROMS), we used a standardised
mean difference (SMD) with 95% CI to summarise the pooled
effect of comparable outcomes. We used risk ratios (RR) and 95%
CIs for dichotomous outcomes, where relevant, or transformed
and treated them as continuous, and summarised them with the
rest of the studies (based on the transformation of an odds ratio
created from the equivalent two-by-two table). We did not back-
transform them due to the variety of scales used in the studies and
lack of consensus on which are the most appropriate.
Unit of analysis issues
Inclusion of cluster-randomised trials leads to potential unit of
analysis problems. Whenever an adjusted (for clustering) effect
was reported, we extracted this for inclusion in the review. No
cluster trials reported analyses without adjusting for clustering and
hence no further adjustment was necessary.
Dealing with missing data
We used intention-to-treat data in our analyses whenever possible.
In cases where data were insufficiently reported in the published
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paper, we contacted the original authors for clarification and fur-
ther information. Many studies reported baseline and endpoint
measures which we used to calculate mean change and standard
deviation. When available, we estimated the correlation coeffi-
cient for the baseline-endpoint values based on alternative studies.
When this was not available, we used a correlation value of 0.5
instead (Follmann 1992).
Assessment of heterogeneity
Where studies were considered similar enough (based on consid-
eration of diagnostic categories, type of intervention, outcome
measures, or population subgroups) to allow pooling of data us-
ing meta-analysis, we assessed the degree of heterogeneity by vi-
sual inspection of forest plots and by examining the Chi² test for
heterogeneity. We quantified heterogeneity using the I² statistic.
An I² value of 70% or more is taken as representing substantial
levels of heterogeneity, but this value has to be interpreted in the
light of size and direction of effect and strength of evidence for
heterogeneity, based on the P value from the Chi² test (Higgins
2011). We did not report pooled results where we detected sub-
stantial clinical, methodological or statistical heterogeneity across
included studies. We assessed possible clinical or methodological
reasons for any variation by grouping studies that were similar in
terms of diagnostic categories, intervention types or population
subgroups to explore differences in intervention effects.
Assessment of reporting biases
We have not assessed publication bias by use of funnel plots be-
cause we had too few studies to do so. Instead we assessed report-
ing bias qualitatively by looking at the properties of the included
studies (for example, if only small studies with positive findings
were identified for inclusion, or where authors indicated that there
were relevant unpublished studies).
Data synthesis
We pooled data using a fixed-effect meta-analysis because of the
small number of studies. In the absence of unit of analysis errors, we
combined data from individual and cluster-randomised controlled
trials.
Subgroup analysis and investigation of heterogeneity
Weaimed to analyse results for the following subgroups to examine
factors that might modify any effects (see Figure 1):
• multi-morbidity: people with multiple (i.e. more than one)
chronic conditions or disabilities. We considered depression
associated with another condition such as diabetes a co-
morbidity, rather than an example of multi-morbidity.
• health literacy: people who face communication or
comprehension problems due to low educational level, minority
language, cognitive impairment or intellectual disability.
In practice we were unable to do this due to a paucity of studies
measuring these issues, so we have reported any relevant results in
the narrative only.
Sensitivity analysis
Weused sensitivity analyses to determine the impact of our choices
and assumptions. We explored the impact of the inclusion of high/
low quality studies in the review (see Assessment of risk of bias in
included studies above).
’Summary of findings’ table
We prepared a ’Summary of findings’ table based on the methods
described in chapter 11 of the Cochrane Handbook for Systematic
Reviews of Interventions (Schünemann 2011). We have presented
the results for the major comparisons of the review (personalised
care planning versus usual care) for each of the primary outcomes
(physical health, psychological health, subjective health status, and
self-management capabilities), as outlined in the Types of outcome
measures section.We have provided a source and rationale for each
assumed risk cited in the tables, and have used the GRADE system
to rank the quality of the evidence (Schünemann 2011).
Consumer participation
We recruited an expert patient advisory group of six people with
experience of livingwith long-term conditions. Between them they
had experience of livingwith the following conditions: Alzheimer’s
disease (carer of family member), anxiety, asthma, bilateral above-
knee amputation, cataracts, depression, epilepsy, erythromelalgia,
irritable bowel syndrome, labyrinthitis, migraine, multiple scle-
rosis, myeloproliferative disorder, over- and under-active thyroid,
peripheral vascular disease, polycystic ovaries, poor circulation,
Raynaud’s syndrome, rheumatoid arthritis, and tendonitis. They
agreed to advise on various aspects of the review, including the
protocol, selection of outcome measures, and emerging findings.
They were paid a fee for their time.
We sought input and advice from the expert patient advisory group
via a secure dedicated website where they could record comments
and queries. The website included a short summary of the research
plan as background information. We encouraged group members
to submit questions about the study at any time via the website.
During the development of the protocol we asked them to review
the outcomeswe had selected for the study.We asked them to indi-
cate which of these should have highest priority in the light of their
own experience, to rank all other outcome measures in order of
priority and to give reasons for their ranking. We also asked them
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to let us know if any important outcomes were missing. Partici-
pants provided detailed and helpful comments on their rankings.
They acknowledged the need to reduce the number of outcomes
to make the review manageable, but at least one participant indi-
cated discomfort with this procedure which they felt smacked of
standardisation rather than personalisation, giving a professional
rather than patient focus to the review. Nevertheless, the results of
this exercise supported the choice of outcomes listed above, and
no outcomes of any significance were identified as missing from
the review.
We asked the group to give their reactions to the findings of the
review and to assess the plain language summary to ensure it was
comprehensible, accessible and relevant. The group has also been
asked to help with disseminating the findings from the completed
review.
R E S U L T S
Description of studies
We restricted the search to randomised controlled trials and clus-
ter-randomised trials evaluating interventions that focused on or
included personalised care planning.
Results of the search
The electronic search yielded 16,151 records. We added a further
12 studies identified in reference scans. Following removal of du-
plicates, we screened a total of 9890 unique abstracts for eligibil-
ity and excluded 9494 of these. We obtained full-text articles for
the remaining 396 abstracts and assessed these for inclusion in
the review. We excluded a total of 353 articles following full-text
analysis. We have listed below (Characteristics of excluded studies)
only those studies where we had to involve a third review author
to resolve any uncertainties or differences in the assessments of the
first two review authors. We deemed a total of 43 articles eligi-
ble for inclusion. These described results from 19 unique studies
and seven protocols (Figure 2). We tried to contact the authors of
eight of the studies to ask for further information or unpublished
data but could not track down current contact details for two. We
received helpful replies from five lead authors (Battersby 2007;
Ludman 2007; Naik 2011; Stanhope 2013; Wilson 2010).
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Figure 2. Study flow diagram.
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Included studies
The 19 completed studies included 16 randomised controlled tri-
als (RCTs) (Battersby 2007; Frosch 2011; Hart 1978; Hiss 2007;
Katon 2010a; Liu 2012; Ludman 2007; Naik 2011; Schillinger
2009; Shearer 2007; Thom 2013; Tsay 2004; Van derWulp 2012;
Wilson 2010; Wolever 2010; Zoffmann 2006), and three cluster
trials (Glasgow 2005a; Kennedy 2013; Stanhope 2013). Thirteen
of the included studies were conducted in the USA and one each
in Australia, China, Denmark, the Netherlands, Taiwan, and the
UK. Details of the studies and the interventions are provided in
the table of Characteristics of included studies and summarised in
Table 1.
We were able to include 16 of the 19 studies in a meta-analysis.
We had to exclude two studies because they used outcome mea-
sures that were unique to these studies so could not be pooled
(Hart 1978; Stanhope 2013). A third study attempted to evaluate
an intervention (a change in practice) that explicitly engaged pa-
tients in personalised care planning as we have defined it, but the
intervention (the intended new style of practice) was not actually
implemented (Kennedy 2013).The authors of this study carried
out a process evaluation that confirmed this (Kennedy 2014). We
therefore excluded it from the meta-analysis on the grounds that
the study cannot tell us anything about the effects of engaging pa-
tients in care planning. The only outcome that this study shared in
common with others in this review (and therefore could have been
pooled) was the Stanford self-efficacy questionnaire. We took the
view that inclusion of data from this study would have introduced
a negative bias into the meta-analysis.
Participants
There was considerable variation in the size of the studies, ranging
from 32 participants (Hart 1978) to 5599 (Kennedy 2013). To-
gether they included a total of 10,856 participants (Table 1). For
trials comparing three or more arms, we selected the study arm
that most closely met our inclusion criteria, so the data included
here represent a subset of those in the published papers for the fol-
lowing studies: Battersby 2007; Ludman 2007; Schillinger 2009;
Wilson 2010.
Twelve studies focused on people with diabetes, with or without
associated conditions (Frosch 2011; Glasgow 2005a; Hiss 2007;
Katon 2010a; Kennedy 2013; Liu 2012; Naik 2011; Schillinger
2009; Thom 2013; Van derWulp 2012;Wolever 2010; Zoffmann
2006), three focused onmental health (Hart 1978; Ludman 2007;
Stanhope 2013), one on heart failure (Shearer 2007), one on end-
stage renal disease (Tsay 2004), one on asthma (Wilson 2010),
and one on various conditions (Battersby 2007). This last study
included eight sub-studies in four different regions in South Aus-
tralia, half of which were separate but linked RCTs using similar
methods andmeasures (the other four sub-studies used geographic
controls so were ineligible for inclusion). The four eligible trials fo-
cused on patients with cardiac conditions, respiratory conditions,
somatisation and problems of old age.
Only one study used a formal assessment of health literacy:
Schillinger 2009 assessed 59% of their participants as having ’lim-
ited’ literacy according to the Test of Functional Health Literacy
in Adults (ToFHLA) scale.
Five studies had participants consisting mainly of people from
lower socio-economic groups or from minority ethnic groups or
from both (Frosch 2011; Hiss 2007; Kennedy 2013; Schillinger
2009; Thom 2013).
No study focused explicitly on patients with multi-morbidities.
One study (Katon 2010a) included patients with depression with
diabetes or coronary heart disease or both but, since depression
is often a side effect of these conditions, we considered this a co-
morbidity rather than a study of the effects on people with multi-
morbidities.
Interventions
While all studies involved interventions that included personalised
care planning (goal setting and action planning), there was con-
siderable variation in the way this was carried out and in the tools
and techniques adopted to support the process (Table 1).
All 19 studies included components that were intended to sup-
port behaviour change among patients, involving either face-to-
face support or telephone support. Three of the interventions
took place in hospital clinics (Shearer 2007; Tsay 2004; Zoffmann
2006), the remainder in primary care or community settings. In
most cases the intervention focused on changing patients’ capabil-
ities and behaviour (15 studies) but four studies (Battersby 2007;
Kennedy 2013; Stanhope 2013; Wilson 2010) aimed to change
the behaviour of both patients and clinicians.
A variety of tools and techniques were used in the interven-
tions, including patient information packages (DVDs, computer
programmes, or booklets); prompts for patients (patient-held
records, worksheets or decision aids); structured consultations us-
ing coaching methods such as motivational interviewing; training
or prompts for clinicians; peer support; and both individual and
group visits (see Table 1).
In most cases (14 studies) the care-planning process was led by
nurses, or nurses and therapists acting as care managers, service co-
ordinators or health coaches. Doctors were actively involved in six
of the studies (Battersby 2007; Hiss 2007; Katon 2010a; Kennedy
2013; Liu 2012; Naik 2011) including one study (Naik 2011)
where physicians were solely responsible. In two studies the main
contact was a peer coach (Thom 2013; Van der Wulp 2012) and
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in two the intervention was provided by mental health providers
including social workers (Hart 1978; Stanhope 2013).
Only five studies relied solely on patients’ usual-care clinicians to
conduct the intervention (Table 1). In 10 studies the intervention
involved contact with additional specially-trained staff or peers
not usually responsible for the patient’s care. Four studies involved
both usual-care clinicians and additional clinicians. Contact be-
tween clinicians or peer coaches and patients was face-to-face in
15 studies, while the remaining four studies relied solely or mainly
on telephone contact.
We grouped studies according to the number of completed stages
in the care-planning cycle (Figure 1). Our prespecified inclusion
criteria selected interventions that had completed at least two of
the seven collaborative-planning stages (B - goal setting, C - action
planning) and some form of follow-up support was included in all
19 studies (F - supporting). Of the other stages, A - preparation
for care planning (for example, preliminary information packages
or sending test results to the patient so they could review these in
advance of the consultation) formed part of the intervention in
only four studies, D - documenting (i.e. a record that is explicitly
sharedwith the patient) featured in seven studies, E - co-ordinating
(i.e. the care manager liaising with clinicians and other staff to
ensure that all issues identified were dealt with) was reported in
five studies, and G - reviewing progress and making further plans
was an explicit feature of only three studies. We classified those
that had completed only three or four of these stages as ’limited’,
while those where the intervention involved five or more of the
stages were classified as ’extended’ (Table 2). Five studies fell into
the ’extended’ group and only two of these (Battersby 2007; Katon
2010a) covered the entire cycle (A - G).
We also classified interventions according to the intensity of the
intervention and the extent to which they were integrated into
clinical practice (Table 3). Where studies did not explicitly state
that a particular process was carried out (for example, a stage in the
care-planning cycle, a precise number of patient-clinician contacts,
or co-ordination with usual care providers), we have assumed that
these were not features of the intervention and have classified them
as ’low’ or ’no’. Eight studies fell into the high-intensity group
and 11 were low-intensity. A different group of eight studies was
classified as integrated with the patient’s usual provider, while 11
were not.Only four studies were rated high on both thesemeasures
(Battersby 2007; Hiss 2007; Katon 2010a; Liu 2012).
Interventions varied in the extent to which the clinician input was
standardised and supervised to ensure fidelity to the design (see
Characteristics of included studies). Some studies used tightly-
controlled interventions involving closely-supervised clinicians,
while others were more pragmatic in design. Reports from one
study (Kennedy 2013) indicated that a majority of participant
clinicians had not delivered the intervention as intended.
A theoretical framework can be useful for explaining how the inter-
vention is expected towork, but this wasmentioned in only nine of
the 19 studies (see Characteristics of included studies). Five studies
cited the Chronic Care Model (Battersby 2007; Glasgow 2005a;
Kennedy 2013; Ludman 2007; Schillinger 2009), one mentioned
Rogers’s Science of Unitary Human Beings (Shearer 2007), one
was based on Bandura’s Social Cognitive Theory (Van der Wulp
2012), one cited Prochaska and di Clemente’s Stages of Change
theory (Zoffmann 2006) and one was a Chinese adaptation of
the Stanford Chronic Disease Self-Management Programme (Liu
2012).
The comparison group was usual care in 12 of the studies. The
remaining seven made a comparison between personalised care
planning and various forms of enhanced usual care (Glasgow
2005a; Katon 2010a; Kennedy 2013; Naik 2011; Stanhope 2013;
Thom 2013; Tsay 2004). Additions to usual care in these studies
included provision of health information, group education, or
enhanced access to primary care physicians and other clinical staff.
Risk of bias in included studies
Details of our judgements and the rationale for these are included
in the Characteristics of included studies table and displayed in
Figure 3 and Figure 4.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 4. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Just over half of the studies (11 out of 19) reported an acceptable
method of random sequence generation. Eight studies did not pro-
vide an adequate description of the randomisation process, so we
classified these as unclear. Allocation concealment appeared satis-
factory in eight of the studies, but it was inadequately described
in 11 studies.
Blinding
Blinding of participants and personnel is almost impossible in
this type of study, so we classified the risk as unclear for 16 of
the studies, since these relied on objective clinical measurements
(e.g. blood tests) and we did not consider the risk of non-blinding
to be especially problematic. Detection bias was rated high for
three studies (Liu 2012; Shearer 2007; Wolever 2010) where both
participants and personnel were aware of treatment status and a
number of outcomes were subjective. Blinding of outcome assess-
ment was adequate in nine studies, but a further nine provided
inadequate evidence. One study (Stanhope 2013) was classified
as high risk because it relied on non-blinded clinicians’ reports of
medication adherence (its primary outcome) with no independent
validation of this measure.
Incomplete outcome data
Most studies (15) were rated at low risk in respect of attrition bias,
but two provided inadequate information and twowere deemed to
be at high risk: Battersby 2007 because of very high attrition rates
(47% loss to follow-up in the intervention group and 50% in the
control group) and Shearer 2007 because of a great deal of missing
data: one or more dependent variable pretest scores were missing
for 24% of the experimental group and 24% of the control group
at baseline, and for 31% and 42%, respectively, at post-test.
Selective reporting
We considered reporting bias to be at low risk in two studies where
there were pre-published protocols, at unclear risk in 16 where we
found no published protocols, and at high risk in one (Battersby
2007), which reported only statistically significant outcomes and
not those that were non-significant. This study comprised a series
of linked trials using similar methods, but only one of these sub-
studies (Pols 2008) provided sufficient information for some out-
come measures to be included in the meta-analysis. We excluded
the other sub-studies because it proved impossible to obtain full
results from the authors. We did not include outcome measures
in the meta-analysis if full data were available for the intervention
group only and not the control group.
Other potential sources of bias
We considered other potential sources of bias, such as selective re-
cruitment and fidelity to the intervention. We classified 13 studies
as at low risk on these criteria, five were unclear and one (Kennedy
2013) was rated at high risk due to the fact that the intervention
was not implemented as intended. The authors reported poor fi-
delity on the part of clinicians: collaboration between clinicians
and patients (shared decision making) at six months was signifi-
cantly less in the intervention group than in the control group (P
= 0.05); only 2% of patients with irritable bowel syndrome were
referred to therapists as required in the protocol; and 42% of clin-
icians failed to use the PRISMS tool which was intended to help
patients express their needs and preferences. A process evaluation
(Kennedy 2014) confirmed this impression of very poor fidelity
to the intervention.
Effects of interventions
See: Summary of findings for the main comparison
Physical health
Eleven studies examined the effects of personalised care planning
on physical health using a variety of standardised clinical indi-
cators, including glycated haemoglobin (HbA1c), blood pressure
(systolic (SBP) and diastolic (DBP)), cholesterol (LDL-C), body
mass index (BMI), lung function (FEV1) and asthma control
(ATAQ) (Table 4). We pooled data from 10 of the 11 studies in at
least one comparison, omitting one study from the meta-analysis
(Wilson 2010) because it used unique measures (FEV1, ATAQ).
1. Glycated haemoglobin: (Analysis 1.1) Nine studies (1916
participants) measured HbA1c at six or 12 months post-
intervention, giving a combined mean difference (MD) between
intervention and control of -0.24%, 95% confidence interval
(CI) -0.35 to -0.14, a small positive effect in favour of
personalised care planning compared to usual care. Excluding
studies with unclear randomisation method and allocation
concealment made little difference (MD -0.25%, 95% CI -0.36
to -0.14).
2. Systolic blood pressure: (Analysis 1.2): Six studies (1200
participants) measured SBP, giving a combined MD of -2.64
mm/Hg, 95% CI -4.47 to -0.82, a small positive effect in favour
of personalised care. However, a sensitivity analysis to exclude
studies at higher risk of bias reduced this to -0.64 mm/Hg, 95%
CI -3.70 to 0.41.
3. Diastolic blood pressure: (Analysis 1.3) the pooled results
from four studies (751 participants) showed no effect on DBP,
MD -0.71 mm/Hg, 95% CI -2.26 to 0.84.
4. Cholesterol: (Analysis 1.4) the pooled results from five
studies (1545 participants) showed no statistically significant
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effect on LDL-C, standardised mean difference (SMD) 0.01 mg/
dL, 95% CI -0.09 to 0.11.
5. Body mass index: (Analysis 1.5) the pooled results from
four studies (822 participants) showed no effect on BMI, MD -
0.11 kg/m², 95% CI -0.35 to 0.13.
6. Other: a single study of asthma patients (Wilson 2010)
reported improvements associated with personalised care
planning in lung function: adjusted mean FEV1 as a percentage
of predicted value was 76.5% in the intervention group versus
73.1% in the control group, and in asthma control measured by
the Asthma Therapy Assessment Questionnaire (ATAQ) (Juniper
1992): odds ratio (OR) of reporting no asthma control problems
1.9, 95% CI 1.3 to 2.9, in favour of personalised care.
Psychological health
Seven studies examined the effects of personalised care planning on
psychological outcomes (Table 5). Where studies used more than
one measure of psychological outcome, we selected the one that
was most conceptually similar to the measures used in the other
studies. We pooled results from those studies that used one of four
standardisedmeasures of depression symptoms: the PatientHealth
Questionnaire (PHQ-9) (Kroenke 2001), the Hopkins Symptom
Checklist 20 (SCL-20) (Derogatis 1974), the Beck Depression
Inventory (Beck 1988), and the Center for Epidemiologic Studies
Depression Scale (CES-D) (Radloff 1977).
1. Depression: (Analysis 2.1) six studies measured depression
using one of the above four measures at various time points post-
intervention. We were able to pool results from five of the studies
(599 participants), giving a SMD of -0.36, 95% CI -0.52 to -
0.20, a small positive effect in favour of personalised care.
However there was substantial heterogeneity in results from the
individual studies. A sensitivity analysis to exclude studies at high
risk of bias increased the effect to SMD -0.55, 95% CI -0.76 to -
0.34. The remaining study (Glasgow 2005a) reported the
proportion of participants with major depression (score 10 or
higher on PHQ-9) and found greater improvement in the
control group than the intervention group (OR 2.94, 95% CI
1.36 to 6.34; 886 participants).
2. Other measures of psychological health: we excluded
several other measures of psychological health from the pooled
analysis, either because the study included another measure that
seemed a better fit, or because the instrument measured a
different concept, for example perceived stress or perceived
benefits of the condition. Katon 2010a used the Patient Global
Rating for Improvement (PGI) in depression measure (Guy
1976) and found that participants in the intervention arm were
more likely to report an improvement in their depression
symptoms (41/92, 45%) than those in the control arm (16/91,
18%) (<0.001). Ludman 2007, which was a pilot study for
Katon 2010a, used the PGI measure but the sample size was too
small to detect differences in outcomes. This study also included
the Structured Clinical Interview for DSM-IV depression
module (SCID) (First 1997), but again they found no effect due
to the small sample size. Wolever 2010 used the Perceived Stress
Scale (PSS-4) (Cohen 1983a) and the Benefit Finding Scale
(Tomich 2004), and found improvements on both measures for
the intervention group but not the control group.
Subjective health status
Ten studies used various patient-reportedmeasures of health status
(or quality of life), including both generic health status measures
and condition-specific ones (Table 6).
1. Generic health status:Analysis 3.1 and Analysis 3.2: five
studies used the SF-36 patient-reported health status measure
(Ware 1992) or the briefer SF-12 (Ware 1996), which
reproduces the eight-scale profile of the SF-36 with fewer levels,
yielding less precise scores but based on the same constructs. The
resulting profile is often presented as two summary scores: the
physical component score (PCS) and the mental component
score (MCS). Three of the included studies used this method, so
we pooled the results from these three studies. The combined
analysis from the three studies (345 participants) gave a SMD on
the PCS of 0.16, 95% CI -0.05 to 0.38, and on the MCS of
0.07, 95% CI -0.15 to 0.28. It was not possible to include the
remaining two studies in this meta-analysis because one
(Kennedy 2013) used only selected sub-scales of the SF-36 and
anyway was withdrawn from the meta-analysis for the reasons
described above, and the other (Wolever 2010) gave a single score
based on the SF-12 without the MCS/PCS breakdown. Neither
of these two studies found a difference between the personalised
care group and the usual care group post-intervention.
2. Other generic measures of health status:Battersby 2007
reported improvements in functioning as measured by the Work
and Social Adjustment Scale (WSAS) (Mundt 2002) in all but
one of their sub-regional trials. Katon 2010a used the Sheehan
Social Role Disability scale (Leon 1997), the WHO Disability
Assessment Schedule (WHODAS-2) (Ustun 2010), and a global
rating scale. They found that participants in the personalised care
arm experienced greater improvements at six and 12 months
from baseline on both the Sheehan Disability scale (effect size
0.30, P = 0.006) and the global quality of life rating scale (effect
size 0.39, P = 0.005) than those in the usual care group. They
found no difference between groups on WHODAS-2. Kennedy
2013 used the Euro-Qol measure (EQ-5D) (Kind 1996), but
found no difference between the groups. We have not pooled
these data as the measures differ from each other conceptually.
3. Condition-specific health status: (Analysis 3.3) four
studies (1330 participants) included a questionnaire to measure
condition-specific health status. In two cases this was the
Problem Areas in Diabetes scale (PAID-2) (Welch 1997), one
study used the Stanford Illness Intrusiveness scale (Devins 2010),
and one the Asthma Quality of Life Questionnaire (AQLQ)
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(Juniper 1999). We considered that these scales were sufficiently
similar to pool the data. The combined results showed no
difference between the groups: SMD -0.01, 95% CI -0.11 to
0.10, but this was characterised by heterogeneity between the
studies.
Self-management capabilities
Nine studies looked at the effect of personalised care on capabilities
related to aspects of self management using a variety of outcome
measures (Table 7).
1. Self efficacy: (Analysis 4.1). Self efficacy refers to an
individual’s confidence to carry out necessary tasks or procedures
to manage their health or health care. Eleven studies used
instruments designed to measure self efficacy for health-related
behaviours, seven of which reported improvements. After
excluding Kennedy 2013 for the reasons stated above, we pooled
results for five of the studies (471 participants) that used similar
scales. These included the Stanford self-efficacy scales (Lorig
1996), a scale called Strategies Used by People to Promote Health
(SUPPH) (Lev 1996), a Dutch scale referred to as the Diabetes
Management Self-Efficacy Scale (Van der Bijl 1999), and the
Perceived Competence in Diabetes Scale (PCDS) (Williams
1998) (Table 7). The combined results showed a positive effect
of personalised care planning: SMD 0.25, 95% CI 0.07 to 0.43.
2. Other self-management capabilities: Self efficacy can be
seen as a contributor to, or partial indicator of, capabilities, but
its measurement is usually restricted to a limited sub-set of the
capabilities for self management that people with long-term
conditions value. A further five studies measured other attributes
that contribute to self-management capabilities, including
knowledge and understanding (the University of Michigan
Diabetes Knowledge Test (Fitzgerald 1998); enablement and
activation (the Patient Enablement Instrument (PEI)) (Howie
1998) and the Patient Activation Measure (PAM-13) (Hibbard
2005)); purposeful participation in attaining health goals (Power
as Knowing Participation in Change Tool (PKPCT)) (Caroselli
1998); coping (Appraisal of Diabetes Scale (ADS)) (Carey
1990); empowerment (Diabetes Empowerment Scale (DES))
(Anderson 2000); and interpersonal support (Interpersonal
Support Evaluation List - ISEL-12) (Cohen 1983b). We did not
attempt to pool these data because they measured different
constructs. The results from the individual studies were mixed
(Table 7). The two studies that used PAM-13 (or parts of it)
found evidence of an effect on patient activation: Wolever 2010
used the PAM-13 scale and found a statistically significant time-
by-group interaction in favour of personalised care. This study
also noted improvements in reported interpersonal support for
the intervention group over the control group using the ISEL-12
scale. Katon 2010a found improvements among the intervention
group in two of the four PAM questions they selected, and Tsay
2004 reported an effect on empowerment for the personalised
care group compared to the control group, but Shearer 2007
found no effect in relation to the PKPCT.
Adverse events
Only one study (Katon 2010a) reported any harms: 27 partici-
pants in the intervention group and 23 in the control group were
hospitalised during the course of the study; one person in the in-
tervention group and two in the control group died. There were
no differences between intervention and usual care groups and
there is no reason to assume that these adverse events were due to
the intervention.
Secondary outcomes
Health-related behaviours
Ten studies included measures of the effects of personalised care
on health-related behaviours, including exercise, diet, medication
adherence and self-care activities (Table 8).
1. Exercise: (Analysis 5.1) we were able to pool the results
from six studies (907 participants) that included patients’ self
reports on exercise frequency, but found no effect: SMD 0.11,
95% CI -0.02 to 0.24.
2. Diet: four studies measured the effect on diet using various
different self-report measures (Frosch 2011; Katon 2010a; Liu
2012; Van der Wulp 2012) which could not be pooled. None of
these found a difference between the intervention and control
groups.
3. Medication adherence: five studies measured the effect on
medication adherence. Two of these presented patients’ self
reports on adherence, two gave pharmacy reports and one gave
clinicians’ reports. We were unable to pool these data because of
the diversity of measures used. Frosch 2011 found no effect of
personalised care on adherence. Katon 2010a found that
patients’ knowledge about their medicines and confidence to
follow medical regimens improved, but adherence (pharmacy
data) did not. Stanhope 2013 reported improvements in
medication adherence (clinician report) among the intervention
group but not for the control group. Wilson 2010 reported
improvements for the intervention group on a number of
different pharmacy-derived measures of adherence. Wolever
2010 found an improvement for the personalised care group over
the control group on the ASK-20 adherence barrier
questionnaire (Matza 2008).
4. Self-care activities: three of the five studies that measured
the impact of personalised care planning on performance of self-
care activities (Katon 2010a; Schillinger 2009; Shearer 2007)
found improvements in the personalised care group compared to
the control group. We were unable to include Katon 2010a in the
meta-analysis because of the way the results were reported (blood
glucose monitoring mean 4.9 days per week in the intervention
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group and 3.8 in the control group, RR = 1.28, P = 0.006; blood
pressure self monitoring 3.6 versus 1.1 days per week, RR = 3.20,
P < 0.001). The pooled results from the other four studies (520
participants; Analysis 6.1) gave an effect estimate of SMD 0.35,
95% CI 0.17 to 0.52, but with substantial heterogeneity
between the studies. The effect reduced to 0.25, 95% CI 0.05 to
0.44 and greater uncertainty with sensitivity analysis.
Attainment of personal goals
Only four of the 19 studies included a report on whether patients
felt they had achieved the goals they had set for themselves, and all
four gave positive results. Battersby 2007 reported a 60% improve-
ment in problem and goals measurement scores; Glasgow 2005a
found improvements in achievement of goals related to healthy
eating and physical activity; Hart 1978 found a two-fold improve-
ment in goal attainment among the intervention group which was
better than that achieved by the control group; and Schillinger
2009 reported that 88% of participants in the intervention group
had succeeded in developing their own goals and repeat action
plans, leading to partial or complete success in goal achievement
for an average of 2.5 plans per participant. The remaining 15 stud-
ies did not report on goal attainment.
Health service use and costs
Three studies included an estimate of the impact of personalised
care planning on subsequent resource use (Table 9), but it was not
possible to produce a pooled summary of these data.
The analysis reported in Battersby 2007 includes data from eight
sub-studies, four of which were eligible for inclusion in our review.
They concluded that the small observed reduction in hospital ad-
missions was insufficient to pay for the costs of their model of co-
ordinated care. These included costs associated with employing
care co-ordinators, administering the trial, training care and ser-
vice co-ordinators, and engaging service providers.
Wilson 2010 found improvements in medication use associated
with personalised care planning, but did not assess whether these
were cost-effective.
Katon 2010a included a formal analysis of the cost effectiveness of
personalised care from the perspective of the health system. They
found that, over 24 months, intervention participants had a mean
of 114 (95% CI 79 to 149) additional depression-free days and
an estimated 0.335 (95% CI -0.18 to 0.85) additional quality-
adjusted life years (QALYs). Intervention participants also had
lower mean outpatient health costs of USD 594 per participant
(95% CI -3241 to 2053) relative to usual care participants. They
concluded that the intervention (TEAMcare) delivered high value
for no or modest additional cost.
Subgroup analysis: Effect of type of intervention
We found evidence in relation toHbA1c of differences in effect due
to the type of intervention used (Table 2 and Table 3). Extended
interventions covering five or more stages in the care-planning cy-
cle (MD -0.43, 95% CI -0.60 to -0.26; 3 trials, 408 participants)
were more effective than those that were limited to four or fewer
(MD -0.12, 95% CI -0.26 to 0.02; 6 trials, 1508 participants)
(Analysis 7.1). High-intensity interventions (those involving one
or more contacts a month for more than three months) (MD -
0.43, 95% CI -0.63 to -0.24; 5 trials, 847 participants) were more
effective than low-intensity ones (MD -0.17, 95% CI -0.29 to -
0.04; 4 trials, 1069 participants) (Analysis 8.1) and integrated in-
terventions (those where the patient’s usual clinician was informed
about the patients’ goals and action plans) (MD -0.45, 95% CI
-0.70 to -0.21; 2 trials, 358 participants) resulted in greater im-
provement than those that were not integrated (MD -0.19, 95%
CI -0.31 to -0.08; 7 trials, 1558 participants) (Analysis 9.1).
We were not able to repeat these comparisons for the other out-
come measures due to the small number of studies in each group.
Nor were we able to examine the effect of the clinician’s role, for
example differences between those interventions that focused on
changing clinicians’ behaviour as well as that of patients, or those
that involved contact with specially trained clinicians or peers in
addition to the patient’s usual-care clinicians versus those that re-
lied on usual-care clinicians only.
Subgroup analysis: Effect of type of participant
Only one study included a formal measure of health literacy
(Schillinger 2009), so we were unable to produce a pooled assess-
ment of its effect on outcomes. No studies focused exclusively on
patients with multi-morbidities, so our original intention to assess
the effects of personalised care planning for these patients remains
unfulfilled.
Of the five studies that recruited a majority of participants from
lower socio-economic groups or minority ethnic populations,
three found improvements on some outcome measures.
D I S C U S S I O N
Despite the proliferation of studies of various aspects of long-term
condition management, personalised care planning (as we defined
it) has been assessed in a relatively small number of randomised
controlled trials. We found 19 trials that fitted our definition; in
other words, they had evaluated interventions designed to encour-
age and support patients to play an active role in identifying their
own goals, determining priorities, and developing plans collabo-
ratively with clinicians.
Fifteen out of the 19 studies reported positive effects for at least
one outcome measure. The four studies that found no difference
in effect between intervention and control groups (Frosch 2011;
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Glasgow 2005a; Kennedy 2013; Ludman 2007) evaluated low-in-
tensity interventions, and all but one (Kennedy 2013) were ’add-
ons’ with no direct involvement of the patient’s usual-care clini-
cians. Ludman 2007 was a small pilot for the larger Katon 2010a
study and as such was not powered to distinguish effects between
the groups. Kennedy 2013 had problems due to poor fidelity to
the intervention, which may explain the lack of effect.
We found moderate-quality evidence that personalised care plan-
ning leads to improvements in physical health (blood glucose lev-
els), psychological health (depression), self-management capabil-
ities (self efficacy) and health behaviours (self-care activities). Ev-
idence of impact on condition-specific health status, medication
adherence, exercise frequency, resource use and cost effectiveness
was mixed. We found no evidence of effects on diastolic blood
pressure, cholesterol, body mass index, generic health status, or
diet. Interventions that were more comprehensive, more inten-
sive, and integrated into routine care achieved greater benefit than
those that were limited, low intensity or not integrated.
Our review suggests that personalised care planning to identify
patients’ needs for clinical care and self-management support offers
promise as an effective way of improving health outcomes for
people with long-term conditions.
Summary of main results
Physical health
Eleven studies measured the effects of personalised care planning
on various clinical indicators of physical health. Six out of nine
studies found improvements in glycated haemoglobin for the in-
tervention group as compared to the control group. Combining
these in a meta-analysis gave moderate confidence that person-
alised care planning for people with diabetes was effective for im-
proving blood glucose control. Six studies included blood pressure
among the outcome measures, and the pooled results showed that
personalised care planning contributed to a small reduction in sys-
tolic blood pressure, but not diastolic. A single study found im-
provements in lung function and control among asthma patients.
No effects were observed on cholesterol levels or body mass index.
Psychological health (depression)
Three out of six studies that measured symptoms of depression
reported improvements. The pooled results for five of these stud-
ies showed that personalised care planning led to a reduction in
symptoms of depression. We were unable to include one study in
the pooled analysis due to differences in the way outcome mea-
sures were reported. This study found greater improvement in the
control group than the intervention group.
Subjective health status (generic and condition-specific)
Impact on subjective health status or quality of life was measured
using a variety of different scales, making it difficult to produce
a pooled estimate. Six studies measured the effects on generic (as
opposed to condition-specific) health status, but only one reported
a significant improvement related to personalised care planning.
Three studies measured generic health status using the physical
component score (PCS) and mental component score (MCS) of
the SF-36 and SF-12. We pooled results from these and found no
effect. Condition-specificmeasures of health status are often found
to be more sensitive to small effects than generic measures. Four
of the included studies measured condition-specific health status
(three for diabetes and one for asthma): the pooled results showed
a small improvement associated with personalised care planning.
Self-management capabilities
Personalised care planning appears to have a positive effect on peo-
ple’s confidence and skills to self-manage their long-term condi-
tion. Seven out of eleven studies that measured the effect on self-
management capabilities found improvements. Six studies used
comparable instruments to measure self efficacy (one relevant in-
dicator of self-management capabilities). After excluding one large
pragmatic trial (Kennedy 2013) in which the intervention was not
implemented by clinicians as intended (and was therefore at high
risk of bias), pooled results from the remaining five studies showed
a small effect favouring personalised care planning.
Secondary outcomes
Ten studies measured the effects of personalised care planning on
various health-related behaviours, including exercise, diet, medica-
tion adherence and self-care activities such as blood glucose mon-
itoring or foot care, nine of which found improvements in one
or more of these measures. We found a positive effect on self-care
activities associated with personalised care planning and a small
positive but non-significant effect on daily exercise levels.We were
unable to pool data for the other behaviours due to the variety of
measures used.
Only three studies included an estimate of impact on resource
use and only two of these included cost data. One study found
that the intervention was cost-effective, whereas the other study
concluded that any savings due to reduced hospitalisation rates
were outweighed by the costs of the intervention.
Subgroups
We had hoped to be able to compare the effects of several different
facets of interventions on the full range of outcomes. The compar-
isons we considered important were as follows: those interventions
wheremost of the stages of the care planning cycle were completed
(extended) compared to those that completed only four or fewer
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(limited); those that attempted to change both clinicians’ and pa-
tients’ behaviours against those focused on patients’ behaviour
only; those classified as high-intensity compared to those that were
low; and those that were integrated into the patient’s usual care
compared to those that were provided as additional services. In
the event we had too few studies to carry out these comparisons
for any of the outcomes apart from blood glucose measurement,
which is applicable to patients with diabetes only. In this case we
found that the effects of personalised care planning were greater
whenmore stages of the care planning cycle were completed, when
contacts between patients and health professionals were more fre-
quent, and when the patient’s usual clinician was involved in the
process.
We were unable to estimate the relative effects of personalised
care planning on participants with low as opposed to high health
literacy, or on those with multiple long-term conditions compared
to those with one condition only, because we found only one study
that included a formal measurement of health literacy and none
of the included studies focused explicitly on multi-morbidity. The
results from the five studies that included amajority of participants
with lower socio-economic status or from minority ethnic groups
were mixed.
Overall completeness and applicability of
evidence
The trials included in our review evaluated complex interventions
applied mainly, but not exclusively, in primary care settings and
involving various different patient groups with different medical
diagnoses and different cultural, ethnic and socio-economic back-
grounds. Thirteen of the 19 studies were conducted in the USA
and 12 of the 19 focused on diabetes.We do not know if the results
are generalisable to other settings and other patient groups, but
we have no reason to think they are not. There were differences
between the included studies in their stated aims and theoreti-
cal underpinnings. Few of the authors described personalised care
planning in precisely the same manner that we have adopted for
this review, and it was not always the primary focus of the evalu-
ations. While all the studies included personalised care planning
as a major component, they involved a variety of additional self-
management tools and techniques, including information pack-
ages, worksheets, group visits, educational interventions, and peer
coaching. We cannot therefore assume that the observed effects
were due solely to the planning process itself.
The interventions were delivered by a range of different types of
clinicians, including doctors, nurses, other therapists and in two
cases, patients as peer coaches (Thom 2013; Van der Wulp 2012).
In some cases the work of these clinicians or coaches was carefully
structured (including scripts or prompts to guide discussions with
patients) and tightly supervised, while other studies relied on brief
training courses only. Other interventions weremore pragmatic in
that they involved usual-care clinicians in the delivery the inter-
vention. This was harder to control and two of the larger studies
(Battersby 2007; Kennedy 2013) had problems persuading clin-
icians to adhere to study protocols, weakening any effects of the
intervention.
The wide diversity of outcome measures used in these trials ham-
pered our efforts to pool the data to some extent. Also, the diver-
sity of outcome measures did not necessarily reflect full coverage
of important outcome domains. This was especially true in rela-
tion to self-management capabilities. We were able to pool results
from studies that measured the effect of the intervention on self
efficacy, but self efficacy refers to self-perceived cognitive abilities,
and the standard measures of self efficacy tend to focus on ability
to carry out medically defined tasks. Self-management capability
is a broader concept that refers to the capacity and opportunity
to manage a condition, to attain valued goals, and more generally
live well with the condition. Research to date has not adequately
addressed the effects of personalised care planning on people’s so-
cially shaped and observed opportunities to manage and live well
with long-term conditions.
We were unable to assess the likely impact of personalised care
planning on people with multiple long-term conditions or on
those with low health literacy. Four of the included studies focused
on populations with low socio-economic status, but the diversity
of approaches and outcome measures made it impossible to make
a reliable assessment of the extent to which the effects may vary
between these population subgroups.
Quality of the evidence
Risk of bias was an issue for many of the included studies. None
of the studies was assessed as having a high risk of bias in relation
to random sequence generation or allocation concealment, but 11
studies provided unclear or no information on these issues. Blind-
ing of participants is almost impossible with this type of interven-
tion and none of the studies achieved this, so we focused on blind-
ing of outcome assessment, which was adequate in nine studies,
unclear in nine studies, and high risk in one study. Detection bias,
attrition bias and reporting bias should be less problematic, but
several studies failed to report these risks adequately and three were
assessed as having a high risk of bias in respect of these factors.
We pooled results from studies with different outcome measures
that appeared to be measuring the same or very similar constructs
(e.g. depression symptoms, self efficacy), but this will have intro-
duced a degree of heterogeneity. We ignored outcome measures
that did not appear to have been validated, but we did not at-
tempt an independent assessment of the psychometric properties
of the included measures. In certain cases (e.g. self-management
capabilities) we had concerns about the measures used: in many
cases these were medically focused and might not have tapped into
the factors that were most important to individual patients. We
excluded studies where people’s choices were restricted to a pre-
determined set of very narrowly defined goals, but in most cases
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there were limits to the options considered, undermining the ex-
tent to which the process could be said to be truly personalised. It
is interesting, and worrying, to note how few studies (only four)
included reports on the extent to which patients achieved their
personal goals.
Several of the studies were too small and underpowered to detect
an effect. Some suffered high rates of attrition and the more natu-
ralistic (pragmatic) studies had problems in encouraging clinicians
to implement the intervention as designed. This was a particular
problem for the largest study in the group (Kennedy 2013), so
we excluded this one from the pooled analysis of effects on self
efficacy (the only outcome measure in this study that was possible
to pool) because its negative findings would have swamped the
others, giving a distorted result.
Potential biases in the review process
Identifying relevant studies in this broad topic area was challeng-
ing. We searched a wide variety of databases, including trial reg-
isters and lists of unpublished sources such as PhD theses. We
scanned reference lists for relevant studies and we searched for ad-
ditional papers reporting other aspects of eligible studies, such as
protocols and additional findings.
Two review authors, working independently, carried out study
identification and data extraction, and referred any disagreements
to a third review author for resolution. Although we were very
careful not to discard relevant studies, we cannot discount the
possibility that we may have missed some. In certain cases the
interventions were poorly described, making it difficult to judge
whether or not personalised care planning had taken place. In
cases of doubt, we excluded the studies. The trials listed in the
Characteristics of excluded studies table are those that we actively
considered for possible inclusion but eventually discarded after
discussion by three of the review authors. Most of the excluded
studies described interventions that in our view were not truly
collaborative.
We used fixed-effect meta-analysis because of the small number
of studies in each analysis. This carries the risk that it may yield
confidence limits that are too narrow. We checked this by doing
a sensitivity analysis using a random-effects model, and found it
made no difference to the main findings, apart from self efficacy
where the positive effect would disappear.
Agreements and disagreements with other
studies or reviews
A 2009 overview of systematic reviews concluded that while there
was good evidence that the processes involved in personalised
care planning would engage patients more effectively in manag-
ing their care, there was little evidence for an impact on health
outcomes of doing so (Graffy 2009). We have now shown that
there are indeed health benefits from this approach. Other reviews
have examined various tools or interventions designed to inform
and engage patients, such as decision aids (Stacey 2014), con-
tracts (Bosch-Capblanch 2007), training for health professionals
(Dwamena 2012), interactive health communication applications
(Murray 2005), and a variety of methods to promote shared deci-
sion making (Legare 2014). For the most part these reviews found
evidence of beneficial effects on the process of care but not on the
outcomes. They focused on specific interventions designed to pro-
mote more collaborative forms of decision making and looked at
whether the interventions produced the desired effect (i.e. shared
decision making). Our starting point was different. We selected
studies where a collaborative approach (personalised care plan-
ning) had been adopted as the intervention, and we assessed the
effects of this on patient outcomes. The distinction is important
because it led to the inclusion of a different set of studies, and
hence a different assessment of the effects of this type of collabo-
ration between patients and clinicians.
Evidence is accumulating that group-based self-management ed-
ucation can lead to improvements in some health outcome mea-
sures (Brady 2013; Foster 2007; Franek 2013; Steinsbekk 2012),
but attending a weekly course does not suit everyone and prob-
lems with availability, infrequent referral by GPs, and low rates of
uptake by patients have been reported, particularly amongst those
groups most in need of self-management support (Jordan 2007).
One-to-one personalised care planning, coupled with appropri-
ate information, health coaching, problem-solving support and
care co-ordination may be a better solution for these people, es-
pecially if it is relatively intensive and integrated into routine care
(Williams 2011a). Implementing all elements of the Chronic Care
Model (patient self-management support, use of clinical informa-
tion systems, delivery system redesign, provider decision support,
linkage to community resources, and organisational development)
could help to ensure that the outcome improvements are sustained
(Woltmann 2012).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Personalised care planning leads to improvements in certain in-
dicators of physical and psychological health status and people’s
ability to self-manage their condition, when compared to usual
care. The effects appear to be greater when the intervention is
more comprehensive, intensive and well-integrated into routine
care. Evidence on the relative cost effectiveness of this approach is
limited and uncertain.
In its ideal form, personalised care planning is fundamentally dif-
ferent fromusual care (Burt 2012). It involves shared control of the
consultation and a focus on the patient as a whole person, not just
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their specific condition. It includes support for self management
and behaviour change, and should be the means by which care
is co-ordinated and integrated around the individual. Achieving
this in practice would require fundamental changes to the organ-
isation and delivery of primary care in most countries to enable
a more proactive, anticipatory and integrated approach (Coulter
2013; Stellefson 2013). The context of primary care differs from
country to country, so any intervention to support new models
of care must be carefully tailored to local circumstances. It will
probably require training for health professionals in how to elicit
patients’ goals and priorities, while avoiding the imposition of an
overly directive model of care that could undermine patients’ con-
fidence to self-manage their conditions (Williams 2011b). Shared
decision making and non-directive motivational interviewing are
well-described methods or competencies that might provide the
core of these training schemes (Elwyn 2014), but their introduc-
tion into routine care needs to be tailored to local circumstances.
The evidence gathered here suggests that investment in relevant
training, support and system redesign could lead to better out-
comes for people with long-term conditions. We found some evi-
dence that more intensive and better integrated approaches to per-
sonalised care planning and self-management support may work
best, but heterogeneity and uncertainties among both the inter-
ventions and the outcome measures mean that current evidence
cannot support a specific blueprint for widespread adoption. Nev-
ertheless, our review offers a comprehensive conceptualmodel that
we hope will inform future interventions.
Implications for research
We found positive effects on blood glucose, blood pressure, de-
pression, condition-specific health status, self-management capa-
bilities, and self-care activities. This is encouraging, but more trials
are required to check the robustness of these findings in diverse
settings and to determine which elements of these complex inter-
ventions are most likely to be effective.
Support for self management of long-term conditions is a growing
area of research.We identified published protocols for seven ongo-
ing studies that may help to address important uncertainties about
the effects of personalised care planning. Future studies should ex-
amine its impact on patients’ self-management capabilities, health
behaviours, goal attainment, and resource use, in addition to clin-
ical indicators and psychological outcomes. Studies should focus
on longer-term outcomes and include measures of resource use
and costs. More studies are also needed to compare outcomes for
patients at different levels of health literacy. The lack of studies
on multi-morbidity is a serious gap in knowledge that has been
noted before (Barnett 2012). Since personalised care planning is
potentially an effective way to co-ordinate care for people with
multiple health problems, we would hope to see many more stud-
ies addressing this issue.
Ideally trials should be conducted in real-life settings, but this is a
difficult topic to study in cluster trials because it involves complex
behaviour change and a time commitment from those delivering
the intervention. Ensuring fidelity to the protocol can be very
difficult in these situations, as evidenced by the experience of the
investigators involved in Kennedy 2013. Their very useful process
review (Kennedy 2014) should be read by all researchers planning
future trials in this field.
Greater standardisation of outcome measures would be very help-
ful for future systematic reviews and meta-analyses. Subjective
health status and self-management capabilities are key outcomes
in studies of care and support for people with chronic conditions,
but the field will not advance until there is greater agreement on
how to measure these constructs. It is of some concern that so few
published studies in this field have attempted to find out whether
patients attained their personal goals, as opposed to those deter-
mined by clinicians or researchers. This implies a disrespect for
patients’ interests, values and capabilities-the antithesis of person-
alised care. Most studies in our review adopted a limited view
of patients’ capabilities, usually restricted to managing health-re-
lated procedures and behaviour change. This ignores many of the
other resources that individuals, families and communities can
contribute to health improvement. We also need more in-depth
information about patients’ experience of personalised care plan-
ning to determine which models work best, for whom and in what
circumstances. We fervently hope that future studies will remedy
these gaps, perhaps by including patient-generated outcome mea-
sures, by conducting qualitative research alongside the randomised
trials, or both.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Battersby 2007
Methods Study design: 8 studies in 4 regions, including 4 RCTs (the others used geographic
controls)
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: South Australian Health Commission; Commonwealth Department
of Health and Aged Care
Conflicting interests: none declared
Participants Country: Australia
Setting: Primary care
Conditions/numbers: 1703 patients with various conditions: Central region: cardiac (n
= 271 intervention, 138 control); Southern region: respiratory (n = 165 intervention, 62
control), somatisation (n = 90 intervention, 35 control), aged care (n = 632 intervention,
310 control) - total 1158 intervention, 545 control. (Battersby 2005 p. 663)
Health literacy: n/a
Multi-morbidity: n/a
Interventions Theoretical framework: Chronic Care Model
Focus: Both clinician and patient
Type of intervention: Structured, face-to-face planning and care co-ordination + staff
training
Clinicians involved: Service co-ordinators (nurses + allied health professionals - addi-
tional) and regular GP
Tools: SAHealthPlusCo-ordinatedCare. Service co-ordinator assisted theGP to develop
a care plan based on a care plan generator. This included patient’s self-defined problems
and goals. Based on this and the GP’s knowledge of the patient, as well as the patient’s
’Problems & Goals’ statements, the GP and patient made a joint decision on what
support and services were needed. Both the GP and the patient signed the care plan,
and copies were made for patient, service co-ordinator, other providers and GP. Service
co-ordinators received 2 days training + competency assessment and group supervision.
The service co-ordinator helped the patient gain access to and co-ordinate community
and patient education services and worked with the patient to achieve his or her goals.
GPs were paid a fee to develop each care plan and an annual fee to oversee patients’ care,
supported by the service co-ordinators
Stages completed: Extended - A, B,C,D,E,F,G
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input:Good (training and ongoing supervision), but “The
[intervention group] GPs needed reminders to order the services scheduled on the care
plan.” (p. 62)
Fidelity: Weak. “The intervention was not in place long enough for its full implemen-
tation” (p. 62)
Attrition: High. More than 50% of participants lost to follow-up following trial exten-
sion (p. 48)
Comparison: Usual care
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Battersby 2007 (Continued)
Outcomes Health status: subjective:Medical Outcomes Study short form (SF-36),Work and Social
Adjustment Scale (WSAS); psychological: Beck Depression Inventory (BDI), State-Trait
Anxiety Inventory (STAI), Hostility and Direction of Hostility Questionnaire (HDHQ)
(Pols 2008)
Self-management capabilities: n/a
Health behaviours: n/a
Attainment of personal goals: problems and goals score
Service use: *service use and costs
Adverse events: none reported
Timing of outcome measures: 12 months; baseline measures not reported
Notes *Primary outcome. Negative results not reported in full. Author contacted - more papers
supplied but no relevant additional data obtained. Data from one sub-trial with complete
results (Pols 2008) included in meta-analysis. Pols 2008: power calculation - required
sample size of 300 participants to detect 15% reduction in hospital admissions but only
124 recruited, so under-powered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Pols 2008: randomisation performed by
random number allocation (p. S133)
Allocation concealment (selection bias) Low risk Pols 2008: random number allocation pro-
vided to the research officer by telephone
from the local evaluation team (p. S133)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Pols 2008: GPs were not blinded to partic-
ipant allocation. All GPs looked after par-
ticipants in both intervention and control
groups, (p. S133)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Pols 2008: research officers were not
blinded to participant allocation, but out-
come assessments were administered in-
dependently by separate contractors using
postal questionnairesmailed to participants
(p. S134)
Incomplete outcome data (attrition bias)
All outcomes
High risk Pols 2008: High levels of attrition: only 42
out of 89 in the intervention group (47%)
and 22 of 44 in the control group (50%)
completed the study. Reasons for loss to fol-
low-up reported for study as a whole but
not for the two randomised sub-trials, so
not possible to isolate these. Service use
analysed on an intention-to-treat basis but
41Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Battersby 2007 (Continued)
not possible for SF-36 and WSAS
Selective reporting (reporting bias) High risk Battersby 2007 reports significant results
only for SF-36 and WSAS, not non-signif-
icant findings, and RCTs and those with
geographical controls are lumped together.
Battersby 2005 reports only significant re-
sults for SF-36, not total scores or non-sig-
nificant results for subscales. Cost data in-
clude only those who had an inpatient ad-
mission prior to entry. These facts are made
clear in the papers. Pols 2008 reports full
results for SF-36 but not for WSAS, but
they state that there was no significant dif-
ference in results for WSAS (p. S136)
Other bias Unclear risk Work and Social Adjustment Scale has not
been validated in a chronically ill popula-
tion and the work questions were omitted
because not relevant to most participants
(p. 46)
Frosch 2011
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources:RobertWood Johnson Foundation; Foundation for InformedMedical
Decision Making; National Institute on Aging; National Institutes of Health
Conflicting interests: fees/grants fromFoundation for InformedMedicalDecisionMak-
ing
Participants Country: USA
Setting: Primary care
Conditions/numbers: 201 diabetes patients (type 2) (100 intervention, 101 control)
Health literacy: Predominantly poor, uninsured ethnic-minority patients with poorly
controlled diabetes (p. 2015)
Multi-morbidity: Charlson co-morbidity index - intervention 0.81 ± 1.3, control 0.66
± 1.2
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Information + structured coaching (phone)
Clinicians involved: Health coach (additional)
Tools: Participants viewed a 24-minute-long DVD plus booklet, followed by up to 5
sessions of telephone coaching with a trained nurse educator. First session was up to 60
minutes, second and third 30minutes, fourth and fifth 15minutes.Maximumamount of
coaching time was 2½ hours. Purpose was to collaborate with participants in identifying
desired and attainable behavioural goals that could have a positive impact on their diabetes
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Frosch 2011 (Continued)
management. The coach collaborated with participants to develop a specific behavioural
plan, which was then monitored and adjusted as participants attempted to implement
their behavioural goals. A single health coach trained in patient-centred approaches to
diabetes management and motivational enhancement saw all participants. Participants
received a call 1 week after enrolment to remind them to review the brochure and DVD.
They were eligible to receive up to 5 sessions of telephone coaching, but there were
frequent delays in contact and only 73% completed 5 coaching sessions
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: Not stated
Standardisation of clinician input: A single trained clinician provided all coaching
sessions.
Fidelity: 73% completed 5 coaching sessions, 15% did not complete any
Attrition: 5% intervention, 14% control lost to follow-up
Comparison: Usual care + booklet
Outcomes Health status: physical: blood glucose (HbA1c)*, cholesterol, blood pressure, BMI
Self-management capabilities: University of Michigan Diabetes Knowledge Test
Health behaviours: 25-item Summary of Diabetes Self-Care Activities measure (diet,
exercise, blood glucose testing, foot care, smoking), adherence to medications
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Timing of outcome measures: Baseline, 1 month, 6 months
Notes *Primary outcome. Power calculation - required sample size of 200 participants to detect
meaningful difference between the groups on HbA1c
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomised into equally
sized control and experimental conditions
using a predetermined randomisation se-
quence concealed in sealed envelopes (p.
2012)
Allocation concealment (selection bias) Low risk Sealed envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not possible to blind participants, but as
most outcomes were objective it is unlikely
to have a significant effect on risk of bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Research staff were not blinded to partic-
ipants’ assignments, but primary outcome
was biological measure that is not sensitive
to unblinding (p. 2016)
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Incomplete outcome data (attrition bias)
All outcomes
Low risk 84% completed the 6-month survey (p.
2013). Intention-to-treat analysis reported
with missing data imputed
Selective reporting (reporting bias) Unclear risk No published protocol.
Other bias Low risk Randomisation occurred after participants
completed their medical consultations to
mask healthcare providers to participants’
assignment (P. 2012)
Glasgow 2005a
Methods Study design: Cluster-RCT
Unit of randomisation: physician
Unit of analysis: patient
Funding sources: Agency for Health Research and Quality
Conflicting interests: none declared
Participants Country: USA
Setting: Primary care
Conditions/numbers: 886 diabetes patients (type 2) (469 intervention, 417 control)
Health literacy: n/a
Multi-morbidity: n/a
Interventions Theoretical framework: Chronic Care Model
Focus: patient
Type of intervention: Information + self-management support (phone or face-to-face)
Clinicians involved: Care manager (additional)
Tools: Diabetes Priority Program. Participants were asked to come 30 minutes early to
2 diabetes-related visits, scheduled 6 months apart, to complete a computerised assess-
ment and action-planning procedure. The CD-Rom-assisted diabetes care enhancement
program with touchscreen assessment and feedback to check receipt of lab tests and
other clinical procedures (NCQ/ADA Diabetes Physician Recognition Program - PRP)
and self-management support, and to develop a self-management action plan focusing
on behaviour change in diet, smoking and physical exercise involving personal goals.
Three printouts summarised results for participant, physician and care manager (nurse
or medical assistant), including prominent notation of areas the participant wished to
discuss. Care managers trained in patient-centred self-management support met with
participants or scheduled phone calls and organised follow-ups to review progress. The
discussion included review of the medical care needs and self-care goals that the par-
ticipant identified and brainstorming additional strategies that participants could use
to overcome barriers to their goals. This took an average of 8 - 10 minutes. The care
manager also attempted a brief follow-up call after each visit to review progress and to
reinforce strategies developed. These procedures were repeated at the next visit about 6
months later
Stages completed: Limited - B, C, D, F
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Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: Care managers received brief training only, none
for physicians
Fidelity: 75% of eligible patients participated, 73% discussed print-out with physicians,
77% met care manager, 67% received at least 1 phone follow-up
Attrition: 19% intervention, 15% control lost to follow-up
Comparison: Completion of touch-screen computer assessment with PRP measures +
general health risk appraisal + same number of visits + printout on general health risks,
without PRP and follow-up calls
Outcomes Health status: physical:HbA1c, cholesterol; psychological: Patient Health Questionnaire
(PHQ-9); subjective: Problem Areas in Diabetes (PAID-2),
Self-management capabilities: n/a
Health behaviours: n/a
Achievement of personal goals: self report
Service use: n/a
Adverse events: none reported
Timing of outcome measures: Baseline, 12 months
Notes Primary outcome - PRP measures (performance of specified clinical procedures) were
excluded because not relevant to this review. Power calculation - required sample size of
32 physicians and 774 patients to detect a moderate effect
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participating physicians were stratified by
size of practice and urban/rural setting.
Randomisation was conducted by the
project statistician, who then notified re-
search staff of condition assignment
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding not described. Not possible to
blind participants.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rates were approximately equiva-
lent (19% intervention and 15% control).
Analyses were conducted on complete cases
Selective reporting (reporting bias) Unclear risk No published protocol.
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Other bias Low risk No evidence of selective recruitment of
clusters. Participating physicianswere strat-
ified by size of practice and urban/rural
setting. No significant differences between
groups at baseline. To avoid contamina-
tion, all physicians within a given clinic
were assigned to the same condition. To
account for clustering of patients within
physician. a generalised regression model
using a random effect for the physician
(a mixed model) was fitted, adjusting for
baseline score on the dependent variable
with a random physician effect and par-
ticipants nested within physician (Glasgow
2004a, p. 1168). Outcomes were evaluated
using mixed-model regression analyses (to
account for clustering) and controlling for
baselines scores on the dependent variable
and any other potential confounding vari-
ables
Hart 1978
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: not stated
Conflicting interests: not stated
Participants Country: USA
Setting: Community mental health centre
Conditions/numbers: 32 mental health patients (diagnoses unspecified) (16 interven-
tion, 16 control)
Health literacy: n/a
Multi-morbidity: n/a
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Individual therapy
Clinicians involved: Clinician ’scaler’ (additional) and psychotherapist (usual)
Tools: The Behavioral Monitoring Process Record (BMPR) was designed to help par-
ticipants set goals and report on their progress at each subsequent therapy session. A 4-
week goal was set with the participant and reviewed each week. Within each problem
area, a weekly goal and method of attainment was specified. Participant and therapist
jointly assessed the degree of attainment of each goal. Goals had to be observable, de-
finable and measurable and structured in a step-by-step manner. All participants com-
pleted an ’intake history’ based on two interview sessions.At a third interview session
they collaboratively prepared a follow-up guide that consisted of setting treatment goals
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and predicting 5 levels of goal attainment with an ’expected’ level of attainment by the
eighth therapy session. ’Collateral persons’ (other people significant to the participant,
such as spouse or probation officer) helped to identify problem areas and to validate the
participant’s self report at follow-up. Randomisation took place after the third session
Stages completed: Limited - B, C, D, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: Only 4 therapists involved
Fidelity: Not reported
Attrition: None reported
Comparison: Same individual therapy without weekly goal setting or monitoring
Outcomes Health status: n/a
Self-management capabilities: n/a
Health behaviours: n/a
Achievement of personal goals:Goal Attainment Scale (GAS) (Kiresuk 1968) - achieve-
ment of personal goals
Service use: n/a
Adverse events: none reported
Timing of outcome measures: Baseline, 3 months
Notes No power calculation reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details provided.
Allocation concealment (selection bias) Unclear risk No details provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No details provided.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No details provided.
Selective reporting (reporting bias) Unclear risk No published protocol.
Other bias Low risk The collateral person was a source of ex-
ternal validation of the participant’s self
report. Validation included identification
and definition of the participant’s problems
at intake (pretest score) and input as to
47Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hart 1978 (Continued)
the level of functioning on the attainment
level of the follow-up guide at the follow-
up evaluation
Hiss 2007
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: National Institutes of Health; National Institute of Diabetes and
Digestive and Kidney Diseases
Conflicting interests: not stated
Participants Country: USA
Setting: Primary care
Conditions/numbers: 197 diabetes patients (type 2) (95 intervention, 102 control)
Health literacy: recruited from community clinics serving under-insured residents
Multi-morbidity: n/a
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Structured face-to-face meetings
Clinicians involved: Nurse care manager (additional) and usual primary care physician
Tools: All participants received a comprehensive evaluation of their diabetes at the com-
munity clinic they attended. A report of the evaluation plus appropriate explanations
and interpretations was mailed to both the participant and his or her physician. This
preceded randomisation. Those in the intervention group then received several indi-
vidually arranged meetings with a nurse care manager where they discussed problem
identification, problem-specific, short-term goal setting and development of a tentative
action plan. This was communicated to the primary care physician who participants
were advised to contact to follow up identified problems. Then followed a collabora-
tive interaction between nurse, physician, and participant focused on short-term goal
attainment, plus proactive and continuous follow-up by the nurse care manager. Long-
term goal setting typically occurred during subsequent nurse/participant meetings as the
participant gained experience in carrying out the action plan. Short- and long-term goals
were participant-specific and based on problems identified in the baseline evaluation.
These included family issues, financial status, employment, insurance status, and access
to and payment for medical care, as well as medical goals
Stages completed: Extended - A, B, C, E, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: Single nurse care manager
Fidelity: In-person and phone contacts monitored and reported
Attrition: 15% intervention, 19% control lost to follow-up
Comparison: Usual care + evaluation of diabetes with report mailed to participant and
physician
Outcomes Health status: physical: HbA1c, serum cholesterol, systolic blood pressure (SBP), dias-
tolic blood pressure (DBP)
Self-management capabilities: n/a
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Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Timing of outcome measures: Baseline, 6 months
Notes No power calculation reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants accounted for. Intervention
group: no post-intervention data obtained
from14participants (moved=4, long-term
care = 1, lost = 7, refused = 2). Control
group: no post-intervention data from 19
(death = 3, moved = 3, long-term care = 1,
lost = 6, refused = 6)
Selective reporting (reporting bias) Unclear risk No published protocol. All outcomes re-
ported, but no intention-to-treat analysis.
MissingBPdata for 3 in intervention group
and 2 controls unaccounted for
Other bias Low risk
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Katon 2010a
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: National Institute of Mental Health; Group Health Cooperative
Conflicting interests: fees/grants fromWyeth, Eli Lilly, Forest, Pfizer, Prescott Medical,
HealthSTAR Communications, World Psychiatry Association, John A Hartford Foun-
dation, Johnson & Johnson, Samepage, Rewarding Health, Roche Diagnostics, Group
Health Cooperative
Participants Country: USA
Setting: Primary care
Conditions/numbers: 214 patients with depression + diabetes and/or CHD (106 in-
tervention, 108 control)
Health literacy: n/a
Multi-morbidity: yes
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Structured, face-to-face self-management support + staff training
Clinicians involved: Nurses (additional), primary care physicians (usual)
Tools: TEAMcare intervention combined support for self care with pharmacotherapy
to control depression, hyperglycemia, hypertension, and hyperlipidemia. Participants
worked collaboratively with nurses and primary care physicians to establish individu-
alised clinical and self-care goals. In structured visits at each participant’s primary care
clinic every 2 to 3 weeks, nurses monitored participant’s progress in management of de-
pression, control of medical disease, and self-care activities. Treatment protocols guided
adjustments of commonly used medicines in participants who did not achieve specific
goals. Nurses followed participants proactively to provide support for medication adher-
ence. Using motivational interviewing and coaching, nurses helped participants solve
problems and set goals for improved medication adherence and self care (e.g. exercising
and self-monitoring blood pressure and glucose levels). Participants received self-care
materials including The Depression Handbook, a video compact disk on depression care, a
booklet and other materials on chronic condition management and self-monitoring de-
vices (e.g. blood pressure or blood glucose meters) appropriate to their condition. Nurses
received weekly supervision with a psychiatrist, primary care physician, and psychologist
to review new cases and participant progress. Supervising physicians recommended ini-
tial choices and changes in medications tailored to the participant’s history and clinical
response. When targeted levels were reached, the nurse and the participant developed
a maintenance plan that included stress reduction, behavioural goals, continued use of
medications, and identification of prodromal symptoms associated with worsening de-
pression and glycemic control. Nurses then followed up with telephone calls every 4
weeks. Participants with disease control that worsened were offered follow-up visits or
telephone calls and protocol-based intensification of treatment regimens
Stages completed: Extended - A, B, C, D, E, F, G
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: strong - 2-day training course attended by the 3
study nurses + educational materials + weekly case-load reviews with physicians + close
monitoring
Fidelity: Data and safety monitoring board, numbers of in-person and phone contacts
50Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Katon 2010a (Continued)
monitored and reported
Attrition: 12% at 6 months and 17% at 12 months lost to follow-up
Comparison: Enhanced usual care
Outcomes Health status: physical: HbA1c, systolic blood pressure, LDL cholesterol; psychological:
Symptom Checklist-20; Patient Global Rating of Improvement*; subjective: Sheehan
social role disability scale,WHODisability Assessment Schedule (WHODAS-2), quality
of life (0 to 10) (NV)
Self-management capabilities: 4 selected questions from short-form Patient Activation
Measure (PAM-13)
Health behaviours: diet, exercise, medication adherence
Achievement of personal goals: n/a
Service use: healthcare costs and cost effectiveness, including depression-free days,
QALYs, outpatient costs
Adverse events: hospitalisations - 27 intervention, 23 control; deaths: 1 intervention, 2
control
Timing of outcome measures: Baseline, 6 months, 12 months
Notes *Primary outcome. Power calculation - 290 participants required to detect a clinically
significant difference in SCL-20 depression scores, HbA1c, systolic blood pressure and
LDL cholesterol. Only 214 recruited so under-powered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned by
computer using a permuted block design
with randomly selected block sizes of 4, 6,
and 8 patients
Allocation concealment (selection bias) Low risk Research assistants who were unaware of
the intervention status implemented study
procedures (Katon 2010a)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Single-blind only - not possible to blind
participants to intervention, but most out-
comes objective so unlikely to affect risk of
bias
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Clinicians were not blinded to outcome as-
sessments because these were part of the in-
tervention
Incomplete outcome data (attrition bias)
All outcomes
Low risk Fully detailed in Figure 1 of Katon 2010a
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Selective reporting (reporting bias) Low risk Protocol published (Katon 2010b). Data
and safety monitoring board reviewed
methods and outcomes every 6 months.
Katon 2010a includes description of pre-
analysis modifications to protocol
Other bias Low risk Intervention provided by research nurses
not involved with control group, in collab-
oration with primary care physicians
Kennedy 2013
Methods Study design: cluster-RCT
Unit of randomisation: general practices
Unit of analysis: patient
Funding sources: National Institute for Health Research; National Primary Care Re-
search and Development Centre
Conflicting interests: none declared
Participants Country: UK
Setting: Primary care
Conditions/numbers: 5599 patients with diabetes, COPD, or irritable bowel syndrome
from 43 practices (2295 intervention, 3304 control)
Multi-morbidity: n/a
Health literacy:Recruited from practices with high levels of socio-economic deprivation
(p. 2)
Interventions Theoretical framework: Chronic Care Model, Normalisation Process Theory
Focus: Both clinician and patient
Type of intervention: Structured face-to-face coaching + staff training
Clinicians involved: Nurse (usual), GP (usual)
Tools:Whole System Informing Self-Management Engagement (WISE). The interven-
tion was intended to be feasible to implement widely in primary care, which put practical
limitations on the intensity of the intervention. Aim was to take several components and
deliver them as a comprehensive package under naturalistic conditions using routine
care providers to maximise real-world applicability. Two training sessions were organised
for practice staff covering ways of embedding self-management tools in practice systems
(session 1) and using core self-management skills in consultations and ensure participants
received, or were directed to, appropriate resources (session 2). Fidelity checks and rein-
forcement sessions were scheduled after training. Two facilitators delivered the training
and provided access to self-management support activities and resources. These included
a tool to assess patient support needs and priorities (PRISMS); self-help guidebooks;
access to community groups and programmes; and enhanced access to psychological
therapists for IBS participants
Stages completed: Limited - B, C, E, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input:Weak - 2 training sessions + manual, but low levels
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of implementation
Fidelity: Poor - shared decision-making at 6 months significantly less in intervention
than control group (P = 0.05); only 2% of IBS participants referred to therapists; 42% of
clinicians failed to use PRISMS tool (p. 4). Process evaluation (Kennedy 2014) examined
reasons for failure to change practice and confirmed that very little personalised care
planning took place
Attrition: 19% at 6 months and 27% at 12 months lost to follow-up
Comparison: Usual care, including information and support
Outcomes Health status: subjective:MedicalOutcomes Study short form (SF-36), Euroqol (EQ5D)
*
Self-management capabilities: self efficacy*, patient enablement
Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: Baseline, 6 months, 12 months
Notes *Primary outcomes. Power calculation - required sample of 40 practices and 48 partici-
pants per condition per practice (total participants = 5760), so slightly under-powered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Wait-list comparator group. Used a min-
imisation procedure based on practice size,
area deprivation and contractual status,
practices were allocated 1:1 to interven-
tion or control. Practices were paired as
closely as possible according to their pre-
ferred training times, and using a minimi-
sation procedure, 1 practice in each pair
was allocated to training in the first year,
with the other practice allocated to training
at the same time the following year (p. 3)
Allocation concealment (selection bias) Unclear risk Research staff recruiting practices were un-
aware of the next allocation in the sequence
at the time of recruitment (Bower 2012,
p. 7). Baseline (and subsequent follow-up)
data collection then tookplace at both prac-
tices in a pair at the same time. Proved
impossible to recruit participants prior to
allocation. Practices required adequate ad-
vance notice of their training date, hence it
became necessary to inform them of their
group allocation prior to participant selec-
tion. Authors confident that any resulting
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bias is small. Recruitmentwas through elec-
tronic health records rather than by pro-
fessional invitation, but practitioners could
exclude patients after identification. These
exclusions represented a relatively small
proportion of patients (COPD 15% inter-
vention, 11% control; diabetes 11% int.,
10% cont; IBS 11% int., 18% cont.)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Personnel were not blinded and outcomes
were patients’ self report
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Analyst blind to practice allocation (sup-
plementary file).
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis. 81%completed
6 month follow-up and 72.8% the 12-
month follow-up. Few differences between
intervention and control in completeness
of outcome data. Missing values for out-
come variables at follow-up were not im-
puted, but addressed through covariate ad-
justment
Selective reporting (reporting bias) Low risk Trial report matched published protocol
apart from certainmeasures that were even-
tually omitted from the study to make the
questionnaire shorter. No evidence of se-
lective outcome reporting
Other bias High risk Fidelity to the intervention was very poor
- shared decision making at 6 months sig-
nificantly less in intervention than control
group (P = 0.05); only 2% of IBS partic-
ipants referred to therapists; 42% of clin-
icians failed to use PRISMS tool (p. 4).
Kennedy 2014 confirms that very little per-
sonalised care planning actually took place,
so we have excluded the study from the
meta-analysis. No evidence of selective re-
cruitment by clusters. Two trial arms were
reasonably well-balanced on all variables at
the participant level, but practices in the
intervention group were on average slightly
smaller (mean list size 4003 vs 4528 pa-
tients)
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Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: Initiative forCardiovascularHealthResearch inDevelopingCountries
Conflicting interests: none declared
Participants Country: China
Setting: Primary care
Conditions/numbers: 208 diabetes patients (type 2) (intervention 119, control 89)
Multi-morbidity: n/a
Health literacy: n/a, 2 rural communities.
Interventions Theoretical Framework: Chronic Disease Self-Management Program (CDSMP)
Focus: patient
Type of intervention: Group visit + face-to-face consultation
Clinicians involved: Nurse (usual), GP (usual), preventive doctor (usual)
Tools: Participants were invited to attend a 12-session (monthly) group visit programme
+ 60-minute one-to-one visit with healthcare provider at the end of each group visit, if
wanted (only ¼ received these). Programme followedChronic Disease Self-Management
Programme (CDSMP) format, including setting goals and making action plans. The
format was adapted from the Chinese version of Stanford CDSMP Leaders Manual.
The content included topics covered in the generic CDSMP course as well as diabetes
specific self-management support topics recommended by Shanghai community diabetes
prevention and control guidelines. Groups were led by existing general practice teams
consisting of 1 GP, 1 preventive doctor, 1 nurse practitioner and 1 patient. Sessions
focused on helping participants build confidence in their ability to deal with diabetes by
incorporating self-efficacy-enhancing strategies, including action-planning and feedback,
modelling of behaviours by participants for one another, reinterpretation of symptoms,
practicing self-management skills, and group problem-solving. Participants made 12 1-
week action plans over the 12 months. Each group also had a lay leader with diabetes
who followed up with group members on their action plans in person or by telephone
within 1 week. Staff attended a 1-day training workshop
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: GPs and nurses involved in design of scripted
programme implemented in 2 rural communities by 3 general practice teams + 1-day
training workshop
Fidelity: 75.6% of participants attended 10 or more sessions. Patients who participated
were significantly older with a higher prevalence of hypertension than those who declined
Attrition: 15% lost to follow-up
Comparison: Usual care provided by a single GP
Outcomes Health status: physical: body mass index (BMI), systolic blood pressure (SBP), diastolic
blood pressure (DBP); subjective: Self-rated health, energy, health distress, fatigue, illness
intrusiveness, depression (Chinese adaptations of Stanford instruments)
Self-management capabilities: self efficacy, symptom management (Stanford)
Health behaviours: exercise (NV), diet (NV)
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
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Length of follow-up: baseline, 12 months
Notes No primary outcome. No power calculation reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was by means of a random
number table with a ratio designed to yield
no fewer than 20 and no more than 25
participants in a group. (p. 5)
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were aware of their assign-
ments. Both participants and personnel
were aware of treatment status and a num-
ber of outcomes were subjective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Data collection was completed by univer-
sity students who did not know the partici-
pants or their allocation status. All those as-
sessing and analysing the data were blinded
to group assignments (p. 5)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 98 out of 119 in the intervention group
completed the 12-month follow-up and 78
out of 89 in the control group. Reasons for
loss to follow-up are documented in the
flow diagram (p. 4)
Selective reporting (reporting bias) Unclear risk No published protocol, but results pre-
sented for all listed outcome measures
Other bias Unclear risk No significant differences at baseline apart
fromprevalence of hypertensionwhich was
higher in the intervention group and fa-
tigue and illness intrusiveness which were
lower in the intervention group
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Methods Study design:4-armpilotRCT, but only caremanagement armwithout group education
included here
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: National Institute of Mental Health
Conflicting interests: none declared
Participants Country: USA
Setting: Primary care
Conditions/numbers: 52 patients with chronic or recurrent depression (26 care man-
agement intervention, 26 usual care)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: Chronic Care Model
Focus: patient
Type of intervention: Telephone monitoring and care management + staff training
Clinicians involved: Care manager (additional)
Tools:Telephonemonitoring and caremanagement - computerised decision support sys-
tem supported systematic tracking of participant contacts, scripted clinical assessments,
automatic application of treatment algorithms, and generation of feedback reports. The
care manager (a master’s level counsellor) contacted each participant at specified intervals
(at least monthly during the first 3 months then at varying intervals) and helped them
create a written care plan + education about medicines adherence and motivational en-
hancement. The care manager communicated with the treating provider when necessary.
Care management training involved 4 hours of didactic training, 4 hours of role play,
and direct observation of 2 care management contacts, followed by certification + weekly
supervision
Stages completed: Extended - B, C, D, E, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: Strong - single care manager, 4 hours didactic
training + 4 hours role play + direct observation of 2 contacts + certification + weekly
supervision
Fidelity: not reported
Attrition: 18% lost to follow-up
Comparison: usual care
Outcomes Health status: psychological: Structured Clinical Interview for DSM-IV (SCID) depres-
sion module, 20-item SCL depression scale, subjective: Patient-Rated Global Improve-
ment (PGI)
Self-management capabilities: n/a
Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 3, 6, 9 and 12 months
Notes Author contacted and additional data supplied. Pilot study - no power calculation re-
ported
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk After baseline interview data manager as-
signed patients to 1 of 4 treatment groups
using computer-generated permuted block
design (p. 1066)
Allocation concealment (selection bias) Low risk Concealed from interviewers.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind participants.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Interviewers and analysts were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Usual care group participants completed
92% of all blinded follow-up interviews,
care management group completed 82%,
prof-led group completed 94% and peer-
led group completed 83% (p. 1069)
Selective reporting (reporting bias) Unclear risk No published protocol. All outcome mea-
sures mentioned, though not all in tabular
form. For example, detailed results for PGI
not reported in full and SCL only in graph-
ical form. Author contacted
Other bias Unclear risk There were some differences between
groups at baseline - authors do not report
on the significance of these
Naik 2011
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: Agency for Healthcare Research and Quality; Doris Duke Charitable
Foundation; National Institute of Aging; Houston Health Services Research and Devel-
opment Center of Excellence
Conflicting interests: none declared
Participants Country: USA
Setting: Primary care
Conditions/numbers: 87 diabetes patients (45 intervention, 42 control)
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Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Group visit + face-to-face consultation
Clinicians involved: Physicians (additional)
Tools: Empowering Patients in Care (EPIC) was a clinician-led, patient-centred group
clinic consisting of 4 sessions on setting self-management action plans (diet, exercise,
home monitoring, medications, etc.). This was followed by a 1-hour group session and
a 10-min consultation with a clinician. Goals focused primarily on diet and exercise
changes, homemonitoring of blood glucose and medication effects, and communication
with primary care providers about medications. The fourth session allowed for construc-
tive reporting and feedback on participants’ progress. Three primary care physicians led
the sessions. Study clinicians sent a research note to participants’ primary care physician
after each session, consisting of participants diabetes ABC status, specific DM goals and
action plans discussed and any changes made to medications. Action plans for nearly
all participants included taking medications prescribed by primary care physicians and
discussing subjective and objective effects of medications
Stages completed: Limited - B, C, F, G
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: strong - 3 study physicians directed the group
sessions
Fidelity: not reported
Attrition: 2 drop-outs (2.3%), 12 (14%) did not complete follow-up survey
Comparison:Traditional - 2 x 2-hour group education sessions with a diabetes educator
and dietician followed by a visit with a primary care provider 12 weeks after enrolment
Outcomes Health status: physical: blood glucose (HbA1c)
Self-management capabilities: diabetes self efficacy (Stanford)
Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 3 months, 1 year
Notes Power calculation - required 98 participants to detect moderate effect on HbA1c, so
slightly under-powered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk After enrolment participants were ran-
domised using a block randomisation of 10
(p. 454)
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Allocation concealment (selection bias) Low risk Allocation of treatment group assignment
was blinded using sequentially numbered
and sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Both participants and personnel were un-
blinded, but primary outcome was objec-
tive so not likely to affect risk of bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Primary outcome is objective so unlikely to
be affected by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk 43 of 45 participants randomised to EPIC
attended some or all of the intervention
sessions, as did all 42 of participants ran-
domised to the traditional group. Only 1
person from each group was lost to fol-
low-up and hence had no HbA1c outcome
measures. Diabetes Self-Efficacy Scale data
were available for 75 participants (87%) at
1-year follow-up
Selective reporting (reporting bias) Unclear risk No published protocol, but both outcome
measures reported.
Other bias Low risk
Schillinger 2009
Methods Study design: 3-armRCT (only automated telephone self-management support - ATSM
and usual care included here)
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: Commonwealth Fund; Agency for Healthcare Research and Quality;
California Endowment; San Francisco Department of Public Health; California Health-
care Foundation; National Institutes of Health
Conflicting interests: none declared
Participants Country: USA
Setting: Primary care
Conditions/numbers: 226 diabetes patients (type 2, poorly controlled) (112 ATDM
intervention, 114 usual care)
Multi-morbidity: n/a
Health literacy: 59% “limited” health literacy measured with the Test of Functional
Health Literacy in Adults (ToFHLA). 42% Spanish-speaking and 12%Cantonese speak-
ers
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Interventions Theoretical framework: Chronic Care Model
Focus: patient
Type of intervention: Structured self-management support (automated phone + nurse
follow-up) vs. group visits (not included here)
Clinicians involved: Care manager (additional)
Tools: Improving Diabetes Efforts Across Language and Literacy (IDEALL) project. Au-
tomated Telephone Self-Management (ATSM) + follow-up calls from specially trained
nurse care manager to promote collaborative goal setting in the form of behavioural
’action’ plans. The ATSM is a pre-recorded automated telephone call that participants
receive each week. Those answering ’out of range’ receive a call back from a nurse care
manager who helps participants problem-solve the issue identified in the report or any
other concerns, with a focus on collaborative goal setting and action plans. The inter-
vention also included individualised assessment, skills enhancement, health education,
follow-up and support, access to community resources and continuity of clinical care. All
care manager-participant interactions, including action plans created and achieved, are
documented via a standardised record linked to the community health network record
and shared with primary care physicians
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: Strong (trained care managers)
Fidelity: 94% completed at least 1 ATSM call,
Attrition: 10% lost to follow-up
Comparison: Usual care
Outcomes Health status: physical: HbA1c, systolic blood pressure (SBP), diastolic blood pressure
(DBP), body mass index (BMI); subjective: Medical Outcomes Study short form (SF-
12)
Self-management capabilities: n/a
Health behaviours: diet, exercise. self monitoring of blood glucose, caring for feet,
diabetes interference
Achievement of personal goals: self report
Service use: cost effectiveness
Adverse events: none reported
Length of follow-up: baseline, 12 months
Notes No primary outcome. No power calculation reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Blocked randomisation strategy stratified
to ensure even distribution of languages
(English, Spanish, Cantonese). Assessed
success of randomisation using t tests,
Chi² and Fisher’s exact to compare baseline
characteristics (Schillinger 2008 p. 670;
Schillinger 2009 p. 560).
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Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel not
possible, but most outcomes were objective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Research assistants were masked to partici-
pants’ group assignment (p. 565)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 90% completed follow-up interviews at 1
year, HbA1c for 88.2%, BP for 94.1%,
BMI for 92.3%. Tested for difference be-
tween the 2 interventions due to attri-
tion bias - greater engagement was asso-
ciated with improvements in self-manage-
ment behaviour and functional status in
both arms, but did not alter size of effect
(p. 564)
Selective reporting (reporting bias) Unclear risk No published protocol.
Other bias Low risk
Shearer 2007
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: not stated
Conflicting interests: not stated
Participants Country: USA
Setting: Secondary care
Conditions/numbers: 90 heart failure patients (45 intervention, 45 control)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: Rogers’ Science of Unitary Human Beings
Focus: patient
Type of intervention: Structured case management (phone) + staff training
Clinicians involved: Nurses (additional)
Tools: Telephone-delivered Empowerment Intervention that provided support and in-
formation to facilitate collaborative care. The nurses focused specifically on what was
important to the participant in self management, goal attainment, and functional health.
Empowerment was facilitated through the mutual patient-nurse process to foster the
participant’s awareness that they had the ability to purposefully participate in change
and attain their own self-management goals. A standardised script guided the calls to
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identify problems, goals and support needs. After sharing concerns and potential solu-
tions, standardised questions related to weight, swelling in legs and abdomen, shortness
of breath, chest pain and course of action if they experienced any of these symptoms
ensued. The conversation remained open to the participant’s needs and concerns, with
the nurse providing support, encouragement, and information. Each telephone call was
audiotaped to monitor intervention integrity. A summary of content discussed during
each telephone call was documented in the participant’s electronic medical record
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: Not stated
Standardisation of clinician input: strong (3 trained nurses following standard script,
calls monitored)
Fidelity: good (participants received 6 phone calls in 12 weeks following discharge)
Attrition: low - 3% lost to follow-up
Comparison: Usual care
Outcomes Health status: subjective: Medical Outcomes Study short form (SF-36) mental and
physical component scores (MCS/PCS)
Self-management capabilities: Power as Knowing Participation in Change Tool VII
(PKPCT)*; Self Management of Heart Failure scale
Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 12 weeks
Notes *Primary outcome. No power calculation reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details given.
Allocation concealment (selection bias) Unclear risk No details given.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Both participants and personnel were un-
blinded and outcomes were subjective
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details given.
Incomplete outcome data (attrition bias)
All outcomes
High risk There was a lot of missing data: 1 or
more dependent variable pretest scores
were missing in 24.4% of the experimental
group and in 24.4% of the control group
at baseline, and in 31% and 42.2%, respec-
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tively, at post-test. When 25% or fewer re-
sponses were found missing within a scale,
the participant’s scale mean was computed
and substituted for a missing value; if less
than 75% of the items on a scale were valid,
the scale score was treated as missing and
the case was excluded from the analysis of
that specific outcome
Selective reporting (reporting bias) Unclear risk No published protocol.
Other bias Unclear risk PKPCT has not been used with heart fail-
ure patients before and some participants
struggled to understand it
Stanhope 2013
Methods Study design: cluster-RCT
Unit of randomisation: community mental health centre
Unit of analysis: patient
Funding sources: Janssen
Conflicting interests: fees/grants from Ortho-McNeil-Janssen and Forest Research In-
stitute
Participants Country: USA
Setting: Community mental health centres, 5/10 randomised to training in person-
centred planning and collaborative documentation
Conditions/numbers: 367 mental health clients (177 intervention, 190 control):
schizophrenia (n = 153, bipolar disorder (n = 88), depression (n = 86), other (n = 40)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: n/a
Focus: both clinician and patient
Type of intervention: Staff training
Clinicians involved: Mental health providers (usual)
Tools: Clinicians received training in person-centred planning via video conferencing,
followed by further coaching and monitoring during monthly meetings. Person-centred
planning provides a blueprint to identify life goals that can be translated into action steps
to inform the collaboration between the provider and the client. The process consisted
of identifying life goals, assessing behavioural health problems, developing service plans
to integrate life goals and behavioural health goals, and keeping a focus on life goals
during the therapeutic sessions. Providers are also trained to focus on client engagement,
following up at the next appointment to discuss missed appointments and problem-solve
how to avoid them. Collaborative documentation consists of re-orienting assessment,
planning, and evaluation documentation to identify and integrate personal goals with
more traditional mental health goals and completing all documentation during face-to-
face sessions with the client
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Stages completed: Limited - B, C, D, F
Usual provider aware of patient’s goals and action plans: Yes
Standardisation of clinician input: Strong (training + coaching and monthly monitor-
ing)
Fidelity: not reported
Attrition: not reported
Comparison: Usual care + centralised scheduling and management of no-shows
Outcomes Health status: n/a
Self-management capabilities: n/a
Health behaviours: medication adherence
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up:monthly for 11 months
Notes Author contacted and supplied additional data. No power calculation reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Cluster-randomised trial, 10 CMHCs, 5
randomly allocated to intervention - no
further details provided
Allocation concealment (selection bias) Unclear risk No details provided, but concurrent inter-
vention with both groups may have helped
to conceal allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind participants.
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Study relied on clinicians’ reports of medi-
cation adherence and no-shows
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Hard towork out fromdata provided - odds
ratios for medication compliance over time
(11 months)
Selective reporting (reporting bias) Unclear risk No published protocol. Each of the main
outcomes is reported
Other bias Unclear risk Insufficient baseline data to determine
whether selective recruitment by cluster oc-
curred or not. Client-level analyses were
conducted separately for CMHCs in the
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experimental and control groups to exam-
ine whether the odds of medication ad-
herence changed over time. Given that the
data included a monthly binary adherence
measure for each client, random-effects lo-
gistic models were used to examine ad-
herence (dependent variable) as a function
of month (independent variable), includ-
ing random effects for CMHCs and par-
ticipants nested within CMHCs.The effect
of time across the intervention groups was
compared by including an intervention-by-
time interaction term in a model contain-
ing both experimental and control sites.
The results of the models were stratified by
relevant participant and CMHC character-
istics, and a 3-way interaction between the
characteristic, the intervention, and time
was calculated to determine whether any
of these key factors moderated medication
adherence. Logisitic regression models, in-
cluding a random effect for site, were run
to calculate the effect of the intervention
on the odds of an appointment no-show.
The models used data received from each
CMHC on the total number of appoint-
ment no-shows and the total number of ap-
pointments (pp. 77-8). Clinician-recorded
adherence was compared with participants’
own reports and corroborated these (p. 79)
Thom 2013
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: American Academy of Family Physicians
Conflicting interests: not stated
Participants Country: USA
Setting: Primary care
Conditions/numbers: 299 diabetes patients (148 intervention, 151 control)
Multi-morbidity: n/a
Health literacy: 36% less than high school education, 46% primary language not En-
glish, 61% income below USD 10,000
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: training for peer coaches
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Clinicians involved: peer coaches (additional)
Tools: Potential peer coaches attended 36 hours of training over 8 weeks in either English
or Spanish. They were trained in active listening and non-judgemental communication,
helping with diabetes self-management skills, providing social and emotional support,
assisting with lifestyle change, facilitating medication understanding and adherence,
navigating the clinic, and accessing community resources. Trainees who passed both a
written and an oral examination became peer coaches in the study. Peer coaches interacted
in personwith the participants they coached at the discretionof the coach andparticipant,
either outside the clinica by telephone or during a clinic visit. Target goals for coaching
sessions were telephone contact at least twice a month and 2 or more in-person contacts
over 6 months. Coaches helped participants design action plans to achieve goals chosen
by the participant
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: Not stated
Standardisation of clinician input: Strong - peer coaches had 36 hours training over 8
weeks + written and oral examination
Fidelity: not reported
Attrition: 8% dropped out
Comparison:Usual care included access to a nutritionist and diabetes educator through
referral from primary care clinician
Outcomes Health status: physical: blood glucose (HbA1c)*, cholesterol (LDL-C), systolic blood
pressure (SBP), body mass index (BMI)
Self-management capabilities: n/a
Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 6 months
Notes *Primary outcome. Power calculation - 400 participants required to detect clinically
significant difference in HbA1c, so under-powered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients who enrolled and completed base-
line data collection were paid USD 10 and
assigned to the usual care or peer-coaching
arm using randomly ordered opaque en-
velopes (p. 139)
Allocation concealment (selection bias) Low risk Opaque envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind participants.
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information about blinding of asses-
sors.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 24 (8%) participants did not complete 6-
month data and were considered to have
dropped out. These participants were likely
to be younger, more likely to smoke, less
likely to report havinghyperlipidaemia, but
otherwise did not vary significantly from
remaining participants (p. 141)
Selective reporting (reporting bias) Unclear risk Nopublished protocol. All outcomes, attri-
tions and exclusions reported, missing data
treated as missing, not imputed
Other bias Low risk
Tsay 2004
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: National Science Council of Taiwan
Conflicting interests: not stated
Participants Country: Taiwan
Setting: Dialysis centres in 2 hospitals
Conditions/numbers:50patientswith end-stage renal disease (ESRD) (25 intervention,
25 control)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Structured, face-to-face self-management support
Clinicians involved: Nurse (additional)
Tools: The programme focused on helping participants develop skills and self awareness
in goal-setting, problem-solving, stress management, coping, social support and moti-
vation. It included participant identification of problem areas for self management of
ESRD, the exploration of emotions associated with these problems, the development
of a set of goals and strategies to overcome these problems and for achieving the goals,
making a behavioural change plan, and initiating self-care behaviours and stress man-
agement. Participants received an information package + individual consulting sessions
3 times a week for 4 weeks (p. 61)
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: Not stated
Standardisation of clinician input: Strong - single clinical nurse specialist provided
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coaching (p. 61)
Fidelity: not reported
Attrition: no drop-outs
Comparison: Information package + usual care
Outcomes Health status: psychological: Beck Depression Inventory
Self-management capabilities: Empowerment scale, Strategies used by People to Pro-
mote Health (SUPPH)
Health behaviours: n/a
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 6 weeks
Notes No primary outcome. Power calculation performed and number of participants reported
as adequate but few details provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were assigned to experimental
or control group based on SPSS statistical
randomisation software (p. 60)
Allocation concealment (selection bias) Unclear risk Researcher and nurse were aware of which
treatments participants were receiving, but
data collector was not
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants’ usual caregivers (physicians,
nurses, dieticians, and/or social workers)
were uninformed about treatment group
(p. 61), but not possible to blind partici-
pants
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The data collector was a trained research
assistant who was unaware of the partici-
pant’s status to maintain double-blind ac-
curacy. (p. 61)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs in either group.
Selective reporting (reporting bias) Unclear risk No published protocol. Results reported
for all outcome measures
Other bias Low risk
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Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: Dutch Diabetes Research Foundation
Conflicting interests: none declared
Participants Country: Netherlands
Setting: Primary care
Conditions/numbers: 119 diabetes patients (type 2) (59 intervention, 60 control)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: Bandura’s Social Cognitive Theory
Focus: peer coach
Type of intervention: Training for peer coaches
Clinicians involved: Peer coaches (additional)
Tools: A peer-led self-management programme was developed with input from patients,
GPs and dieticians. The primary objective was to increase self efficacy in patients with
Type 2 diabetes. Secondary objectives were to improve physical activity and dietary
habits. Five expert patients with diabetes were recruited through advertisements. They
received 3 training sessions, each lasting 3½ hours. They learnt the basic principles of
motivational interviewing (how to support self efficacy, coping with resistance, showing
empathy, exploring discrepancies). A script was developed for use by expert patients (peer
coaches) who carried out 3monthly 1-hour home visits to discuss participant’s priorities,
goals and action plans, with subsequent follow-up calls. During the first visit, areas for
lifestyle change were explored. In the second visit, participants discussed the feasibility of
lifestyle changes and set goals to work on over the next month. Progress towards the goals
was evaluated in the third visit. Home visits lasted 1 hour on average. Within 2 weeks
after each visit the expert patients contacted their participants by phone to evaluate the
previous visit and answer any questions. Between visits participants could contact their
expert patient by phone or email as often as they liked
Stages completed: Limited - B, C, F
Usual provider aware of patient’s goals and action plans: not stated
Standardisation of clinician input: Strong - 5 expert patients received 3 x 3½-hour
training sessions in motivational interviewing + follow-up meetings and supervision (p.
391)
Fidelity: not reported
Attrition: 13 participants dropped out (11%) and 23 did not return questionnaires
(19%)
Comparison: Usual care
Outcomes Health status: psychological: Center for Epidemiologic Studies Depression Scale (CES-
D); subjective:WHO Well-Being Index; Problem Areas in Diabetes (PAID-2)
Self-management capabilities: Diabetes Self-Efficacy*, Diabetes Coping;
Health behaviours: Physical Activity Scale for the Elderly, Fatlist
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 3 months, 6 months
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Notes * Primary outcome measure. Power calculation - 80 participants required to demonstrate
difference between groups in relation to self efficacy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computerised randomisation model allo-
cated participants to intervention or con-
trol (p. 396)
Allocation concealment (selection bias) Low risk Randomisation conducted by person not
familiar with study or researchers
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind participants or peer
coaches.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Nothing reported re blinding of assessors.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data patterns were analysed and re-
vealed that data were missing completely
at random, so missing values were imputed
by means of regression analysis. Attrition
accounted for in detail (p. 392)
Selective reporting (reporting bias) Unclear risk No published protocol. All outcome mea-
sures reported.
Other bias Low risk Intervention took place in participants’
homes with peer coaches. Contamination
unlikely
Wilson 2010
Methods Study design: 3-arm RCT (only shared decision-making arm (SDM) and usual care
included in review)
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: National Institutes of Health
Conflicting interests: fees/grants from Asthmatix, GlaxoSmithKline, AstraZeneca,
Merck, Sepracor, Schering Plough, Pfizer, Palo Alto Medical Foundation Research In-
stitute, Novartis, Bohringer Ingelheim, Vanguard Health Care, Kaiser Permanante
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Participants Country: USA
Setting: Primary care
Conditions/numbers: 408 asthma patients (asthma poorly controlled at baseline) (204
SDM intervention, 204 usual care)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: n/a
Focus: both patient and clinician
Type of intervention: Information + shared decision-making + follow-up phone calls +
staff training
Clinicians involved: Care managers (usual)
Tools: Better Outcomes of Asthma Treatment (BOAT). Scripts were provided for use by
specially trained care managers, together with visual aids and worksheets for participants.
These were based on a shared decision-making process, involving stage-setting, gath-
ering information from the participant (symptoms, perceptions of control, medication
use, alternative treatments, environmental triggers, participant’s goals and preferences),
providing information (current understanding of asthma, review information and com-
prehension), negotiation (summarising goals and preferences, discussing options, nego-
tiating decisions), wrapping-up (prescribe, give action plan, teach inhaler technique, give
asthma diary), and 3 follow-up phone calls. At the end of session 1 a written asthma
management and action plan was created, and potential barriers to medication adherence
were elicited and addressed using motivational interviewing techniques. Care managers
documented each encounter in the participant’s chart, shared this with clinicians and
discussed their recommendations
Stages completed: Limited - A, B, C, F
Usual provider aware of patient’s goals and action plans: yes
Standardisation of clinician input: Strong - training for care managers + scripts +
supervised tape-recorded practice sessions with feedback + monthly conference calls +
ongoing quality control - 10% of sessions audiotaped + participants’ reports
Fidelity: Good. Adherence to protocol formally assessed as high (online supplement p.
16)
Attrition: 11% intervention, 7% usual care lost to follow-up
Comparison: usual care
Outcomes Health status: physical:AsthmaTherapyAssessmentQuestionnaire (ATAQ)*, lung func-
tion - FEV1; subjective: Juniper Mini Asthma Quality of Life questionnaire*
Self-management capabilities: n/a
Health behaviours: medication adherence
Achievement of personal goals: n/a
Service use: asthma health care utilisation*
Adverse events: none reported
Length of follow-up: baseline, 12 months
Notes * Primary outcomes. Author contacted and supplied additional data. No power calcula-
tion reported
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computer-based adaptive randomisation
algorithm was used (p. 567)
Allocation concealment (selection bias) Low risk Computer randomisation ensured conceal-
ment from staff. Randomisation was im-
plemented by having a designated, non-
blinded research staffmember at the site en-
ter the relevant participant descriptors into
the randomisation module on the BOAT
website, which immediately performed the
randomisation, stored the result, and re-
turned the participant’s study assignment
for implementation of the experimental as-
signment as indicated. All other study per-
sonnel, with the exception of the care man-
agers, were blinded to participant’s study
assignment (online suppl. p. 3)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk There was no intent that the participant’s
physicians be fully blinded to intervention
assignment, nor obviously could the care
manager be blinded to both the participa-
tion and study assignments of other partic-
ipants, but they were not informed about
this
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All study personnel apart from care man-
agers were blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data were not imputed: baseline
and follow-up analyses were restricted to
those participants with complete data for
the analytic model variables at both time
points (numbers on p. 570)
Selective reporting (reporting bias) Unclear risk No published protocol. All outcomes re-
ported.
Other bias Low risk
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Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: GlaxoSmithKline
Conflicting interests: none declared
Participants Country: USA
Setting: Community
Conditions/numbers: 56 diabetes patients (30 intervention, 26 control)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: n/a
Focus: patient
Type of intervention: Information + structured coaching (phone)
Clinicians involved: Health coaches (additional)
Tools: Integrative Health coaching. The intervention group received a binder of educa-
tional materials at the initial visit. An initial telephone call then offered participants 30-
minute coaching sessions by telephone (8 weekly calls, 4 bi-weekly calls and 1 final call
a month later). In the initial call participants were asked what was important to them in
terms of diabetes care, how well they were managing their health, and what challenges
they faced. The Wheel of Health (taking medicines as prescribed, stress reduction and
self care, exercise, communication and relationships, nutrition, personal development)
was used to guide the discussion. Priorities and goals were those of the participants. Goals
were broken down into small, realistic action steps. Participants could select any goal for
coaching support. Each participant received USD 75
Stages completed: Limited - A, B, C, F
Usual provider aware of patient’s goals and action plans: not stated
Standardisation of clinician input: Strong - 2 experienced health coaches
Fidelity: not reported
Attrition: 7 withdrawals (12.5%), 3 coaching, 4 control
Comparison: usual care
Outcomes Health status: physical: blood glucose (HbA1c); psychological:Perceived Stress Scale (PSS-
4), subjective:Medical Outcomes Study short form (SF-12)
Self-management capabilities: Patient Activation Measure (PAM-13), Appraisal of Di-
abetes Scale (illness perception), Interpersonal Support Evaluation List (ISEL-12) (per-
ceived social support), Benefit-Finding Scale (perceived benefits of the condition)
Health behaviours: Adherence - ASK-20, Morisky Adherence Scale, exercise frequency
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 6 months
Notes No primary outcome. No power calculation reported.
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk No details given
Allocation concealment (selection bias) Unclear risk No details given
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded and
most outcomes are subjective. No primary
outcome reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Pre-assessments and post-assessments were
administered by blinded study staff but
most outcomes are self-reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up - 3/30 (10%) in the in-
tervention group and 4/26 (15%) in the
control group. Reasons for withdrawal re-
ported
Selective reporting (reporting bias) Unclear risk Nopublished protocol, but results reported
for all outcomes
Other bias Low risk
Zoffmann 2006
Methods Study design: RCT
Unit of randomisation: patient
Unit of analysis: patient
Funding sources: Danish Health Insurance Foundation; Novo Nordisk; Ely Lilly; Re-
search Initiative in Aarhus; Danish Nurses’ Organization; Aarhus University Hospital
Conflicting interests: not stated
Participants Country: Denmark
Setting: Hospital outpatients
Conditions/numbers: 61 diabetes patients (type 1) (36 intervention, 25 control)
Multi-morbidity: n/a
Health literacy: n/a
Interventions Theoretical framework: Prochaska’s Stages of Change
Focus: patient
Type of intervention: Group visit + structured face-to-face coaching + staff training
Clinicians involved: Nurses (additional)
Tools:Guided Self-Determination (GSD) aimed at increasing patients’ life skills. Partici-
pants received group training + semi-structured worksheets + follow-up appointments ei-
ther individually or in a group. Participants were prompted to systematically explore and
express their personal difficulties through words and drawings. Reflections are recorded
on worksheets designed to increase patients’ ability to express their views and prepare
them for active participation in the care process. Groups of about 10 members met over
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8 weeks for 2-hour sessions. A researcher introduced the sessions and worked together
with GSD-trained nurses as coaches in smaller groups, supporting and challenging par-
ticipants to develop their problem-solving skills. Participants set their own goals for fu-
ture diabetes care. Three central worksheets comprising person-specific knowledge and
agreements on strategies for problem-solving were saved in a folder in the participant’s
medical record for follow-up at outpatient appointments. Appointments between nurse
and participant during 1-year follow-up were arranged either individually or on a group
basis according to participant’s preferences
Stages completed: Extended - A, B, C, D, F
Usual provider aware of patient’s goals and action plans: not stated
Standardisation of clinician input: Strong - 7 training lectures + supervision
Fidelity: participants’ reports indicated that GSD-GT-initiated autonomy support had
taken place as intended (p. 84)
Attrition: 11 drop-outs (18%)
Comparison: usual care
Outcomes Health status: physical: HbA1c; subjective: Problem Areas in Diabetes (PAID-2)
Self-management capabilities:Treatment Self-Regulation Questionnaire (TSRQ), Per-
ceived Competence in Diabetes scale (PCD),
Health behaviours: Self-Measured Blood Glucose (SMBG) frequency (NV)
Achievement of personal goals: n/a
Service use: n/a
Adverse events: none reported
Length of follow-up: baseline, 1 year
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation took place at the 2 diabetes
clinics. Written assignments were placed
in sealed opaque envelopes, numbered and
stacked randomly (p. 80)
Allocation concealment (selection bias) Unclear risk If 2 participants were closely acquainted
they were assigned to the same group. Can
see why they did this but it means alloca-
tion was not completely concealed and not
completely random (p. 80)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding of participants and personnel
possible.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not blinded.
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Rate of attrition reported and all outcome
measures given.
Selective reporting (reporting bias) Unclear risk No published protocol. All outcome mea-
sures reported.
Other bias Low risk
NV: not validated
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alamo 2002 Not collaborative - clinicians decide on care plan.
Anderson 2005 Patient education only.
Bieber 2006 Collaborative goal-setting element is insufficient. More akin to a decision aid trial
Brown 2005 Collaborative goal-setting element is insufficient, only self-management support
Chambers 2008 Intervention involves decision counselling and problem-solving without collaborative action-plan-
ning and goal-setting
Chin 2007 There is no action-planning and the way participants are involved is unclear
Coleman 2006 No collaboration. Patient information/education and personal health record only. Goal and plans
restricted to medicines only
Cooper 2011 Intervention is aimed specifically at overcoming barriers without collaborative action-planning or
goal-setting
Cooper 2013 Participants are involved, but not in action-planning or goal-setting process
Deen 2011 Intervention lacks collaborative care planning.
Druss 2010 Educational intervention where participants are taught to create a care plan, rather than making one
in collaboration
Eakin 2007 Goals predetermined and constrained - diet and exercise only
Estabrooks 2005 Initial goals are set using a computer programme, not in collaboration
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Glasgow 2010 No real engagement between patient and professional.
Halpern 2004 Goals and actions planned restricted to medication or psychotherapy
Hamann 2006 Intervention lacks collaborative goal-setting and action-planning
Harris 2009 Intervention lacks collaborative goal-setting and action-planning
Heisler 2013 Intervention lacks collaborative goal-setting and action-planning. Collaborative discussion with
nurse is optional
Joosten 2011 No action-planning and predetermined limited goals only.
Kilbourne 2013 Patient education only.
Koelewijn-van Loon 2010 Most participants do not have long-term conditions.
Lin 2006 Restricted options and most decisions made by nurse and other clinicians
Maindal 2011 Little evidence of collaborative planning.
McKay 2002 Care planning is limited to dietary changes only.
Patja 2012 Little evidence of collaborative planning.
Redfern 2010 Predetermined options and plans, Little opportunity for patients to influence
Richardson 2010 Little evidence of collaborative planning.
Riley 2001 Goals predetermined and constrained - exercise, diet, smoking only
Ruggiero 2010 Patient education only. Goals based on provider recommendations
Ruland 2003 Not collaborative.
Sciamanna 2011 Not collaborative.
Simon 2002 Little evidence of collaborative goal setting or planning.
Simon 2011 Little evidence of collaborative planning.
Smeulders 2009 Patient education only.
Smith 2008 Patient information only.
Sobell 2000 Collaboration between patient and spouse, not clinician.
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Sol 2008 Action plans developed by nurse, not collaboratively.
Street 2010 Focused on communication only, not action-planning/
Stringer 2011 Goals determined by professional team.
Van GestelTimmermans 2012 Patient education only.
Vestala 2013 Participation in documentation only, no collaborative goal setting or action-planning
Von Korff 2003 Prescriptive. Very little collaboration involved.
Walker 2005 Information only.
Wennberg 2010 Not possible to isolate those patients with long-term conditions
Woltmann 2011 Very little collaboration involved - client and case manager complete electronic plans individually
Wright 2003 No evidence of collaborative goal setting or action-planning
Characteristics of ongoing studies [ordered by study ID]
Altiner 2012
Trial name or title MultiCare AGENDA
Methods 2-arm cluster-RCT
Participants Patients aged 65 - 84 with at least 3 chronic conditions
Interventions Clinician-focused. Training for GPs in planned, structured collaborative consultations and narrative-based
medicine
Outcomes EQ-5D, Health Care Empowerment questionnaire, medication use, Leipzig Supply and Cost
Starting date Not stated
Contact information in.schaefer@uke.de
Notes ISRCTN46272088
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Trial name or title Case management in oncology rehabilitation (CAMON)
Methods Multi-centre, 2-arm RCT
Participants Patients aged 18 and over with any type of cancer
Interventions Clinician-focused. Training for case managers (rehabilitation coaches) on how to provide self-management
support, including goal-setting, action-planning and review
Outcomes FACT-G quality of life, activity restrictions, Jerusalem & Schwarzer questionnaire (self management and
perceived self efficacy), PACIC-5A
Starting date May 2010
Contact information irene.bachmann@usz.ch
Notes ISRCTN41474586
Battersby 2010
Trial name or title Flinders Program
Methods Practice-based RCT
Participants Patients aged over 45 with COPD, CAD, cerebrovascular disease, chronic heart failure, diabetes, muscu-
loskeletal disorders
Interventions Focused both on patients and clinicians. Set of tools to enable health workers and patients to collaboratively
identify problems, set goals, and develop individual care plans covering self care, medical, psychosocial and
carer issues
Outcomes SF-12, Partners in Health scale, Stanford measures
Starting date Sept 2009
Contact information melanie.harris@flinders.edu.au
Notes
Coventry 2012
Trial name or title Collaborative Interventions for Circulation and Depression (COINCIDE)
Methods Pragmatic cluster-RCT
Participants Patients aged 18 and over with diabetes and/or coronary heart disease plus depression
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Coventry 2012 (Continued)
Interventions Clinician-focused. Training + supervision in collaborative goal-setting and action-planning for psychological
well-being practitioners
Outcomes EQ-5D, WHOQoL-BREF, Diabetes Quality of Life, Seattle Angina Questionnaire, Generalized Anxiety
Disorder (GAD-7), SheehanDisability Scale, Relationship ScalesQuestionnaire (RSQ), Stanford Self-Efficacy
scale, Health Education Impact Questionnaire (heiQ), PACIC-5A, ENRICHD Social Support Instrument
(ESSI), Patient Service Utilization Questionnaire
Starting date Not stated
Contact information peter.a.coventry@manchester.ac.uk
Notes ISRCTN80309252
Reed 2011
Trial name or title Flinders Program (2)
Methods RCT
Participants Patients aged 60 and over with 2 or more chronic conditions
Interventions Focused both on patients and clinicians. Set of tools to enable health workers and patients to collaboratively
identify problems, set goals, and develop individual care plans covering self-care, medical, psychosocial and
carer issues
Outcomes Stanford scales for fatigue, pain, health distress, energy, illness intrusiveness, PHQ-9, self efficacy, heiQ,
Flinders scales,exercise, medication adherence, GP visits, ED visits, hospital admissions
Starting date Not stated
Contact information richard.reed@flinders.edu.au
Notes
Tylee 2012
Trial name or title UPBEAT-UK
Methods Pilot RCT
Participants Patients aged 18 and over with CHD and depression
Interventions Patient-focused. Case managers working with patients on a collaborative basis to develop a personalised care
plan
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Tylee 2012 (Continued)
Outcomes HADS depression sub-scale, PHQ-9, Modified Rose Angina questionnaire, specific activity schedule, Guy’s
hospital chest pain questionnaire, EQ-5D, SF-12, Warwick-Edinburgh Mental Well-Being scale, Brief Illness
Perceptions Questionnaire, Psychlops, adapted Morisky adherence questionnaire, Client Service Receipt In-
ventory (CSRI)
Starting date 2011
Contact information a.tylee@iop.kcl.ac.uk
Notes ISRCTN21615909
Van der Voort 2011
Trial name or title Collaborative Care
Methods 2-arm cluster-RCT
Participants Patients aged 18 - 65 with bipolar disorder
Interventions Focused both on patients and clinicians. Formulation of Collaborative Care team including patient and
family member or friend. All decisions to be shared; development of personalised care plan; psycho education;
problem-solving treatment; mood-charting
Outcomes Functioning Assessment Short Test (FAST-NL-P), Clinical Global Impression for Bipolar Disorder (CGI-
BP), Brief Symptom Inventory, Quick Inventory for Depressive Symptoms (QIDS-SR), Altman Self Rating
Mania Scale, Life Chart Method, WHOQoL-BREF, Sense of Mastery scale, costs - TiC-P
Starting date Not stated
Contact information n.vandervoort@ggzingeest.nl
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Physical health (personalised care planning vs usual care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 HbA1c (change) 9 1916 Mean Difference (IV, Fixed, 95% CI) -0.24 [-0.35, -0.14]
2 SBP (change) 6 1200 Mean Difference (IV, Fixed, 95% CI) -2.64 [-4.47, -0.82]
3 DBP (change) 4 751 Mean Difference (IV, Fixed, 95% CI) -0.71 [-2.26, 0.84]
4 Cholesterol (change) 5 1545 Std. Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.09, 0.11]
5 BMI (change) 4 822 Mean Difference (IV, Fixed, 95% CI) -0.11 [-0.35, 0.13]
Comparison 2. Psychological health (personalised care planning vs usual care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Depression 5 599 Std. Mean Difference (IV, Fixed, 95% CI) -0.36 [-0.52, -0.20]
Comparison 3. Subjective health status (personalised care planning vs usual care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Generic health status (physical) 3 345 Std. Mean Difference (IV, Fixed, 95% CI) 0.16 [-0.05, 0.38]
2 Generic health status (mental) 3 345 Std. Mean Difference (IV, Fixed, 95% CI) 0.07 [-0.15, 0.28]
3 Condition-specific health status 4 1330 Std. Mean Difference (IV, Fixed, 95% CI) -0.01 [-0.11, 0.10]
Comparison 4. Self-management capabilities (personalised care planning vs usual care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Self efficacy 5 471 Std. Mean Difference (IV, Fixed, 95% CI) 0.25 [0.07, 0.43]
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Comparison 5. Health-related behaviours (personalised care planning vs usual care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Exercise 6 907 Std. Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.02, 0.24]
Comparison 6. Self-care activities (personalised care planning vs usual care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Self care (days per week) 4 520 Std. Mean Difference (IV, Fixed, 95% CI) 0.35 [0.17, 0.52]
Comparison 7. Type of intervention (HbA1c) (extended vs limited)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 HbA1c (change) 9 1916 Mean Difference (IV, Fixed, 95% CI) -0.24 [-0.35, -0.14]
1.1 Extended 3 408 Mean Difference (IV, Fixed, 95% CI) -0.43 [-0.60, -0.26]
1.2 Limited 6 1508 Mean Difference (IV, Fixed, 95% CI) -0.12 [-0.26, 0.02]
Comparison 8. Type of intervention (HbA1c) (high intensity vs low intensity)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 HbA1c (change) 9 1916 Mean Difference (IV, Fixed, 95% CI) -0.24 [-0.35, -0.14]
1.1 High 5 847 Mean Difference (IV, Fixed, 95% CI) -0.43 [-0.63, -0.24]
1.2 Low 4 1069 Mean Difference (IV, Fixed, 95% CI) -0.17 [-0.29, -0.04]
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Comparison 9. Type of intervention (HbA1c) (integrated vs not integrated)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 HbA1c (change) 9 1916 Mean Difference (IV, Fixed, 95% CI) -0.24 [-0.35, -0.14]
1.1 High 2 358 Mean Difference (IV, Fixed, 95% CI) -0.45 [-0.70, -0.21]
1.2 Low 7 1558 Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.31, -0.08]
Analysis 1.1. Comparison 1 Physical health (personalised care planning vs usual care), Outcome 1 HbA1c
(change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 1 Physical health (personalised care planning vs usual care)
Outcome: 1 HbA1c (change)
Study or subgroup Personalised care Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Glasgow 2005a 379 -0.19 (1.217) 354 -0.17 (1.065) 41.4 % -0.02 [ -0.19, 0.15 ]
Zoffmann 2006 30 -0.6 (0.4157) 20 -0.19 (0.4157) 20.5 % -0.41 [ -0.65, -0.17 ]
Hiss 2007 81 -0.42 (1.35) 83 -0.22 (1.5488) 5.7 % -0.20 [ -0.64, 0.24 ]
Schillinger 2009 101 -0.6 (1.8217) 103 -0.5 (1.8217) 4.5 % -0.10 [ -0.60, 0.40 ]
Wolever 2010 27 -0.4 (1.684) 22 0.1 (1.902) 1.1 % -0.50 [ -1.52, 0.52 ]
Katon 2010a 99 -0.77 (1.0302) 95 -0.21 (1.0302) 13.5 % -0.56 [ -0.85, -0.27 ]
Frosch 2011 100 -0.5 (1.7) 101 -0.6 (1.79) 4.9 % 0.10 [ -0.38, 0.58 ]
Naik 2011 44 -0.81 (1.21) 41 -0.1 (1.213) 4.3 % -0.71 [ -1.23, -0.19 ]
Thom 2013 122 -1.07 (2.0343) 114 -0.38 (2.0343) 4.2 % -0.69 [ -1.21, -0.17 ]
Total (95% CI) 983 933 100.0 % -0.24 [ -0.35, -0.14 ]
Heterogeneity: Chi2 = 22.05, df = 8 (P = 0.005); I2 =64%
Test for overall effect: Z = 4.48 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 1.2. Comparison 1 Physical health (personalised care planning vs usual care), Outcome 2 SBP
(change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 1 Physical health (personalised care planning vs usual care)
Outcome: 2 SBP (change)
Study or subgroup Personalised care Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hiss 2007 79 -7.3 (21.3317) 82 4.1 (19.9218) 8.2 % -11.40 [ -17.78, -5.02 ]
Schillinger 2009 107 0 (19.0768) 108 3.2 (19.0768) 12.9 % -3.20 [ -8.30, 1.90 ]
Katon 2010a 105 -4.7 (12.9696) 106 -1.3 (12.9696) 27.3 % -3.40 [ -6.90, 0.10 ]
Frosch 2011 100 1.5 (18.2) 101 0.5 (18.13) 13.3 % 1.00 [ -4.02, 6.02 ]
Liu 2012 98 1.48 (12.03) 78 5.2 (12.34) 25.4 % -3.72 [ -7.35, -0.09 ]
Thom 2013 122 1.4 (19.8597) 114 -2 (19.8597) 13.0 % 3.40 [ -1.67, 8.47 ]
Total (95% CI) 611 589 100.0 % -2.64 [ -4.47, -0.82 ]
Heterogeneity: Chi2 = 15.28, df = 5 (P = 0.01); I2 =67%
Test for overall effect: Z = 2.84 (P = 0.0046)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.3. Comparison 1 Physical health (personalised care planning vs usual care), Outcome 3 DBP
(change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 1 Physical health (personalised care planning vs usual care)
Outcome: 3 DBP (change)
Study or subgroup Personalised care Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hiss 2007 78 -0.96 (11.4813) 81 0.65 (12.6) 17.1 % -1.61 [ -5.35, 2.13 ]
Schillinger 2009 107 0.4 (13.092) 108 2 (13.092) 19.5 % -1.60 [ -5.10, 1.90 ]
Frosch 2011 100 1.1 (11.9) 101 -0.4 (11.15) 23.5 % 1.50 [ -1.69, 4.69 ]
Liu 2012 98 1.45 (8.86) 78 2.65 (7.72) 39.8 % -1.20 [ -3.65, 1.25 ]
Total (95% CI) 383 368 100.0 % -0.71 [ -2.26, 0.84 ]
Heterogeneity: Chi2 = 2.47, df = 3 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Physical health (personalised care planning vs usual care), Outcome 4
Cholesterol (change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 1 Physical health (personalised care planning vs usual care)
Outcome: 4 Cholesterol (change)
Study or subgroup Personalised care Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Glasgow 2005a 379 -0.15 (1.4) 354 -0.24 (1.42) 47.5 % 0.06 [ -0.08, 0.21 ]
Hiss 2007 81 -2.5 (55.8) 83 -8.9 (45.5522) 10.6 % 0.13 [ -0.18, 0.43 ]
Katon 2010a 105 -14.9 (31.127) 106 -5.8 (31.127) 13.6 % -0.29 [ -0.56, -0.02 ]
Frosch 2011 100 3.5 (46.91) 101 -1.7 (44.4) 13.0 % 0.11 [ -0.16, 0.39 ]
Thom 2013 122 -3.9 (29.2483) 114 -1.9 (29.2483) 15.3 % -0.07 [ -0.32, 0.19 ]
Total (95% CI) 787 758 100.0 % 0.01 [ -0.09, 0.11 ]
Heterogeneity: Chi2 = 6.71, df = 4 (P = 0.15); I2 =40%
Test for overall effect: Z = 0.17 (P = 0.87)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 1.5. Comparison 1 Physical health (personalised care planning vs usual care), Outcome 5 BMI
(change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 1 Physical health (personalised care planning vs usual care)
Outcome: 5 BMI (change)
Study or subgroup Personalised care Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Frosch 2011 100 0.1 (7.81) 101 0.1 (7.48) 1.3 % 0.0 [ -2.11, 2.11 ]
Liu 2012 98 0.06 (1.14) 78 0.28 (1.26) 44.6 % -0.22 [ -0.58, 0.14 ]
Schillinger 2009 104 0.4 (1.844) 105 0.3 (1.844) 23.1 % 0.10 [ -0.40, 0.60 ]
Thom 2013 122 -0.1 (1.6889) 114 0 (1.6889) 31.0 % -0.10 [ -0.53, 0.33 ]
Total (95% CI) 424 398 100.0 % -0.11 [ -0.35, 0.13 ]
Heterogeneity: Chi2 = 1.05, df = 3 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.87 (P = 0.39)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours personalised care Favours usual care
89Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Psychological health (personalised care planning vs usual care), Outcome 1
Depression.
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 2 Psychological health (personalised care planning vs usual care)
Outcome: 1 Depression
Study or subgroup Personalised care Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Tsay 2004 25 -0.64 (0.9086) 25 0 (0.9086) 8.1 % -0.69 [ -1.27, -0.12 ]
Ludman 2007 20 -0.42 (0.61) 23 -0.47 (0.5619) 7.4 % 0.08 [ -0.52, 0.68 ]
Katon 2010a 105 -0.91 (0.5558) 106 -0.5 (0.5558) 34.3 % -0.74 [ -1.01, -0.46 ]
Liu 2012 98 4.49 (4.99) 78 3.92 (5.01) 30.1 % 0.11 [ -0.18, 0.41 ]
Van der Wulp 2012 59 -2.46 (8.4909) 60 1.61 (8.8579) 20.1 % -0.47 [ -0.83, -0.10 ]
Total (95% CI) 307 292 100.0 % -0.36 [ -0.52, -0.20 ]
Heterogeneity: Chi2 = 20.40, df = 4 (P = 0.00042); I2 =80%
Test for overall effect: Z = 4.34 (P = 0.000014)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 3.1. Comparison 3 Subjective health status (personalised care planning vs usual care), Outcome 1
Generic health status (physical).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 3 Subjective health status (personalised care planning vs usual care)
Outcome: 1 Generic health status (physical)
Study or subgroup personalised care usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Shearer 2007 34 2.87 (9.998) 34 2.3 (9.315) 20.4 % 0.06 [ -0.42, 0.53 ]
Battersby 2007 49 2.53 (8.175) 22 -1.36 (8.175) 17.8 % 0.47 [ -0.04, 0.98 ]
Schillinger 2009 101 8.9 (24.5272) 105 6.2 (24.5272) 61.8 % 0.11 [ -0.16, 0.38 ]
Total (95% CI) 184 161 100.0 % 0.16 [ -0.05, 0.38 ]
Heterogeneity: Chi2 = 1.73, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 3.2. Comparison 3 Subjective health status (personalised care planning vs usual care), Outcome 2
Generic health status (mental).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 3 Subjective health status (personalised care planning vs usual care)
Outcome: 2 Generic health status (mental)
Study or subgroup personalised care usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Shearer 2007 34 4.44 (12.09) 34 3.75 (11.84) 20.4 % 0.06 [ -0.42, 0.53 ]
Battersby 2007 49 -1.86 (12.1728) 22 1.68 (12.1728) 18.1 % -0.29 [ -0.79, 0.22 ]
Schillinger 2009 101 9.8 (20.8664) 105 6.1 (20.8664) 61.5 % 0.18 [ -0.10, 0.45 ]
Total (95% CI) 184 161 100.0 % 0.07 [ -0.15, 0.28 ]
Heterogeneity: Chi2 = 2.51, df = 2 (P = 0.29); I2 =20%
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 3.3. Comparison 3 Subjective health status (personalised care planning vs usual care), Outcome 3
Condition-specific health status.
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 3 Subjective health status (personalised care planning vs usual care)
Outcome: 3 Condition-specific health status
Study or subgroup personalised care usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Glasgow 2005a 379 -0.6 (4.59) 354 -1.7 (4.893) 55.4 % 0.23 [ 0.09, 0.38 ]
Zoffmann 2006 30 -6.4 (3.11) 20 -4.2 (5.23) 3.5 % -0.53 [ -1.11, 0.05 ]
Wilson 2010 182 -1.06 (1.225) 189 -0.7 (1.212) 27.9 % -0.29 [ -0.50, -0.09 ]
Liu 2012 98 2.5 (15.68) 78 6.81 (18.2) 13.1 % -0.25 [ -0.55, 0.04 ]
Total (95% CI) 689 641 100.0 % -0.01 [ -0.11, 0.10 ]
Heterogeneity: Chi2 = 23.79, df = 3 (P = 0.00003); I2 =87%
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
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Analysis 4.1. Comparison 4 Self-management capabilities (personalised care planning vs usual care),
Outcome 1 Self efficacy.
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 4 Self-management capabilities (personalised care planning vs usual care)
Outcome: 1 Self efficacy
Study or subgroup personalised care usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Tsay 2004 25 6.04 (8.2625) 25 -1.6 (8.2625) 9.8 % 0.91 [ 0.33, 1.49 ]
Zoffmann 2006 30 0.5 (2.828) 20 1.5 (5.318) 10.4 % -0.25 [ -0.81, 0.32 ]
Naik 2011 42 -0.03 (1.937) 34 -0.24 (2.119) 16.4 % 0.10 [ -0.35, 0.56 ]
Van der Wulp 2012 59 5 (12.93) 60 3.09 (14.96) 26.0 % 0.14 [ -0.22, 0.50 ]
Liu 2012 98 0.18 (1.9903) 78 -0.53 (1.9903) 37.4 % 0.36 [ 0.06, 0.65 ]
Total (95% CI) 254 217 100.0 % 0.25 [ 0.07, 0.43 ]
Heterogeneity: Chi2 = 9.09, df = 4 (P = 0.06); I2 =56%
Test for overall effect: Z = 2.66 (P = 0.0078)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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Analysis 5.1. Comparison 5 Health-related behaviours (personalised care planning vs usual care), Outcome
1 Exercise.
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 5 Health-related behaviours (personalised care planning vs usual care)
Outcome: 1 Exercise
Study or subgroup Personalised care Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Schillinger 2009 101 325 (399.3911) 105 201.1 (399.3911) 22.7 % 0.31 [ 0.03, 0.58 ]
Wolever 2010 27 0.4 (1.065) 22 -0.1 (1.576) 5.3 % 0.37 [ -0.19, 0.94 ]
Katon 2010a (1) 79 0.24 (1.1089) 78 0 (1.1089) 17.4 % 0.22 [ -0.10, 0.53 ]
Frosch 2011 100 0.2 (2.2) 100 0.69 (2.252) 22.2 % -0.22 [ -0.50, 0.06 ]
Liu 2012 98 23.11 (176.71) 78 -18.27 (156.22) 19.2 % 0.25 [ -0.05, 0.54 ]
Van der Wulp 2012 59 -6.95 (51.196) 60 1.24 (67.39) 13.2 % -0.14 [ -0.50, 0.22 ]
Total (95% CI) 464 443 100.0 % 0.11 [ -0.02, 0.24 ]
Heterogeneity: Chi2 = 11.24, df = 5 (P = 0.05); I2 =56%
Test for overall effect: Z = 1.62 (P = 0.11)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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(1) Katon reported binary. Converted into SMD based on handbook transformation.
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Analysis 6.1. Comparison 6 Self-care activities (personalised care planning vs usual care), Outcome 1 Self
care (days per week).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 6 Self-care activities (personalised care planning vs usual care)
Outcome: 1 Self care (days per week)
Study or subgroup Personalised care Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Zoffmann 2006 30 12 (15.18) 20 1.5 (18.43) 9.1 % 0.62 [ 0.04, 1.20 ]
Shearer 2007 33 3.18 (2.33) 31 0.99 (2.87) 11.7 % 0.83 [ 0.32, 1.34 ]
Schillinger 2009 101 0.7 (1.0982) 105 0.1 (1.0982) 39.5 % 0.54 [ 0.27, 0.82 ]
Frosch 2011 100 0.38 (2.71) 100 0.51 (2.71) 39.8 % -0.05 [ -0.33, 0.23 ]
Total (95% CI) 264 256 100.0 % 0.35 [ 0.17, 0.52 ]
Heterogeneity: Chi2 = 14.02, df = 3 (P = 0.003); I2 =79%
Test for overall effect: Z = 3.92 (P = 0.000090)
Test for subgroup differences: Not applicable
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Analysis 7.1. Comparison 7 Type of intervention (HbA1c) (extended vs limited), Outcome 1 HbA1c
(change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 7 Type of intervention (HbA1c) (extended vs limited)
Outcome: 1 HbA1c (change)
Study or subgroup
Extended (
5
stages) Limited ( 4 stages)
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Extended
Zoffmann 2006 30 -0.6 (0.4157) 20 -0.19 (0.4157) 20.5 % -0.41 [ -0.65, -0.17 ]
Hiss 2007 81 -0.42 (1.35) 83 -0.22 (1.5488) 5.7 % -0.20 [ -0.64, 0.24 ]
Katon 2010a 99 -0.77 (1.0302) 95 -0.21 (1.0302) 13.5 % -0.56 [ -0.85, -0.27 ]
Subtotal (95% CI) 210 198 39.6 % -0.43 [ -0.60, -0.26 ]
Heterogeneity: Chi2 = 1.83, df = 2 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 4.99 (P < 0.00001)
2 Limited
Glasgow 2005a 379 -0.19 (1.217) 354 -0.17 (1.065) 41.4 % -0.02 [ -0.19, 0.15 ]
Schillinger 2009 101 -0.6 (1.8217) 103 -0.5 (1.8217) 4.5 % -0.10 [ -0.60, 0.40 ]
Wolever 2010 27 -0.4 (1.684) 22 0.1 (1.902) 1.1 % -0.50 [ -1.52, 0.52 ]
Frosch 2011 100 -0.5 (1.7) 101 -0.6 (1.79) 4.9 % 0.10 [ -0.38, 0.58 ]
Naik 2011 44 -0.81 (1.21) 41 -0.1 (1.213) 4.3 % -0.71 [ -1.23, -0.19 ]
Thom 2013 122 -1.07 (2.0343) 114 -0.38 (2.0343) 4.2 % -0.69 [ -1.21, -0.17 ]
Subtotal (95% CI) 773 735 60.4 % -0.12 [ -0.26, 0.02 ]
Heterogeneity: Chi2 = 12.41, df = 5 (P = 0.03); I2 =60%
Test for overall effect: Z = 1.72 (P = 0.085)
Total (95% CI) 983 933 100.0 % -0.24 [ -0.35, -0.14 ]
Heterogeneity: Chi2 = 22.05, df = 8 (P = 0.005); I2 =64%
Test for overall effect: Z = 4.48 (P < 0.00001)
Test for subgroup differences: Chi2 = 7.82, df = 1 (P = 0.01), I2 =87%
-2 -1 0 1 2
Favours extended Favours limited
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Analysis 8.1. Comparison 8 Type of intervention (HbA1c) (high intensity vs low intensity), Outcome 1
HbA1c (change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 8 Type of intervention (HbA1c) (high intensity vs low intensity)
Outcome: 1 HbA1c (change)
Study or subgroup High intensity Low intensity
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High
Hiss 2007 81 -0.42 (1.35) 83 -0.22 (1.5488) 5.7 % -0.20 [ -0.64, 0.24 ]
Schillinger 2009 101 -0.6 (1.8217) 103 -0.5 (1.8217) 4.5 % -0.10 [ -0.60, 0.40 ]
Katon 2010a 99 -0.77 (1.0302) 95 -0.21 (1.0302) 13.5 % -0.56 [ -0.85, -0.27 ]
Wolever 2010 27 -0.4 (1.684) 22 0.1 (1.902) 1.1 % -0.50 [ -1.52, 0.52 ]
Thom 2013 122 -1.07 (2.0343) 114 -0.38 (2.0343) 4.2 % -0.69 [ -1.21, -0.17 ]
Subtotal (95% CI) 430 417 29.0 % -0.43 [ -0.63, -0.24 ]
Heterogeneity: Chi2 = 4.45, df = 4 (P = 0.35); I2 =10%
Test for overall effect: Z = 4.30 (P = 0.000017)
2 Low
Glasgow 2005a 379 -0.19 (1.217) 354 -0.17 (1.065) 41.4 % -0.02 [ -0.19, 0.15 ]
Zoffmann 2006 30 -0.6 (0.4157) 20 -0.19 (0.4157) 20.5 % -0.41 [ -0.65, -0.17 ]
Naik 2011 44 -0.81 (1.21) 41 -0.1 (1.213) 4.3 % -0.71 [ -1.23, -0.19 ]
Frosch 2011 100 -0.5 (1.7) 101 -0.6 (1.79) 4.9 % 0.10 [ -0.38, 0.58 ]
Subtotal (95% CI) 553 516 71.0 % -0.17 [ -0.29, -0.04 ]
Heterogeneity: Chi2 = 12.58, df = 3 (P = 0.01); I2 =76%
Test for overall effect: Z = 2.57 (P = 0.010)
Total (95% CI) 983 933 100.0 % -0.24 [ -0.35, -0.14 ]
Heterogeneity: Chi2 = 22.05, df = 8 (P = 0.005); I2 =64%
Test for overall effect: Z = 4.48 (P < 0.00001)
Test for subgroup differences: Chi2 = 5.02, df = 1 (P = 0.03), I2 =80%
-2 -1 0 1 2
Favours high intensity Favours low intensity
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Analysis 9.1. Comparison 9 Type of intervention (HbA1c) (integrated vs not integrated), Outcome 1
HbA1c (change).
Review: Personalised care planning for adults with chronic or long-term health conditions
Comparison: 9 Type of intervention (HbA1c) (integrated vs not integrated)
Outcome: 1 HbA1c (change)
Study or subgroup Integrated Not integrated
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 High
Hiss 2007 81 -0.42 (1.35) 83 -0.22 (1.5488) 5.7 % -0.20 [ -0.64, 0.24 ]
Katon 2010a 99 -0.77 (1.0302) 95 -0.21 (1.0302) 13.5 % -0.56 [ -0.85, -0.27 ]
Subtotal (95% CI) 180 178 19.2 % -0.45 [ -0.70, -0.21 ]
Heterogeneity: Chi2 = 1.77, df = 1 (P = 0.18); I2 =43%
Test for overall effect: Z = 3.65 (P = 0.00026)
2 Low
Glasgow 2005a 379 -0.19 (1.217) 354 -0.17 (1.065) 41.4 % -0.02 [ -0.19, 0.15 ]
Zoffmann 2006 30 -0.6 (0.4157) 20 -0.19 (0.4157) 20.5 % -0.41 [ -0.65, -0.17 ]
Schillinger 2009 101 -0.6 (1.8217) 103 -0.5 (1.8217) 4.5 % -0.10 [ -0.60, 0.40 ]
Wolever 2010 27 -0.4 (1.684) 22 0.1 (1.902) 1.1 % -0.50 [ -1.52, 0.52 ]
Frosch 2011 100 -0.5 (1.7) 101 -0.6 (1.79) 4.9 % 0.10 [ -0.38, 0.58 ]
Naik 2011 44 -0.81 (1.21) 41 -0.1 (1.213) 4.3 % -0.71 [ -1.23, -0.19 ]
Thom 2013 122 -1.07 (2.0343) 114 -0.38 (2.0343) 4.2 % -0.69 [ -1.21, -0.17 ]
Subtotal (95% CI) 803 755 80.8 % -0.19 [ -0.31, -0.08 ]
Heterogeneity: Chi2 = 16.76, df = 6 (P = 0.01); I2 =64%
Test for overall effect: Z = 3.21 (P = 0.0013)
Total (95% CI) 983 933 100.0 % -0.24 [ -0.35, -0.14 ]
Heterogeneity: Chi2 = 22.05, df = 8 (P = 0.005); I2 =64%
Test for overall effect: Z = 4.48 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.53, df = 1 (P = 0.06), I2 =72%
-2 -1 0 1 2
Favours integrated Favours not integrated
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A D D I T I O N A L T A B L E S
Table 1. Included studies and interventions
Study ID Type of
study
Country Setting Condition
(s)
No. of parti-
cipants
Main focus
of interven-
tion
Clinicians
involved
(usual/
additional)
Tools/
techniques
Battersby
2007
RCT Australia Primary care Cardiac, res-
piratory, so-
matisation,
aged care
1703 Both
patients and
clinicians
Ser-
vice co-ordi-
nators (addi-
tional) and
GPs (usual)
Problem &
goals state-
ments, care
plan genera-
tor, face-to-
face contact
Frosch
2011
RCT USA Primary care Diabetes 201 Patients Health
coach (addi-
tional)
DVD +
booklet,
phone con-
tact
Glasgow
2005a
Cluster
RCT
USA Primary care Diabetes 886 Patients Care man-
agers (usual)
CD-Rom
care en-
hancement
programme,
phone con-
tact
Hart 1978 RCT USA Community
clinic
Mental
health
32 Patients Clin-
ician ’scaler’
(addi-
tional) and
psychother-
apist (usual)
Behavioural
monitor-
ing process
record, face-
to-face con-
tact
Hiss 2007 RCT USA Primary care Diabetes 197 Patients Nurse care
manager
(additional)
and primary
care physi-
cian (usual)
Structured
collabo-
ration, face-
to-face con-
tact
Katon
2010a
RCT USA Primary care Depres-
sion + dia-
betes and/or
CHD
214 Patients Nurses (ad-
ditional),
primary care
physicians
(usual)
DVD,
booklet,
self-moni-
toring de-
vices, face-
to-face con-
tact
Kennedy
2013
Cluster
RCT
UK Primary care Diabetes,
COPD, irri-
5599 Both
patients and
Nurses
(usual), GPs
PRISMS
tool, book-
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Table 1. Included studies and interventions (Continued)
table bowel clinicians (usual) lets, face-to-
face contact
Liu 2012 RCT China Primary care Diabetes 208 Patients Nurse
(usual), GP
(usual), pre-
ventive doc-
tor (usual)
Group edu-
ca-
tion + face-
to-face con-
tact
Ludman
2007
RCT USA Primary care Depression 52 Patients Care
manager
(additional)
Comput-
erised deci-
sion sup-
port, phone
contact
Naik 2011 RCT USA Primary care Diabetes 87 Patients Physicians
(additional)
Group edu-
ca-
tion + face-
to-face con-
tact
Schillinger
2009
RCT USA Primary care Diabetes 226 Patients Care
manager
(additional)
Automated
telephone
+ phone fol-
low-up
Shearer
2007
RCT USA Hospital
clinic
Heart failure 90 Patients Nurses (ad-
ditional)
Structured
collabo-
ration, face-
to-face con-
tact
Stanhope
2013
Cluster
RCT
USA Community
clinic
Mental
health
367 Both
patients and
clinicians
Mental
health
providers
(usual)
Structured
collabo-
ration, face-
to-face con-
tact
Thom 2013 RCT USA Primary care Diabetes 299 Patients Peer coaches
(additional)
Structured
collabo-
ration, face-
to-face con-
tact
Tsay 2004 RCT Taiwan Hospital
clinic
End-stage
renal disease
50 Patients Nurse (addi-
tional)
Informa-
tion + struc-
tured collab-
o-
ration, face-
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Table 1. Included studies and interventions (Continued)
to-face con-
tact
Van der
Wulp 2012
RCT Netherlands Primary care Diabetes 119 Patients Peer coaches
(additional)
Structured
collabo-
ration, face-
to-face con-
tact
Wilson
2010
RCT USA Primary care Asthma 408 Both
patients and
clinicians
Care man-
agers (usual)
Informa-
tion + struc-
tured collab-
o-
ration, face-
to-face con-
tact
Wolever
2010
RCT USA Community
clinic
Diabetes 56 Patients Health
coaches (ad-
ditional)
Information
+ Wheel of
Health,
face-to-face
contact
Zoffmann
2006
RCT Denmark Hospital
clinic
Diabetes 61 Patients Nurses (ad-
ditional)
Group vis-
its + face-to-
face contact
CHD: coronary heart disease; COPD: chronic obstructive pulmonary disease
Table 2. Care planning cycle: stages completed
Study ID Interven-
tion type
A. Prepara-
tion
B. goal set-
ting
C. Action-
planning
D. Docu-
menting
E. Co-ordi-
nating
F. Support-
ing
G. Review-
ing
Battersby
2007
Extended X X X X X X X
Frosch
2011
Limited X X X
Glasgow
2005a
Limited X X X X
Hart 1978 Limited X X X X
Hiss 2007 Extended X X X X X
Katon
2010a
Extended X X X X X X X
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Table 2. Care planning cycle: stages completed (Continued)
Kennedy
2013
Limited X X X X
Liu 2012 Limited X X X
Ludman
2007
Extended X X X X X
Naik 2011 Limited X X X X
Schillinger
2009
Limited X X X
Shearer
2007
Limited X X X
Stanhope
2013
Limited X X X X
Thom 2013 Limited X X X
Tsay 2004 Limited X X X
Van der
Wulp 2012
Limited X X X
Wilson
2010
Limited X X X
Wolever
2010
Limited X X X X
Zoffmann
2006
Extended X X X X X
Table 3. Degree of intensity and integration of the care planning intervention
Study ID Duration of in-
tervention
Number of con-
tacts between
clinician (care
manager or
peer coach) and
participant
Intensity
(1 or more con-
tacts per month
for more than 3
months = high)
Usual care clini-
cian involved in
care-planning
intervention
Usual-care clin-
ician informed
about patient’s
goals and plans
In-
tegration (usual
clinician both
involved and in-
formed = high)
Battersby 2007 12 months 8 to 12 High Yes Yes Yes
Frosch 2011 6 months Up to 5 Low No No No
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Table 3. Degree of intensity and integration of the care planning intervention (Continued)
Glasgow 2005a 6 months 2 to 4 Low No Yes No
Hart 1978 3 months 3 Low Yes Yes Yes
Hiss 2007 6 months mean = 7 High Yes Yes Yes
Katon 2010a 12 months 16 to 24 High Yes Yes Yes
Kennedy 2013 12 months Not reported Low Yes Yes Yes
Liu 2012 12 months 12 High Yes Yes Yes
Ludman 2007 12 months 3 or more Low No Yes No
Naik 2011 3 months 4 Low No Yes No
Schillinger
2009
9 months 39 or more High No Yes No
Shearer 2007 3 months 6 Low No No No
Stanhope 2013 11 months Not reported Low Yes Yes Yes
Thom 2013 6 months 14+ High No No No
Tsay 2004 1 month 12 Low No No No
Van der Wulp
2012
3 months 3+ High No No No
Wilson 2010 9 months 4 Low Yes Yes Yes
Wolever 2010 6 months 14 High No No No
Zoffmann 2006 12 months 8+ Low No No No
Table 4. Physical health
Study Condi-
tion
No. of
partici-
pants
Timing
of
outcome
measure-
ment
HbA1c SBP DBP LDL-C BMI Other Effects of interven-
tion
as reported
Frosch
2011
Diabetes 201 6 months X X X X X No significant effects
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Table 4. Physical health (Continued)
Glasgow
2005a
Diabetes 886 12
months
X X No significant effects
Hiss
2007
Diabetes 197 6 months X X X X HbA1c improved
SBP improved
Katon
2010a
Depres-
sion +
diabetes/
CHD
214 12
months
X X X HbA1c improved
SBP improved
LDL-C improved
Liu 2012 Diabetes 208 12
months
X X X SBP improved
Naik
2011
Diabetes 87 12
months
X HbA1c improved
Schillinger
2009
Diabetes 226 12
months
X X X X No significant effects
Thom
2013
Diabetes 299 6 months X X X X HbA1c improved
Wilson
2010
Asthma 408 12
months
FEV1,
ATAQ
FEV1 improved
ATAQ improved
Wolever
2010
Diabetes 56 6 months X HbA1c improved
Zoff-
mann
2006
Diabetes 61 12
months
X HbA1c improved
ATAQ: Asthma Therapy Assessment Questionnaire; BMI: body mass index; DBP: diastolic blood pressure; FEV1: lung function;
HbA1c: glycated haemoglobin; LDL-C: cholesterol; SBP: systolic blood pressure
Table 5. Psychological health
Study Condition No. of partici-
pants
Timing of out-
come
measurement
Outcomes
included
in meta-analy-
sis
Outcomes not
included
in meta-analy-
sis
Results as re-
ported
Glasgow 2005a Diabetes 886 12 months PHQ-9 No significant
effects
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Table 5. Psychological health (Continued)
Katon 2010a Depression +
diabetes/CHD
214 12 months SCL-20 PGI Depression im-
proved
Liu 2012 Diabetes 208 12 months PHQ-9 No significant
effects
Ludman 2007 Depression 52 12 months SCL-20 PGI, SCID No significant
effects
Tsay 2004 End-stage
renal disease
50 6 weeks Beck Depression
Inventory
Depression im-
proved
Van der Wulp
2012
Diabetes 119 6 months CES-D No significant
effects
Wolever 2010 Diabetes 56 6 months PSS-4, Benefit
Finding
Stress improved
Benefit finding
improved
CES-D: Center for Epidemiologic Studies Depression scale; CHD: coronary heart disease; PGI: Patient Global rating for Improvement;
PHQ-9: Patient Health Questionnaire; PSS-4: Perceived Stress Scale; SCID: Structured Clinical Interview for DSM-IV Depression;
SCL-20: Symptom Checklist 20
Table 6. Subjective health status
Study Condition No. of partici-
pants
Timing of
outcome
measurement
Generic
health status
Other generic
measures not
included in
meta-analysis
Condition-
specific
health status
Results as re-
ported
Battersby
2007
Various 1703 (124 in-
cluded
in meta-analy-
sis)
12 months SF-36 (PCS,
MCS)
WSAS No significant
effects
Glasgow
2005a
Diabetes 886 12 months PAID-2 No significant
effects
Katon 2010a Depression +
diabetes/
CHD
214 12 months WHODAS-2,
Sheehan
disability
scale, global
rating
score
Sheehan
improved
Global rating
improved
Kennedy
2013
Diabetes,
COPD, IBS
5599 12 months Selected sub-
scales
No significant
effects
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Table 6. Subjective health status (Continued)
of SF-36, EQ-
5D
Liu 2012 Diabetes 208 12 months Stanford
Illness
Intrusiveness
Illness intru-
siveness
improved
Schillinger
2009
Diabetes 226 12 months SF-12 (PCS,
MCS)
No significant
effects
Shearer 2007 Heart failure 90 3 months SF-36 (PCS,
MCS)
No significant
effects
Wilson 2010 Asthma 408 12 months AQLQ AQLQ
improved
Wolever 2010 Diabetes 56 6 months SF-12 (single
score)
No significant
effects
Zoffmann
2006
Diabetes 61 12 months PAID-2 No significant
effects
AQLQ: Asthma Quality of Life Questionnaire; CHD: coronary heart disease; COPD: chronic obstructive pulmonary disease; EQ-
5D: Euro-Qol; IBS: irritable bowel syndrome; PAID-2: Problem Areas in Diabetes scale; SF-36, SF-12 (PCS, MCS): Health survey
(physical component score, mental component score);
WHODAS: WHO Disability Assessment Schedule; WSAS: Work and Social Adjustment Scale
Table 7. Self-management capabilities
Study Condition No. of partici-
pants
Timing of out-
come
measurement
Self efficacy Other measures
not
included in
meta-analysis
Results as re-
ported
Frosch 2011 Diabetes 201 6 months Michigan
Diabetes
Knowledge
No significant
effects
Katon 2010a Depression +
diabetes/CHD
214 12 months 4 items from
PAM-13
2 PAM items
improved
Kennedy 2013 Diabetes,
COPD, IBS
5599 12 months Stanford
self efficacy
PEI No significant
effects
Liu 2012 Diabetes 208 12 months Stanford
self efficacy
Self efficacy
improved
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Table 7. Self-management capabilities (Continued)
Naik 2011 Diabetes 87 12 months Stanford
self efficacy
Self efficacy
improved
Shearer 2007 Heart failure 90 3 months PKPCT No significant
effects
Tsay 2004 End-stage
Renal Disease
50 6 weeks SUPPH Diabetes
Empowerment
Scale (DES)
Self efficacy and
empowerment
improved
Van der Wulp
2012
Diabetes 119 6 months Diabetes
self efficacy
No significant
effects
Wolever 2010 Diabetes 56 6 months ADS, ISEL-12,
PAM-13
ISEL-12 and
PAM-13
improved
Zoffmann 2006 Diabetes 61 12 months PCDS PCDS improved
ADS: Appraisal of Diabetes Scale; CHD: coronary heart disease; CPOD: chronic obstructive pulmonary disease; IBS: irritable bowel
syndrome; ISEL-12: Interpersonal Support Evaluation List; PAM-13: Patient Activation Measure; PCDS: Perceived Competence in
Diabetes Scale; PEI: Patient Enablement Instrument; PKPCT: Power as Knowing Participation in Change Tool; SUPPH: Strategies
Used by People to Promote Health
Table 8. Health behaviours
Study Condition No. of parti-
cipants
Timing of
outcome
measure-
ment
Exercise Diet Medication
adherence
Self-care ac-
tivities
Results as
reported
Frosch
2011
Diabetes 201 6 months At least 30
mins, d/wk
General
diet,
d/wk
Self report
(SDSCA)
Blood glu-
cose testing,
foot care
(SDSCA
days/wk)
Exercise im-
proved
Katon
2010a
Depression
+
diabetes/
CHD
214 12 months At least 30
mins, d/wk
General
diet,
d/wk
CMA phar-
macy refill
Blood glu-
cose testing
and BP
monitoring
(days/wk)*
Self care im-
proved
Liu 2012 Diabetes 208 12 months Aerobic ex-
ercise
mins/wk
Specific
questions,
no summary
Exercise im-
proved
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Table 8. Health behaviours (Continued)
Schillinger
2009
Diabetes 226 12 months Moderate
activity,
mins/wk
Selfmanage-
ment
days/wk
Exercise im-
proved
Self care im-
proved
Shearer
2007
Heart failure 90 3 months Selfmanage-
ment
(SMHF - ex-
perience)
Self care im-
proved
Stanhope
2013
Mental
health
367 11 months Clinician re-
port
Medication
adherence
improved
Van der
Wulp 2012
Diabetes 119 6 months Specific ac-
tivities, hrs/
d (PASE)
Saturated fat
intake
(Fatlist)
No signifi-
cant effects
Wilson
2010
Asthma 408 24 months CMA phar-
macy refill,
other adher-
ence
measures
Medication
adherence
improved
Wolever
2010
Diabetes 56 6 months At least 15
mins, d/mth
Self report
(Morisky),
ASK-20
Medica-
tion adher-
ence (ASK-
20)
improved
Zoffmann
2006
Diabetes 61 12 months Blood glu-
cose testing
(frequency)
No signifi-
cant effects
* Excluded from meta-analysis because published data were incompletely reported
ASK-20: Adherence barrier questionnaire; CHD: coronary heart disease; CMA: continuous medication acquisition; PASE: Physical
Activity Scale for the Elderly; SMHF: Self-Management of Heart Failure
Table 9. Resource use and costs
Study Condition No. of participants Timing of outcome
measurement
Resource use Results as reported
Battersby 2007 Various 1703* 12 months Primary care, medi-
cations,
hospital admissions
No reduction in ser-
vice use, no cost sav-
ings
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Table 9. Resource use and costs (Continued)
Katon 2010a Depression +
diabetes/CHD
214 24 months Health plan
accounting records,
QALYs
0.335 additional
QALYs for interven-
tion group and
lower outpatient
costs
Wilson 2010 Asthma 408 12 months Medications Significant changes
inmedication use; no
assessment of cost ef-
fectiveness
* This figure includes 8 sub-regional studies, 4 of which used geographic controls and were not randomised.
CHD: coronary heart disease; QALY: quality-adjusted life year
A P P E N D I C E S
Appendix 1. Search strategy
The cumulative search of electronic databases was as follows:
• Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library) (July 2013 Issue 7)
• Dissertations & Theses (Proquest) (1743 - July 2013)
• Embase (Ovid) (1974 to July 2013)
• Medline & Medline In-process (Ovid) (1946 to July 2013)
• PsycINFO (Ovid) (1967 to July 2013)
• Clinicaltrials.gov (21st June 2013)
Search results
Database: Interface: Coverage: Dates: Hits:
Cochrane Central Regis-
ter of Controlled Trials
Cochrane Library, Wiley 31/07/2013 2351
Dissertations & Theses Proquest 1743 - present 31/07/2013 657
Embase OvidSP 1974 - present 31/07/2013 6811
Medline & Medline In-
process
OvidSP 1946 - present 31/07/2013 4806
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(Continued)
PsycINFO OvidSP 1967 - present 31/07/2013 1526
Final: 16151
Duplicates: 6273
Final total: 9878
CENTRAL:
#1 (chronic*):ti,ab,kw (Word variations have been searched)
#2 ((persistent or long* term or ongoing or degenerative) near/3 (disease* or ill* or condition* or insufficienc* or disorder*)):ti,ab,kw
(Word variations have been searched)
#3 ((longterm or long-term or “long term”) next care):ti,ab,kw (Word variations have been searched)
#4 MeSH descriptor: [Cardiovascular Diseases] explode all trees
#5 “heart disease*” or “heart failure” or “myocardial ischemia” or “coronary disease” * or “coronary artery disease*” or “myocardial
infarct*” or hypertension or “high blood pressure”:ti,ab,kw (Word variations have been searched)
#6 (“cardiovascular disease*” or cvd):ti,ab,kw (Word variations have been searched)
#7 “sickle cell”:ti,ab,kw (Word variations have been searched)
#8 MeSH descriptor: [Lung Diseases, Obstructive] explode all trees
#9 “obstructive lung disease*” or “obstructive pulmonary disease*” or copd or asthma or bronchitis:ti,ab,kw (Word variations have
been searched)
#10 emphysema:ti,ab,kw (Word variations have been searched)
#11 “cystic fibrosis” or “respiratory distress”:ti,ab,kw (Word variations have been searched)
#12 MeSH descriptor: [Nervous System Diseases] explode all trees
#13 (brain next (disease* or damage* or injur*)):ti,ab,kw (Word variations have been searched)
#14 cerebrovascular or “brain isch?emia” or “cerebral infarc*” or “carotid artery disease*” or stroke or epilep* or seizure*:ti,ab,kw (Word
variations have been searched)
#15 neurodegenerative or Huntington* or Parkinson* or “amyotrophic lateral sclerosis” or “multiple sclerosis” or “motor neuron
disease”:ti,ab,kw (Word variations have been searched)
#16 paralys* or quadriplegi* or tetraplegi* or paraplegi* or “locked-in syndrome”:ti,ab,kw (Word variations have been searched)
#17 ((communication or learning or consciousness or perceptual or speech or voice or vision or hearing or psychomotor) next disorder*):
ti,ab,kw (Word variations have been searched)
#18 “hearing loss” or “hearing aid*” or deaf* or blind* or stutter*:ti,ab,kw (Word variations have been searched)
#19 “down* syndrome” or “cerebral palsy”:ti,ab,kw (Word variations have been searched)
#20 MeSH descriptor: [Gastrointestinal Diseases] explode all trees
#21 gastroenter* or intestinal or bowel or colonic:ti,ab,kw (Word variations have been searched)
#22 ((renal or kidney) next (failure* or insufficienc*)):ti,ab,kw (Word variations have been searched)
#23 (diabetes or diabetic*):ti,ab,kw (Word variations have been searched)
#24 MeSH descriptor: [Nutrition Disorders] explode all trees
#25 underweight or malnutrition or malnourished or overweight or obes*:ti,ab,kw (Word variations have been searched)
#26 arthritis or osteoarthritis or rheumati* or fibromyalgia:ti,ab,kw (Word variations have been searched)
#27 ((back or neck) adj pain):ti,ab,kw (Word variations have been searched)
#28 MeSH descriptor: [Thyroid Diseases] explode all trees
#29 thyroid:ti,ab,kw (Word variations have been searched)
#30 MeSH descriptor: [Hypersensitivity] explode all trees
#31 allerg* or hypersensitivit* or tierg* or intolerance or anaphyla*:ti,ab,kw (Word variations have been searched)
#32 MeSH descriptor: [Neoplasms] explode all trees
#33 cancer* or oncolog* or neoplasm* or carcinom* or tumo?r* ormalignan* or leuk?emia:ti,ab,kw (Word variations have been searched)
#34 MeSH descriptor: [HIV Infections] explode all trees
111Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
#35 (“hiv infect*” or “hiv disease*”):ti,ab,kw (Word variations have been searched)
#36 MeSH descriptor: [Mental Disorders] explode all trees
#37 MeSH descriptor: [Behavioral Symptoms] explode all trees
#38 ((mental* or psychiatr* or psychological* or behavio*) next (ill* or disorder* or disease* or distress* or disab* or problem* or health*
or patient* or treatment)):ti,ab,kw (Word variations have been searched)
#39 (psychosis or psychoses or psychotic* or paranoi* or schizo* or neurosis or neuroses or neurotic* or delusion* or depression or
depressive or bipolar or mania or manic or obsessi* or compulsi* or panic or phobic or phobia or anorexia or bulimia or neurastheni*
or dissociative or autis* or Asperger* or Tourette or dyslex* or affective or borderline or narcissis* or suicid* or self injur* or self harm
or adhd):ti,ab,kw (Word variations have been searched)
#40 ((personality or mood or dysthymic or cognit* or anxiety or stress or eating or adjustment or reactive or somatoform or conversion
or behavior or perception or psycho* or “impulse control” or development* or “attention deficit” or hyperactivity or conduct or “motor
skills” or movement or tic or “substance related”) next disorder*):ti,ab,kw (Word variations have been searched)
#41 (((substance or drug or alcohol) next abuse) or “substance use” or “illegal drug use” or addict* or alcoholism or (problem* near/1
drinking)):ti,ab,kw (Word variations have been searched)
#42 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #
20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38
or #39 or #40 or #41
#43 MeSH descriptor: [Patient Care Planning] this term only
#44 ((care or action or treatment) next plan*):ti,ab,kw (Word variations have been searched)
#45 MeSH descriptor: [Decision Making] this term only
#46 MeSH descriptor: [Choice Behavior] this term only
#47 (patient* near/7 (decision* or choice*)):ti,ab,kw (Word variations have been searched)
#48 (patient* near/3 (preference* or priorit* or value*)):ti,ab,kw (Word variations have been searched)
#49 MeSH descriptor: [Patient Preference] explode all trees
#50 (treatment next (option* or choice*)):ti,ab,kw (Word variations have been searched)
#51 MeSH descriptor: [Goals] explode all trees
#52 (goal* adj2 (set* or plan*)):ti,ab,kw (Word variations have been searched)
#53 MeSH descriptor: [Patient-Centered Care] explode all trees
#54 (patient next (cent*red or focus*ed or oriented)):ti,ab,kw (Word variations have been searched)
#55 MeSH descriptor: [Individualized Medicine] explode all trees
#56 (individualise? or individualize? or individualising or individualizing or personalise? or personalize? or personalising or personalizing
or tailor or tailored or tailoring):ti,ab,kw (Word variations have been searched)
#57 #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56
#58 (patient* near/3 (participat* or involv*)):ti,ab,kw (Word variations have been searched)
#59 (negotiat* or agreement or concordan* or cooperat* or co-operat* or collaborat* or partnership):ti,ab,kw (Word variations have
been searched)
#60 #58 or #59
#61 #57 and #60
#62 MeSH descriptor: [Patient Participation] explode all trees
#63 (patient* near/2 (empower* or activat*)):ti,ab,kw (Word variations have been searched)
#64 ((shared or joint or informed or collaborative) near/2 decision making):ti,ab,kw (Word variations have been searched)
#65 ((involv* or participat*) near/3 (choice* or decision*)):ti,ab,kw (Word variations have been searched)
#66 (decision next (aid* or support or tool*)):ti,ab,kw (Word variations have been searched)
#67 (“patient provider agreement*” or “decisional self efficacy” or “personal budget*” or “direct payment*” or “record access” or “patient
held record*”):ti,ab,kw (Word variations have been searched)
#68 ((“self management” or “self care”) near/2 support*):ti,ab,kw (Word variations have been searched)
#69 #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68
#70 #42 and #69
Dissertations & Theses:
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(((all((chronic NEAR/3 (disease* OR ill* OR condition* OR insufficienc* OR disorder*))) OR all((longterm NEAR/3 (disease* OR
ill* OR condition* OR insufficienc* OR disorder*))) OR all((long-term NEAR/3 (disease* OR ill* OR condition* OR insufficienc*
OR disorder*))) OR all((persistent NEAR/3 (disease* OR ill* OR condition* OR insufficienc* OR disorder*))) OR all((ongoing
NEAR/3 (disease*OR ill*OR condition*OR insufficienc*ORdisorder*)))OR all((chronicNEAR/3 (disease*OR ill*OR condition*
OR insufficienc* OR disorder*)))) OR All(cardiovascular disease* or heart disease* or heart failure or myocardial ischemia or coronary
disease* or coronary artery disease* ormyocardial infarctionor hypertensionor high bloodpressure)ORAll(obstructive lungdisease* or
obstructive pulmonary disease* or copd or asthma or bronchitis or emphysema or “cystic fibrosis” or respiratory distress) OR All(brain
disease* or brain damage* or brain injur*) OR All(cerebrovascular or brain ischemia or cerebral infarction or carotid artery disease*
or stroke or epilep* or seizure or Huntington* or Parkinson* or amyotrophic lateral sclerosis or multiple sclerosis or motor neuron
disease or paralys* or quadriplegi* or tetraplegi* or paraplegi* or locked-in syndrome) OR All((disorder NEAR1 (communication or
learning or consciousness or perceptual or speech or voice or vision or hearing or psychomotor))) OR All(hearing loss or hearing aid*
or deaf* or blind* or stutter*) OR All(down* syndrome or cerebral palsy) OR All(gastroenter* or intestinal or bowel or colonic) OR
All(gastroenter* or intestinal or bowel or colonic) OR All(diabetes or diabetic*) OR All(underweight or malnutrition or malnourished
or overweight or obes*) OR All(arthritis or osteoarthritis or rheumati* or fibromyalgia or back pain or neck pain) OR All(thyroid*)
OR All(hypersensitivit* or allerg* or intolerance or anaphyla*) OR All(cancer* or oncolog* or neoplasm* or carcinom* or tumo?r*
or malignan* or leuk?emia) OR All(hiv infect* or hiv disease*) OR All(“mental illness” OR “mentally ill” OR “mental disorder*”
OR “mental disease* OR “mental distress” OR “mental disab*” OR “mentally disabled” OR “mental problem*” OR “mental health”
OR “mental patient*” OR “mental treatment”) OR All(“psychiatric illness” OR “psychiatrically ill” OR “psychiatric disorder*” OR
“psychiatric disease* OR “psychiatric distress” OR “psychiatric disab*” OR “psychiatrically disabled” OR “psychiatric problem*”
OR “psychiatric health” OR “psychiatric patient*” OR “psychiatric treatment”) OR All(personality disorder* or mood disorder* or
dysthymic disorder* or cognit* disorder* or anxiety disorder* or stress disorder* or eating disorder* or adjustment disorder* or reactive
disorder* or somatoform disorder* conversion disorder* or behaviour* disorder* or perception disorder* or psycho* disorder* or
impulse control disorder* or development* disorder* or attention deficit disorder* or hyperactivity disorder* or conduct disorder*
or motor skills or movement disorder* or tic disorder* or substance related) OR All(psychosis or psychotic* or paranoi* or schizo*
or neuros#s or neurotic* or delusion* or depression or depressive or bipolar or mania or manic or obsessi* or compulsi* or panic or
phobic or phobia or anorexia or bulimia or neurastheni* or dissociative or autis* or Asperger* or Tourette or dyslex* or affective or
borderline or narcissis* or suicid* or self injur* or self harm or adhd or psychoses) OR All(substance abuse or drug abuse or alcohol
abuse or “substance use” or “illegal drug use” or addict* or alcoholism or problem drinking)) AND (((All((plan* NEAR/1 (care or
action or treatment))) ORAll((patient* NEAR/7 (decision* or choice*))) ORAll((patient*NEAR/3 (preference* or priorit* or value*)
)) OR All((treatment NEAR/1 (option* or choice*))) OR All((goal* NEAR/2 (set* or plan*))) OR All((patient NEAR/1 (cent*red
or focus*ed or oriented))) OR All(individuali#e? or individuali#ing or personali#e? or personali#ing or tailor or tailored or tailoring)
) AND (All((patient* NEAR/3 (participat* or involv*))) OR All(negotiat* or agreement or concordan* or cooperat* or co-operat* or
collaborat* or partnership))) OR All((patient* NEAR/2 (empower* or activat*))) OR All((decision making NEAR/2 (shared or joint
or informed or collaborative))) OR (All((involv* NEAR/3 (choice* or decision*))) or All((participat* NEAR/3 (choice* or decision*)
))) OR All(decision aid* or decision support or decision tool*) OR All(patient provider agreement* or decisional self efficacy or
personal budget* or direct payment* or record access or patient held record*) OR All((support AND (self management or self care))
))) AND (ti((random* OR placebo* OR double blind*)) OR ab((random* OR placebo* OR double blind*)))
Medline:
1. chronic*.mp.
2. ((persistent or long* term or ongoing or degenerative) adj3 (disease* or ill* or condition* or insufficienc* or disorder*)).tw.
3. long term care/
4. long* term care.tw.
5. exp cardiovascular diseases/
6. (heart disease* or heart failure or myocardial ischemia or coronary disease* or coronary artery disease* or myocardial infarction
or hypertension or high blood pressure).tw.
7. sickle cell.mp.
8. exp lung diseases obstructive/
9. (obstructive lung disease* or obstructive pulmonary disease* or copd or asthma or bronchitis).tw.
10. exp emphysema/
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11. exp pulmonary emphysema/
12. emphysema.tw.
13. (cystic fibrosis or respiratory distress),mp.
14. exp nervous system diseases/
15. (brain adj (disease* or damage* or injur*)).tw.
16. (cerebrovascular or brain ischemia or cerebral infarction or carotid artery disease* or stroke or epilep* or seizure*).tw.
17. (neurodegenerative or Huntingdon* or Parkinson* or amyotrophic lateral sclerosis or multiple sclerosis or motor neuron
disease).tw.
18. (paralys* or quadriplegi* or tetraplegi* or paraplegi* or locked-in syndrome).tw.
19. ((communication or learning or consciousness or perpetual or speech or voice or vision or hearing or psychomotor) adj
disorder*).tw.
20. (hearing loss or hearing aid* or deaf* or blind* or stutter*).tw.
21. down* syndrome.tw.
22. cerebral palsy.tw.
23. exp gastrointestinal diseases/
24. (gatroenter* or intestinal or bowel or colonic).tw.
25. renal insufficiency/
26. ((renal or kidney) adj (failure* or insufficienc*)).tw.
27. diabetes mellitus/
28. (diabetes or diabetic*).tw.
29. exp nutrition disorders/
30. (underweight or malnutrition or malnourished or overweight or obes*).tw.
31. exp arthritis/
32. exp rheumatic diseases/
33. (arthritis or osteoarthritis or rheumati* or fibromyalgia).tw.
34. ((back or neck) adj pain).tw.
35. exp thyroid diseases/
36. thyroid.tw.
37. exp hypersensitivity/
38. (hypersensitivit* or allerg* or intolerance or anaphyla*).mp.
39. exp neoplasms/
40. (cancer* or oncolog* or neoplasm* or carcinom* or tumo?r* or malignan* or leuk?emia).tw.
41. exp hiv infections/
42. (hiv infect* or hiv disease*).tw.
43. exp mental disorders/
44. exp behavioral symptoms/
45. ((mental* or psychiatr* or psychological*) adj (ill* or disorder* or disease* or distress* or disab* or problem* or health* or
patient* or treatment)).tw.
46. ((personality or mood or dysthymic or cognit* or anxiety or stress or eating or adjustment or reactive or somatoform or
conversion or behavior or perception or psycho* or impulse control or development* or attention deficit or hyperactivity or conduct
or motor skills or movement or tic or substance related) adj disorder*).tw.
47. (psychos#s or psychotic* or paranoi* or schizo* or neuros#s or neurotic* or delusion* or depression or depressive or bipolar or
mania or manic or obsessi* or compulsi* or panic or phobic or phobia or anorexia or bulimia or neurastheni* or dissociative or autis*
or Asperger* or Tourette or dyslex* or affective or borderline or narcissis* or suicid* or self injur* or self harm or adhd).tw.
48. (((substance or drug or alcohol) adj abuse) or “substance use” or “illegal drug use” or addict* or alcoholism or (problem* adj1
drinking)).tw.
49. or/1-48
50. patient care planning/
51. ((care or action or treatment) adj plan*).tw.
52. decision making/
53. choice behavior/
54. (patient* adj7 (decision* or choice*)).tw.
55. patient preference/
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56. (patient* adj3 (preference* or priorit* or value*)).tw.
57. (treatment adj (option* or choice*)).tw.
58. goals/
59. (goal* adj2 (set* or plan*)).tw.
60. patient centered care/
61. (patient adj (cent*red or focus*ed or oriented)).tw.
62. individualised medicine/
63. (individuali#e? or individual#ing or personali#e? or personali#ing or tailor or tailored or tailoring).tw.
64. or/50-63
65. cooperative behavior/
66. (patient* adj3 (participat* or involv*)).tw.
67. (negotiat* or agreement or concordan* or cooperat* or co-operat* or collaborat* or partnership).tw.
68. or/65-67
69. 64 and 68
70. patient participation/
71. (patient* adj2 (empower* or activat*)).tw.
72. ((shared or joint or informed or collaborative) adj2 decision making).tw.
73. ((involv* or participat*) adj3 (choice* or decision*)).tw.
74. (decision adj (aid* or support or tool*)).tw.
75. patient provider agreement*.tw.
76. decisional self efficacy.tw.
77. (personal budget* or direct payment*).tw.
78. (record access or patient held record*).tw.
79. ((self management or self care) adj2 support*).tw.
80. or/69-79
81. 49 and 80
82. randomised controlled trial.pt.
83. controlled clinical trial.pt.
84. randomised.ab.
85. placebo.ab.
86. clinical trials as topic.sh.
87. randomly.ab.
88. trial.ti.
89. or/82-88
90. exp animals/ not humans.sh.
91. 89 not 90
92. 81 and 91
Embase:
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1chronic.mp.Multimedia(41469)
1193893
2
((persistent or long* term or ongoing or degenerative) adj3 (disease* or ill* or condition* or insufficienc* or disorder*)).tw.Multimedia
(964)
47182
3
long term care/Multimedia(791)
86414
4
long* term care.tw.Multimedia(42583)
16373
5
exp cardiovascular disease/Multimedia(1325)
2892644
6
(heart disease* or heart failure or myocardial ischemia or coronary disease* or coronary artery disease* or myocardial infarction or
hypertension or high blood pressure).tw.Multimedia(11507)
822423
7
sickle cell.mp.Multimedia(745)
28624
8
exp chronic obstructive lung disease/Multimedia(3138)
68712
9
(obstructive lung disease* or obstructive pulmonary disease* or copd or asthma or bronchitis).tw.Multimedia(0)
206623
10
lung emphysema/ or emphysema/Multimedia(4273)
26391
11
emphysema.tw.Multimedia(27099)
22105
12
(cystic fibrosis or respiratory distress).mp.Multimedia(14905)
117951
13
(“degenerative disease/” and “exp cerebrovascular disease/”).mp. [mp=title, abstract, subject headings, heading word, drug trade name,
original title, device manufacturer, drug manufacturer, device trade name, keyword]Multimedia(1304)
0
14
(brain adj (disease* or damage* or injur*)).tw.Multimedia(69)
70039
15
(cerebrovascular or brain ischemia or cerebral infarction or carotid artery disease* or stroke or epilep* or seizure*).tw.Multimedia
(13394)
417021
16
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(neurodegenerative or Huntington* or Parkinson* or amyotrophic lateral sclerosis or multiple sclerosis or motor neuron disease).tw.
Multimedia(1200)
216767
17
(paralys* or quadriplegi* or tetraplegi* or paraplegi* or locked-in syndrome).tw.Multimedia(1768)
63002
18
((communication or learning or consciousness or perceptual or speech or voice or vision or hearing or psychomotor) adj disorder*).
tw.Multimedia(17946)
8558
19
(hearing loss or hearing aid* or deaf* or blind* or stutter*).tw.Multimedia(1599)
335955
20
down* syndrome.tw.Multimedia(32938)
20827
21
cerebral palsy.tw.Multimedia(16626)
18883
22
exp gastrointestinal diseases/Multimedia(13895)
63741
23
(gastroenter* or intestinal or bowel or colonic).tw.Multimedia(2692)
432591
24
kidney failure/Multimedia(7815)
99730
25
((renal or kidney) adj (failure* or insufficienc*)).tw.Multimedia(12246)
121257
26
exp diabetes mellitus/Multimedia(181990)
567599
27
(diabetes or diabetic*).tw.Multimedia(5638)
535423
28
exp nutritional disorder/Multimedia(6911)
536110
29
(underweight or malnutrition or malnourished or overweight or obes*).tw.Multimedia(6437)
272692
30
exp arthritis/Multimedia(39318)
329119
31
(arthritis or osteoarthritis or rheumati* or fibromyalgia).tw.Multimedia(3378)
244558
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32
((back or neck) adj pain).tw.Multimedia(541500)
43381
33
exp thyroid disease/Multimedia(1618)
171643
34
thyroid.tw.Multimedia(1088)
160664
35
exp hypersensitivity/Multimedia(2033)
459735
36
(hypersensitivit* or allerg* or intolerance or anaphyla*).mp.Multimedia(1245)
415671
37
exp neoplasm/Multimedia(121)
3319359
38
(cancer* or oncolog* or neoplasm* or carcinom* or tumo?r* or malignan* or leuk?emia).tw.Multimedia(585)
2861707
39
exp Human immunodeficiency virus infection/Multimedia(3406)
296469
40
(hiv infect* or hiv disease*).tw.Multimedia(93687)
94757
41
exp mental disease/Multimedia(1043)
1504884
42
((mental* or psychiatr* or psychological*) adj (ill* or disorder* or disease* or distress* or disab* or problem* or health* or patient* or
treatment)).tw.Multimedia(13857)
218664
43
((personality or mood or dysthymic or cognit* or anxiety or stress or eating or adjustment or reactive or somatoform or conversion
or behavior or perception or psycho* or impulse control or development* or attention deficit or hyperactivity or conduct or motor
skills or movement or tic or substance related) adj disorder*).tw.Multimedia(25768)
146882
44
(psychos#s or psychotic* or paranoi* or schizo* or neuros#s or neurotic* or delusion* or depression or depressive or bipolar or mania
or manic or obsessi* or compulsi* or panic or phobic or phobia or anorexia or bulimia or neurastheni* or dissociative or autis* or
Asperger* or Tourette or dyslex* or affective or borderline or narcissis* or suicid* or self injur* or self harm or adhd).tw.Multimedia
(99)
723209
45
(((substance or drug or alcohol) adj abuse) or “substance use” or “illegal drug use” or addict* or alcoholism or (problem* adj1 drinking)
).tw.Multimedia(315)
142653
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46
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25
or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45Multimedia
(108)
11136325
47
patient care planning/Multimedia(135)
26543
48
((care or action or treatment) adj plan*).tw.Multimedia(693)
61446
49
decision making/Multimedia(0)
133248
50
(patient* adj7 (decision* or choice*)).tw.Multimedia(0)
62144
51
patient preference/Multimedia(20)
3624
52
(patient* adj3 (preference* or priorit* or value*)).tw.Multimedia(0)
49062
53
(treatment adj (option* or choice*)).tw.Multimedia(89)
73666
54
(goal* adj2 (set* or plan*)).tw.Multimedia(0)
5819
55
(patient adj (cent*red or focus*ed or oriented)).tw.Multimedia(50298)
12376
56
personalized medicine/Multimedia(12880)
6173
57
(individuali#e? or individuali#ing or personali#e? or personali#ing or tailor or tailored or tailoring).tw.Multimedia(7255)
99601
58
47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57Multimedia(3116)
488955
59
cooperation/Multimedia(13470)
28755
60
(patient* adj3 (participat* or involv*)).tw.Multimedia(219)
73668
61
(negotiat* or agreement or concordan* or cooperat* or co-operat* or collaborat* or partnership).tw.Multimedia(0)
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478234
62
59 or 60 or 61Multimedia(0)
563462
63
58 and 62Multimedia(0)
31136
64
patient participation/Multimedia(0)
16290
65
(patient* adj2 (empower* or activat*)).tw.Multimedia(0)
7200
66
((shared or joint or informed or collaborative) adj2 decision making).tw.Multimedia(0)
4162
67
((involv* or participat*) adj3 (choice* or decision*)).tw.Multimedia(0)
8984
68
(decision adj (aid* or support or tool*)).tw.Multimedia(0)
10090
69
patient provider agreement*.tw.Multimedia(0)
9
70
decisional self efficacy.tw.Multimedia(0)
8
71
(personal budget* or direct payment*).tw.Multimedia(0)
171
72
(record access or patient held record*).tw.Multimedia(0)
119
73
((self management or self care) adj2 support*).tw.Multimedia(0)
1035
74
or/63-73Multimedia(0)
72116
75
46 and 74Multimedia(0)
38039
76
randomised controlled trial/Multimedia(0)
355130
77
controlled clinical trial/Multimedia(0)
403750
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78
single blind procedure/ or double blind procedure/Multimedia(0)
136026
79
crossover procedure/Multimedia(0)
37988
80
random*.tw.Multimedia(0)
845821
81
placebo*.tw.Multimedia(0)
198596
82
((singl* or doubl*) adj (blind* or mask*)).tw.Multimedia(0)
161143
83
(crossover or cross over or factorial* or latin square).tw.Multimedia(0)
93133
84
(assign* or allocat* or volunteer*).tw.Multimedia(0)
481400
85
or/76-84Multimedia(0)
1484254
86
75 and 85Multimedia(0)
6811
PsycINFO:
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1chronic.mp.Multimedia(41469)
94544
2
((persistent or long* term or ongoing or degenerative) adj3 (disease* or ill* or condition* or insufficienc* or disorder*)).tw.Multimedia
(964)
5920
3
long term care/Multimedia(791)
3027
4
long* term care.tw.Multimedia(42583)
4722
5
exp Cardiovascular Disorders/Multimedia(1325)
39516
6
(heart disease* or heart failure or myocardial ischemia or coronary disease* or coronary artery disease* or myocardial infarction or
hypertension or high blood pressure).tw.Multimedia(11507)
21137
7
sickle cell.mp.Multimedia(745)
982
8
exp chronic obstructive pulmonary disease/Multimedia(3138)
673
9
(obstructive lung disease* or obstructive pulmonary disease* or copd or asthma or bronchitis).tw.Multimedia(4273)
6270
10
emphysema.tw.Multimedia(27099)
187
11
(cystic fibrosis or respiratory distress).mp.Multimedia(14905)
1534
12
exp nervous system disorders/Multimedia(1304)
192500
13
(brain adj (disease* or damage* or injur*)).tw.Multimedia(69)
25607
14
(cerebrovascular or brain ischemia or cerebral infarction or carotid artery disease* or stroke or epilep* or seizure*).tw.Multimedia
(13394)
53354
15
(neurodegenerative or Huntington* or Parkinson* or amyotrophic lateral sclerosis or multiple sclerosis or motor neuron disease).tw.
Multimedia(1200)
38227
16
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(paralys* or quadriplegi* or tetraplegi* or paraplegi* or locked-in syndrome).tw.Multimedia(1768)
3518
17
((communication or learning or consciousness or perceptual or speech or voice or vision or hearing or psychomotor) adj disorder*).
tw.Multimedia(17946)
5077
18
(hearing loss or hearing aid* or deaf* or blind* or stutter*).tw.Multimedia(1599)
54139
19
down* syndrome.tw.Multimedia(32938)
5746
20
cerebral palsy.tw.Multimedia(16626)
4063
21
exp Gastrointestinal Disorders/Multimedia(13895)
5340
22
(gastroenter* or intestinal or bowel or colonic).tw.Multimedia(2692)
4580
23
kidney diseases/Multimedia(7815)
1325
24
((renal or kidney) adj (failure* or insufficienc*)).tw.Multimedia(12246)
954
25
diabetes mellitus/Multimedia(181990)
3480
26
(diabetes or diabetic*).tw.Multimedia(5638)
17556
27
(underweight or malnutrition or malnourished or overweight or obes*).mp.Multimedia(6911)
26822
28
exp arthritis/Multimedia(6437)
2959
29
(arthritis or osteoarthritis or rheumati* or fibromyalgia).tw.Multimedia(39318)
6754
30
((back or neck) adj pain).tw.Multimedia(3378)
4155
31
exp Thyroid Disorders/Multimedia(537836)
1083
32
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thyroid.tw.Multimedia(1618)
3066
33
exp allergic disorders/Multimedia(1088)
722
34
(hypersensitivit* or allerg* or intolerance or anaphyla*).mp.Multimedia(2033)
6828
35
exp Neoplasms/Multimedia(1245)
31715
36
(cancer* or oncolog* or neoplasm* or carcinom* or tumo?r* or malignan* or leuk?emia).tw.Multimedia(121)
48707
37
exp HIV/Multimedia(585)
29689
38
(hiv infect* or hiv disease*).tw.Multimedia(3406)
11515
39
exp mental disorders/ or exp behavior disorders/Multimedia(100174)
508536
40
((mental* or psychiatr* or psychological*) adj (ill* or disorder* or disease* or distress* or disab* or problem* or health* or patient* or
treatment)).tw.Multimedia(1043)
224025
41
((personality or mood or dysthymic or cognit* or anxiety or stress or eating or adjustment or reactive or somatoform or conversion
or behavior or perception or psycho* or impulse control or development* or attention deficit or hyperactivity or conduct or motor
skills or movement or tic or substance related) adj disorder*).tw.Multimedia(13857)
133493
42
(psychos#s or psychotic* or paranoi* or schizo* or neuros#s or neurotic* or delusion* or depression or depressive or bipolar or mania
or manic or obsessi* or compulsi* or panic or phobic or phobia or anorexia or bulimia or neurastheni* or dissociative or autis* or
Asperger* or Tourette or dyslex* or affective or borderline or narcissis* or suicid* or self injur* or self harm or adhd).tw.Multimedia
(7953)
485242
43
(((substance or drug or alcohol) adj abuse) or “substance use” or “illegal drug use” or addict* or alcoholism or (problem* adj1 drinking)
).tw.Multimedia(205)
97963
44
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or
25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43Multimedia(315)
1125312
45
exp treatment planning/Multimedia(108)
3766
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46
((care or action or treatment) adj plan*).tw.Multimedia(135)
10862
47
decision making/ or choice behavior/Multimedia(693)
54275
48
(patient* adj7 (decision* or choice*)).tw.Multimedia(0)
8370
49
Preferences/Multimedia(0)
13343
50
(patient* adj3 (preference* or priorit* or value*)).tw.Multimedia(20)
3968
51
(treatment adj (option* or choice*)).tw.Multimedia(0)
6524
52
goals/ or goal setting/Multimedia(89)
10517
53
(goal* adj2 (set* or plan*)).tw.Multimedia(0)
6892
54
(patient adj (cent*red or focus*ed or oriented)).tw.Multimedia(57)
2779
55
(individuali#e? or individuali#ing or personali#e? or personali#ing or tailor or tailored or tailoring).tw.Multimedia(0)
25208
56
45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55Multimedia(0)
130577
57
client centered therapy/ or cooperation/Multimedia(0)
13168
58
(patient* adj3 (participat* or involv*)).tw.Multimedia(0)
8767
59
(negotiat* or agreement or concordan* or cooperat* or co-operat* or collaborat* or partnership).tw.Multimedia(0)
129514
60
57 or 58 or 59Multimedia(0)
140373
61
56 and 60Multimedia(0)
10549
62
125Personalised care planning for adults with chronic or long-term health conditions (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
client participation/Multimedia(0)
1229
63
(patient* adj2 (empower* or activat*)).tw.Multimedia(0)
1107
64
((shared or joint or informed or collaborative) adj2 decision making).tw.Multimedia(0)
1887
65
((involv* or participat*) adj3 (choice* or decision*)).tw.Multimedia(0)
7235
66
(decision adj (aid* or support or tool*)).tw.Multimedia(0)
2979
67
patient provider agreement*.tw.Multimedia(0)
6
68
decisional self efficacy.tw.Multimedia(0)
5
69
(personal budget* or direct payment*).tw.Multimedia(0)
98
70
(record access or patient held record*).tw.Multimedia(0)
23
71
((self management or self care) adj2 support*).tw.Multimedia(0)
403
72
or/61-71Multimedia(0)
23163
73
44 and 72Multimedia(0)
7590
74
random*.ti,ab,hw,id.Multimedia(0)
117493
75
trial*.ti,ab,hw,id.Multimedia(0)
107701
76
controlled stud*.ti,ab,hw,id.Multimedia(0)
8451
77
placebo*.ti,ab,hw,id.Multimedia(0)
29001
78
((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).ti,ab,hw,id.Multimedia(0)
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20444
79
(cross over or crossover or factorial* or latin square).ti,ab,hw,id.Multimedia(0)
19231
80
(assign* or allocat* or volunteer*).ti,ab,hw,id.Multimedia(0)
106789
81
treatment effectiveness evaluation/Multimedia(0)
14681
82
mental health program evaluation/Multimedia(0)
1823
83
exp experimental design/Multimedia(0)
45559
84
“2000”.md.Multimedia(0)
24302
85
or/74-84Multimedia(0)
341836
86
73 and 85Multimedia(0)
1526
Trial registers:
Clinicaltrials.gov http://clinicaltrials.gov - 21st June 2013
Main search: De-duplicated results = 508
PCP search: results = 735
The following terms were used in the Advanced search - Intervention search box - 8 separate searches.
“personal care plan” OR “personal care planning” OR “personal treatment plan” OR “personal treatment planning”
(“decision making” OR choice OR choices OR care) AND (“patient involvement” OR “patient participation” OR “patient empower-
ment”)
“shared decision making” OR “informed decision making” OR “joint decision making” OR “collaborative decision making”
“patient provider agreement” OR “patient provider agreements” OR “decisional self efficacy” OR “personal budget” OR “personal
budget” OR “direct payment” OR “direct payments” OR “record access” OR “patient held record” OR “patient held records”
(“self management” OR “self care”) AND support
(“patient centered care” OR “patient centred care” OR “patient focused care” OR “patient oriented care”) AND (participation OR
involvement)
(“individualised care” OR “individualized care” OR “individualised medicine” OR “individualized medicine” OR “tailored care” OR
“personalized care” OR “personalised care”) AND (participation OR involvement)
“decision aid” OR decision aids” OR “decision support” OR “decision tool” OR “decision tools” (This search string gives loads of results - you
might want to exclude from the search)
WHO ICTRP http://apps.who.int/trialsearch/ - 21st June 2013
Main search: De-duplicated results = 106
PCP search: Deduplicated results = 104
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“individualised care” OR “individualized care” OR “individualised medicine” OR “individualized medicine” OR “tailored care” OR
“personalized care” OR “personalised care”
personal care plan OR personal care planning OR personal treatment plan OR personal treatment planning
shared decision making OR informed decision making OR “joint decision making” OR “collaborative decision making”
“patient provider agreement” OR “patient provider agreements” OR “decisional self efficacy” OR “personal budget” OR “personal
budget” OR “direct payment” OR “direct payments” OR “record access” OR “patient held record” OR “patient held records”
“patient centered care” OR “patient centred care” OR “patient focused care” OR “patient oriented care”
self care support OR self management support
“decision aid” OR decision aids” OR “decision support” OR “decision tool” OR “decision tools”
WH A T ’ S N E W
Last assessed as up-to-date: 1 January 2014.
Date Event Description
23 March 2015 Amended minor correction to author affiliation
C O N T R I B U T I O N S O F A U T H O R S
Angela Coulter conceived the review and drafted the protocol. Abi Eccles led the design of the search strategy and organised the
consumer involvement. Sara Ryan, Abi Eccles and Angela Coulter selected studies for inclusion. Sara Ryan and Angela Coulter extracted
the data. Rafael Perera led the statistical analysis. All authors contributed to the study design and analysis.
D E C L A R A T I O N S O F I N T E R E S T
Angela Coulter: in addition to her part-time post at the University of Oxford, Angela acts as a paid consultant for the InformedMedical
Decisions Foundation, a division of Healthwise, a global not-for-profit provider of health information.
Vikki Entwistle: none known
Abi Eccles: none known
Sara Ryan: none known
Sasha Shepperd: none known
Rafael Perera: none known
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S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Department of Health Policy Research Programme, UK.
This is an independent report commissioned and funded by the Policy Research Programme in the Department of Health, England.
The views expressed are not necessarily those of the Department.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Some ambiguity in our inclusion/exclusion criteria was noted in respect of one trial (Kennedy 2013). This was designed as a trial of
personalised care planning and self-management support, but in the event participating clinicians did not change their practice which
remained the same in both the intervention group and the usual care group (Kennedy 2014). We therefore included this study in the
review, but excluded it from themeta-analysis on the grounds that it was not a fair test of personalised care planning. Future iterations of
this review should explicitly state that studies will be excluded if there is evidence that no change in practice (and hence no personalised
care planning) actually occurred.
We changed the method used for dealing with missing data from that outlined in the protocol because we needed to impute standard
deviations of change in some cases. Also, we originally planned to use a random-effects meta-analysis, but in the event this was not
appropriate because of the small number of studies, so we used fixed-effect instead.
There were too few studies to group outcomes according to length of follow-up period as originally intended, so we took the final
measurement in each case. We pooled outcomes if we felt the measures used were comparable, rather than by any other criterion.
We added additional subgroup analyses to explore key characteristics (intensity, integration) once we had seen what the complex
interventions actually involved.
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